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Abstract
The development of a new iminium-activation approach towards asymmetric
organic catalysis is described.  This strategy has been successfully applied to a 1,3-
dipolar cycloaddition reaction to produce the first enantioselective catalytic [3+2]
cycloaddition between nitrones and a,b-unsaturated aldehydes.  This methodology
highlights the ability of this new organocatalytic strategy to access chemical
transformations not attainable though traditional Lewis acid catalysis.
We have also applied this iminium-activation strategy towards the successful
development of an enantioselective organocatalytic intramolecular Diels-Alder (IMDA)
reaction.  This variant of the IMDA reaction is capable of accessing a range of
stereochemically complex [4.3.0] and [4.4.0] ring systems in good yields and with
excellent selectivities.  Furthermore, we have successfully developed the first asymmetric
Type II intramolecular Diels-Alder cyclization.  Finally, the utility of this methodology
was demonstrated in the efficient total synthesis of (–)-solanapyrone D where an
asymmetric organocatalytic IMDA reaction comprised the pivotal bond construction.
Progress has been made towards the total synthesis of guanacastepene A.
Significant efforts were directed towards a pursuing a 3-component coupling/
intramolecular Diels-Alder approach towards the natural product. IMDA precursors were
synthesized in an efficient and convergent manner.  It was found, however, that these
substrates were unable to undergo the desired cyclization.  By modifying our synthetic
approach towards guanacastepene A, we found that the stereochemically complex
cyclohexene portion of the natural product could be synthesized via an intermolecular
Diels-Alder.  Therefore recent efforts have been directed towards the pursuing a more
convergent intermolecular Diels-Alder/ conjugate addition/ Dieckman condensation
strategy towards guanacastepene A.
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1Chapter 1
New Strategies for Organic Catalysis
I. Background
Over the last 50 years, great strides have been made in the area of metal-based
enantioselective catalysis, which in turn has provided the synthetic chemist with a
wealth of new asymmetric oxidation, reduction, p-bond activation and Lewis acid
catalyzed methodology.1 However, there are relatively few examples in the literature
where purely organic molecules are used as asymmetric reaction catalysts.  This is true
despite the potential economic and practical benefits that organic catalysts offer. In
contrast to their metal-based counterparts, organic chemicals are generally insensitive to
oxygen and moisture and thus do not require the use of special, expensive air- and
moisture-free experimental techniques. Furthermore, nature provides an abundance of
organic compounds in an enantiopure form (e.g., a-amino acids, a-hydroxy acids,
carbohydrates), making chiral organic catalysts easily accessible from the natural chiral
pool.   As a consequence, using simple organic catalysts should be generally
inexpensive, operationally easy, and time, and energy, efficient.
Although there is a scarcity of chemical literature on the topic of asymmetric
organic catalysis (organocatalysis), relative to its metal-based counterpart, the benefits
of organocatalysis have not been lost on the chemical community.  Over the last 40
years, a number of important contributions have been published, demonstrating the
value of non-metal based catalysis.
Interestingly, two of the earliest reported asymmetric catalytic reactions
involved the use of organic catalyst systems.  In 1960, Pracejus published seminal work
on the development of an asymmetric catalytic ketene methanolysis reaction.2   In the
presence of 1 mol% of catalyst 3, the methanolysis of phenyl-a-o-trimethyleneketene
(1) produced methyl ester 2 in 76% ee (eq. 1).  About 10 years later, two research
groups independently showed that L-proline 4 catalyzed the asymmetric Robinson
2annulation of the symmetrical triketone 5 to afford the corresponding ketol (6) with
good levels of enantiocontrol (eq. 2).3  This reaction, known as the Hajos-Parrish-Eder-
Sauer-Wiechert reaction, remained relatively under-explored for the next 25 years until
List and coworkers were able to demonstrate the first intermolecular variant of this
aldol reaction in 2000.4
Some of the most notable examples of asymmetric organocatalytic
transformations in recent years include seminal contributions by O’Donnell and Corey
in the area of phase transfer catalysis.5  Corey and coworkers have found that optimized
quinuclidine catalyst 7 can effect the alkylation of ketone 8 to produce the protected a-
amino ester 9 with excellent selectivity (eq. 3). In an extension of this work, he later
reported the use of catalyst 7  in the epoxidation of a,b-unsaturated aryl ketones,
producing epoxides with ee’s greater than 90%.
One of the most general and successful approaches to enantioselective acyl
transfer is the alcohol desymmetrization of Fu and coworkers (eq. 4).6  Although these
structures do contain a ferrocenyl backbone, the chemistry occurs entirely on the
nitrogen of the DMAP ring, and thus the catalytically active portion of the molecule is
purely organic in nature.  Miller and coworkers have also pursued the use of minimal
peptides as enzyme mimics for asymmetric acyl transfer processes.7
3Other notable examples include development of organic catalyst systems by
Jacobsen and Corey that are capable of facilitating the asymmetric hydrocyanation of
imines.8  Whereas Jacobsen uses a high-throughput combinatorial method to identify
useful peptide-like catalysts (eq. 5a), such as 13a, Corey uses a C2 symmetric guanidine
catalyst (13b) (eq. 5b).  Notably, both catalyst methods generate hydrocyanation
products with good to excellent ee’s.
4One of the most widely recognized enantioselective organic catalyst systems is
that developed Shi, Yang, and Denmark for the epoxidation of olefins.9   These systems
use chiral ketone catalysts, such as 18, to mediate the asymmetric transfer of oxygen
from oxone to unfunctionalized olefins with excellent levels of selectivity (eq. 6).10
The research outlined above represents some of the most important contributions
put forth over the last several decades to advance the field of asymmetric synthesis.
However, these examples also highlight an important limitation that organocatalysis has
suffered from since its inception.  In general, the activation mechanism by which most
organic catalysts operate was applicable to only a single transformation, and hence a
new catalyst had to be developed for each new reaction type investigated. Furthermore,
there were few general activation mechanisms known to be amenable to organic
catalysis, thus making it difficult to devise catalysts systems that could be applied to a
range of chemical transformations.11  This was in sharp contrast to the area of metal-
mediated asymmetric catalysis, which has shown that metal complexes derived from
BINOL, BINAP, Salen, and bisoxazoline ligand systems can catalyze a broad range of
transformations with varying activation pathways.12  Therefore, we became interested in
developing a new general strategy for organic catalysis that would allow chiral organic
compounds to serve as reaction catalysts for a variety of chemical transformations.
II.  Iminium-Activation Approach to Enantioselective Organocatalysis
This new approach was founded on principles and concepts borrowed from
asymmetric Lewis acid catalysis, a field that has been proven to be generally applicable
to a range of chemical reactions.  In considering a general Lewis acid catalyzed process,
such as the Diels-Alder reaction shown in Scheme 1, it is apparent that there were two
key features to the mechanism of this reaction that make it so successful.  First, Lewis
acid coordination of the substrate activates it through LUMO-lowering electronics
towards reaction with another reactant partner.  The resultant rate acceleration ensures
the participation of the chiral Lewis acid in the bond-forming transition state, therefore
promoting the formation of enantioenriched products.  Secondly, the kinetic lability of
5the product-Lewis acid bond permits the catalyst to turn over upon completion of the
reaction, therefore allowing it to go on and catalyze another Diels-Alder reaction.  This
feature is key to creating a catalyst system that employs substoichiometric amounts of
the chiral catalyst.
We speculated that the equilibrium dynamics and p-orbital electronics of the
Lewis acid system (eq. 7) could be emulated in a carbogenic system though the
reversible formation of iminium ions from a,b-unsaturated aldehydes and chiral
secondary amines (eq. 8).  Although, to our knowledge, this iminiuim-catalysis strategy
had not been previously documented prior to our studies, this hypothesis was supported
by established methodological studies of other research groups.  Work published by
Jung and coworkers in 1989 on the Diels-Alder reaction revealed that a,b-unsaturuated
iminium ions are significantly more reactive as dienophiles than a,b-unsaturated
aldehydes, acid chlorides, ketones, nitriles, or esters.13  This suggested that formation of
the chiral iminium would provide enough LUMO-lowering activation to achieve the
needed rate accleration for the enantioselective bond-forming step.  Futhermore, Grieco
and coworkers had demonstrated that transiently generated iminium ions will undergo
Aza-Diels-Alder reactions under aqueous conditions.14 This provided good precedent
for the ability of electron-rich substrates to undergo a selective reaction with transiently
generated iminiums in the presence of other aldehydes.
6This new iminium activation strategy was attractive from the standpoint that
simple chiral amines might be able to function as asymmetric catalysts (Scheme 2).
Furthermore, since this approach was based on general principles borrowed from Lewis
acid catalysis, this methodology could potentially be applied to a wide range of
chemical transformations that traditionally utilize metal catalysts.
The proposed iminium-activation catalytic cycle for a general reaction (shown
here for the specific case of the Diels-Alder) would begin with the condensation of the
secondary amine catalyst (19) with an a,b-unsaturated aldehyde (20) to produce the
iminium species 21.  This LUMO-lowered intermediate is then activated to undergo a
cyclization reaction with cyclopentadiene to generate the iminium-bound product 22.
Hydrolysis of 22 liberates the product 23 while regenerating the catalyst (19) so that it
can participate in another reaction cycle.
The following two chapters detail our efforts towards demonstrating the utility
of this new methodology.  Chapter Two discusses the successful development of an
asymmetric organocatalytic variant of a 1,3-dipolar cycloaddition that had been
traditionally inaccessible using metal catalysts.  Chapter Three details our elaboration of
a general organocatalytic intramolecular Diels-Alder reaction, and the application of
this methodology toward the total synthesis of the natural product solanapyrone D.
These organocatalytic transformations illustrate the ability of this methodology to
access stereochemically complex products in high enantiopurity.
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9Chapter 2
Enantioselective Organic
Catalysis of the 1,3-Dipolar Cycloaddition
of Nitrones and a, b- Unsaturated Aldehydes
I. Introduction
Chapter 1 of this thesis detailed a new approach towards organic catalysis, which
we felt could be applicable to a diverse spectrum of chemical transformations.  This new
iminium-activation strategy was first tested on the bimolecular Diels-Alder reaction by
Kateri Ahrendt; preliminary studies produced promising results that indicated that this
was indeed a viable approach (vide infra).  Therefore we immediately became interested
in extending this methodology to other chemical processes, especially those inaccessible
via traditional Lewis acid catalysis. In this context, the cycloaddition reaction between
nitrones and a,b-unsaturated aldehydes was chosen for study and this chapter details our
efforts towards the successful development of the first asymmetric, organocatalytic 1,3-
dipolar cycloaddition reaction (eq. 1).
A. Background
A wealth of literature attests to the synthetic utility of the 1,3-dipolar
cycloaddition reaction, and amongst the various dipoles studied in this process, nitrones
are arguably one of the most useful.1  The 1,3-dipolar cycloaddition reaction of alkenes 1
with nitrones 2 is one of the most efficient methods for generating isoxazolidine ring
systems 3.  In one step, this reaction can provide access to up to three contiguous
stereocenters in a heterocyclic framework, all from relatively simple starting materials.2
Furthermore, the highly ordered transition state of this reaction often allows the regio-
and stereochemical preference of a given nitrone to be predicted.  The isoxazolidines 3
10
formed in these reactions have proven to be versatile synthetic building blocks, due
largely to the ease with which they can be opened to form chiral 1,3-amino alcohols (eq.
2).  This cycloaddition/reductive cleavage route has been extensively used to access a
range of biologically important compounds, such as nucleosides, b-amino acids,
alkaloids, amino sugars, and b-lactams.
Because three chiral centers are formed simultaneously in the nitrone reaction,
there is a potential to form up to 8 different isoxazolidine isomers.  Coercing the reaction
to produce only one of the 8 possible isomers requires the control of three different
selectivity elements: regioselectivity, diastereoselectivity, and enantioselectivity.
The reaction of a nitrone and a mono-substituted alkene produces two possible
regioisomers: a 4-substituted isoxazolidine and a 5-substituted isoxazolidine (Figure 1).
Regioselectivity is controlled by both steric and electronic factors, with strong electronics
often taking precedence over steric control elements.  The cycloaddition of electron-rich
or electron-neutral alkenes with nitrones produces mainly 5-substituted isoxazolidine
products for both steric and electronic reasons.  These so-called “inverse-electron
demand” cycloadditions are governed primarily by LUMOdipole–HOMOdipolarophile
interactions.   As Figure 1 illustrates, the LUMOdipole has the largest coefficient at the
carbon atom of the nitrone and the HOMOdipolarophile has the largest amplitude at the b-
carbon of the alkene; thus the two components combine to favor formation of the 5-
substituted cycloadduct.  This phenomenon is reinforced by steric factors, since the
sterically demanding end of the alkene is being placed away from the more bulky C-
substituent on the nitrone.
In contrast, the cycloaddition of nitrones and electron-deficient alkenes is
primarily controlled by HOMOdipole–LUMOdipolarophile interactions.  Since the largest orbital
coefficients are on the oxygen atom of the HOMOdipole and the b -carbon on the
LUMOdipolarophile, these “normal electron demand” cycloadditions electronically favor
formation of the 4-substituted product.  These interactions are enhanced when a Lewis
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Acid is used to activate the alkene component of the reaction, thus creating an even larger
electronic bias for forming the 4-substituted cycloadduct.  When terminal alkenes are
used, steric factors oppose the electronic bias of the reaction, which frequently results in
the formation of a mixture of regioisomers in the non-Lewis acid catalyzed reaction.
However, in the reaction of nitrones with 1,2-disubstituted electron deficient alkenes, the
steric factor is eliminated, thus resulting in the FMO-controlled formation of the 4-EWG-
substituted isomer as the sole product.
The formation of diastereomers also has to be considered in the 1,3-dipolar
cycloaddition reaction of nitrones and alkenes.  In these reactions, the nitrone can
approach the alkene in an endo or exo fashion, giving rise to two different diastereomers.
This endo/exo nomenclature is borrowed from the Diels-Alder reaction, where the endo
isomer arises though a transition state that is stabilized by secondary p-orbital
interactions (Figure 2).  Similarly, the endo isoxazolidine isomer is formed in a normal
electron demand cycloaddition reaction though a transition state where the nitrogen atom
of the nitrone is oriented towards the electron withdrawing group on the alkene.
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However the actual interaction between the N-nitrone pz orbital and the vicinal pz orbital
on the alkene is small, and thus this interaction contributes very little to electronically
stabilizing the endo transition state.  The endo/exo selectivity in the 1,3-dipolar
cycloaddition reaction is therefore largely controlled by the structure of the catalyst and
substrates.
When dealing with achiral starting materials, the issue of enantioselectivity must
also be considered.   The development and application of catalytic asymmetric 1,3-
dipolar cycloaddition reactions is a relatively new area.   In contrast to its Diels-Alder
counterpart, which has evolved since the mid-1980’s, the use of enantioselective catalysts
in asymmetric 1,3-dipolar cycloadditions remained almost completely unexplored until
1993.  Specifically, the asymmetric catalytic [3+2] cycloaddition of nitrones and alkenes
has received considerable attention over the last 5 to 6 years; some of these advancements
will be covered in the following section.
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B. Asymmetric 1,3-Dipolar Cycloadditions of Nitrones and Alkenes
The diastereoselective 1,3-dipolar cycloaddition reaction of nitrones and alkenes
is the most widely used method of inducing asymmetry in these reactions.  The most
common diastereoselective reactions are those involving the use of chiral nitrones, chiral
dipolarophiles, or both (which is usually in the form of intramolecular cyclizations) to
relay stereochemistry to the newly formed stereocenters on the isoxazolidine ring system.
A variety of removable chiral auxiliaries have also been utilized for the asymmetric
synthesis of isoxazolidines.  In these cases, the auxiliary is most frequently attached to
the dipolarophile in the form of an unsaturated ester or amide; however there are also a
few cases where it is tethered from the dipole. The literature on diastereoselective 1,3-
dipolar cycloadditions is vast, and since there have been excellent reviews published on
these areas, they should be referred to for further details on these topics.2-4
The field of asymmetric catalysis of 1,3-dipolar cycloaddition reactions involving
nitrones is relatively young.  The first study on enantioselective, catalytic, normal
electron-demand5 1,3-dipolar cycloaddition of nitrones and alkenes was published in
1994 by Jørgensen and coworkers, in which the authors examined a series of chiral TiCl2-
TADDOLates in the reaction of 3-N-alk-2-enoyloxazolidinones 5 with nitrones 6 (eq. 3).6
Ultimately they found that catalyst 7a was most effective, catalyzing the reaction of 5 and
6 to preferentially form exo cycloadduct 8 with selectivities that varied from poor to fair
(1:1 to 9:1 exo/endo, 10-60% ee).
The authors were later able to improve on these results by switching to the more
sterically demanding catalyst 7b.7  Treatment of alkenes 5 with N-aryl nitrones 6 in the
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presence of 50 mol% 7b reversed the diastereoselectivity of the reaction, providing endo
products with good selectivities (eq. 4).  This methodology was also extended to include
acrylate derivatives.8  Reaction of acrylimides 5  (R1=H) with nitrones 6 produced
isoxazolidine cycloadducts with high endo  selectivity, but only moderate
enantioselectivities (48-70% ee).  Although selectivities using these Ti-TADDOLate
catalysts were relatively modest, these studies represent the first foray into the
development of reactions of these types and helped to establish an interest in the
development of asymmetric catalytic variants.
The Jørgensen group has also published on the use of chiral bisoxazoline (BOX)
magnesium complexes as catalysts for the 1,3-dipolar cycloaddition of nitrones and
alkenes (eq. 5).  In the presence of 4Å molecular sieves (MS), magnesium complex 13
was found to serve as an effective catalyst in the reaction of oxazolidinone 11 with
nitrone 10, catalyzing the reaction with 73:27 endo/exo selectivity and 82% ee (endo).9
Interestingly, these reactions exhibited the reverse mode of enantioselectivity when they
were run in the absence of 4Å MS (Table 1).  In fact, these selectivities appeared to be
dependent on the amount of 4Å MS used since reactions run in the presence of 50 mg of
4Å MS produced cycloadducts with ee’s nearly two times higher than those run with 10
mg of 4Å MS.  Experimental results suggested that the sieves were not simply serving as
a dehydrating agent since reactions run in the presence of magnesium sulfate were
ineffective as reversing selectivity.  Based on these results, the authors speculated that the
MS are integrally involved in the catalytic cycle, potentially through the binding of the
magnesium (II)-(R,R)-bisoxazoline alkenoyloxazolidinone intermediate to the sieve’s
surface.
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In 1997, two independent research groups reported the development of two
different chiral ytterbium catalysts for the asymmetric 1,3-dipolar cycloaddition reaction.
The Jørgensen group (eq. 6a) reported the use of Yb(OTf)2-pyridine-bisoxazoline
complex 17 in the reaction of nitrones 14 with alkenoyloxazolidines  15 to preferentially
produce endo cycloadducts with modest enantioselectivities (up to 73% ee).10  Kobayashi
and coworkers separately described a 1,3-dipolar cycloaddition catalyzed by 20 mol% 18
in the presence of the achiral tertiary amine 19.11  Reaction of 14 with 15 (eq. 6b)
produced isoxazolidine products with high endo  selectivities and modest
enantioselectivities (up to 78% ee).  It was found, however, that when the reaction was
run with 20 mol% 18 and 40 mol% of chiral amine 20, the enantioselectivities of the
reaction were significantly increased; diastereoselectivities in this reaction for the
substrates studied were generally high (c.a. 99:1 endo:exo) and enantioselectivities
ranged from 79-96% ee.12  Interestingly, similar to the Mg(II)(BOX) catalyzed reactions,
the absolute stereoselectivity of this reaction was also found to be influenced by the 4Å
MS.  The reaction catalyzed by complex 18 with 20 (eq. 6c) as an additive afforded endo-
16 (R=Bn, R1=Me) in 96% ee in the presence of 4Å MS; in the absence of 4Å MS the
opposite enantiomer was obtained in 50% ee.13
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Furukawa and coworkers have recently reported the successful use of palladium, a
relatively soft metal, in asymmetric catalytic 1,3-dipolar cycloadditions between nitrones
14 and alkene 21.  Catalysis of the cycloaddition using complex 23 generally produced
mixtures of endo-22 and exo-22, each in moderate to good enantioselectivities (54-91%
ee endo, 34-93% ee exo). Transition state model 24 was proposed to account for the
observed absolute enantioselectivities.  In the enantiodetermining intermediate 24, the
BINAP ligand and crotonoyl oxazolidinone substrate are arranged in a square planar
fashion around the metal center; approach of the nitrone from the less sterically
demanding si face of the alkene provides the observed product 22.
17
Finally, Kanemasa and coworkers have reported the successful application of
their dibenzofuranyl 2,2’-bisoxazoline (DBFOX) ligand to the 1,3-dipolar cycloaddition
reaction.14  Treatment of aryl and alkyl nitrones 25 with crotonoyloxazolidinone 21 in the
presence of 4Å MS and aqua Ni-DBFOX complex 27 produces isoxazolidines 26 with
excellent diastereo- and enantiocontrol (eq. 7).  Molecular sieves also had a marked effect
on the diastereo- and enantioselectivities in this reaction.  In contrast to the Mg(II)(BOX)
and Yb(BINOL) catalyst systems, experiments suggested that the MS were serving
simply as a dehydrating agent in this case.   The authors proposed that the coordination of
water to the Ni(DBFOX) complex forces the ligands to orient around the metal in an
octahedral geometry.  This octahedral transition state structure provides inferior p-facial
coverage of the crotonoyloxazolidinone olefin than does the dehydrated trigonal
bipyramidal transition state structure, thereby leading to poorer selectivities in the
absence of 4Å MS.  This catalyst system was one of the most selective metal catalyst to
date for normal electron-demand 1,3-dipolar cycloaddition reaction between nitrones and
alkenes.
C.  Organocatalysis vs. metal catalysis of 1,3-dipolar cycloadditions
As the examples in the previous section illustrate, significant advances have been
made over the last 10 years in the field of asymmetric catalytic 1,3-dipolar cycloaddition
reactions of nitrones and electron-deficient alkenes.  However there are noticeable
shortcomings in these systems that we felt an organocatalytic variant of this reaction
could address. Prior to the publication of the organocatalytic work described below,15 all
normal electron-demand enantioselective catalytic 1,3-dipolar cycloadditions required the
use of an achiral oxazolidinone auxiliary.  This is because monodentate a,b-unsaturated
carbonyl compounds, such as aldehydes and ketones, are poor substrates for metal
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catalyzed nitrone cycloadditions, presumably due to the preferential coordination of
Lewis acids to nitrone oxides (28) over monodentate carbonyls (29) (Figure 4).  In order
to activate an a,b-unsaturated carbonyl compound towards cycloaddition, the equilibrium
must be shifted towards the desired Lewis acid-carbonyl complex 29.  Furthermore, any
of the Lewis acid-carbonyl adduct 29 that might be formed possesses poor organizational
control, since there is potential for free rotation around the Lewis acid-carbonyl bond
(generating 30).  This lack of structural rigidity generally leads to poor enantiocontrol.
In all the metal catalyzed systems discussed in the previous section, this
equilibrium shift was accomplished though the use of bidentate chelating oxazolidinones
31 with metal catalysts that favor this type of bidentate coordination.  The resultant
complex 32 contains the aforementioned requisite structural rigidity that 29/30 does not,
therefore potentially allowing for good levels of enantiocontrol.
A new asymmetric organocatalytic variant of the nitrone cycloaddition reaction
was chosen for development because we felt that our new technology would be able to
address some of the shortcomings of the metal mediated processes.  Although these
oxazolidinone auxiliaries can be used to overcome the reactivity and selectivity issues
discussed above, they have to be removed with additional steps subsequent to the
cycloaddition reaction.  An organocatalytic variant of this reaction would allow for direct
access to a desirable aldehyde functionality, thereby obviating the need for extra steps
following the completion of the reaction.   Furthermore, since the mechanism of
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iminium-activation differs from metal-mediated catalysis, our organocatalysis strategy
could allow us to overcome functional-group compatibility issues associated with metal
catalysis.
In contrast to metal catalysts, we expected our chiral amine catalysts to be inert to
nitrone association, thereby enabling a,b-unsaturated aldehydes to undergo iminium
activation and subsequent [3+2] cycloaddition (eq. 8).  Additionally, since the amine
catalyst is bound to the alkene substrate though a rigid double bond, iminium
intermediate (eq. 8, boxed) would be expected to possess the structural rigidity necessary
to enforce organizational control and provide cycloadducts with high enantioselectivities.
Thus, we became interested in developing an organocatalyic variant of the nitrone
cycloaddition reaction. This methodology would not only extend the scope of the reaction
by providing access to the first enantioselective catalytic 1,3-dipolar cycloaddition
between nitrones and a,b-unsaturated aldehydes, but would also demonstrate the broad
utility of our new organocatalytic strategy.
It should be noted that subsequent to the publication of this work, three different
groups independently reported the development of four metal-based catalyst systems
capable of catalyzing the [3+2] cycloaddition between nitrones and a,b-unsaturated
aldehydes with varying degrees of success.  Kanemasa and coworkers have used pinhole
aluminum catalysts16 and chiral DBFOX/ Ph-Zn or Ni catalysts17 to effect the desired
transformation, while Kundig and coworkers have applied their single coordinate (CpRu-
BIPHOP-F) and (CpFe-BIPHOP-F) catalysts to the [3+2] cycloaddition of nitrones to a-
methyl substituted enals.18  Most recently, Yamada and coworkers have reported the use
of cationic cobalt (III) complexes to catalyze the formation of the desired aldehyde-
functionalized isoxazolidines.19
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II.  Results and Discussion
Our iminium-activation strategy (Chapter 1) was first tested by Kateri Ahrendt,
who began by examining the capacity of (S )-proline methyl ester (33 ) to
enantioselectively catalyze the Diels-Alder reaction between cinnamaldehyde and
cyclopentadiene.20  She found that the introduction of 20 mol% 33 to the reaction resulted
in formation of the bicyclic Diels-Alder adduct in 81% yield and more importantly 48%
ee (endo) (eq. 9).  Exposure of the a,b-unsaturated aldehyde to diene in the absence of
the amine resulted only in recovery of starting materials.  These initial results indicated
that iminium-activation strategy was indeed viable.  We became interested in developing
a new enantioselective amine catalyzed variant of the 1,3-dipolar cycloaddition between
nitrones and a,b-unsaturated aldehydes (eq. 1).
A. Initial Optimization of Reaction Conditions
Our catalytic [3+2] cycloaddition strategy was first evaluated using N-
benzylidenebenzylamine N-oxide 34 with  (E)-crotonaldehyde 35 (eq. 10).  Reaction
conditions were initially optimized using 20 mol% (S)-proline methyl ester (33), since
this catalyst had been found by Kateri to be effective in the Diels-Alder reaction.   A
variety of reaction conditions were surveyed, and two reaction variables were found to
have a dramatic effect on the rate, yields, and selectivities of the reaction: solvent and
water.
A survey of a variety of solvents with dielectric constants varying from 7.6 to 47
revealed that aprotic, polar solvents work best at promoting the desired [3+2]
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cycloaddition reaction.  These effects can be rationalized by examining the catalytic cycle
of the reaction, shown in Figure 5. (See Chapter 1 for discussion of catalytic cycle.)
Polar solvents are perhaps most effective at promoting the desired cycloaddition reaction
due to their ability to stabilize the positive charge in iminium 38, a key intermediate
along this catalytic pathway.  Furthermore, protic solvents appeared to facilitate an acid
catalyzed decomposition of nitrone 34 through a disproportionation reaction with
crotonaldehyde 35 to produce benzaldehyde 41 and the conjugated, but unreactive nitrone
40.  This side reaction generally leads to lower conversions and yields for reactions run in
protic media. Based on these observations,  nitromethane was ultimately chosen as the
optimal reaction solvent, providing the cycloadduct 36 in 43% ee (endo) and 35%
conversion after 12 hours.
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One of the benefits of organocatalysis is that these reactions do not need to be run
under the strict exclusion of water since the chiral amine catalysts are not particularly
sensitive to water or oxygen.  In fact, since it plays an integral role in the catalytic cycle,
water can have a marked effect on the rate of the reaction, and therefore this reaction
parameter was also optimized.  Since water participates at two separate steps in the
catalytic cycle (highlighted in green in Figure 5), enough H2O has to be added to
facilitate catalyst turnover (converting 39 to 36) without hindering the formation of
iminium intermediate 38 from crotonaldehyde 35 and catalyst 37. A study of the effect of
water, summarized briefly in Table 3, found that 3 equivalents of H2O was an appropriate
amount for this reaction.  Thus these optimized conditions provided the desired
cycloadduct in 42% ee, 1.3:1 endo/exo, with 46% conversion after 12 hours.
B. Catalyst Development21
With these reaction conditions in hand, a variety of chiral amines were surveyed
to assess the reactivity and enantioselectivity potential of various structural frameworks.
As Table 4 illustrates, these studies revealed that the general catalyst structure had a large
influence on the reactivity of the [3+2] cycloaddition.  Relatively basic acyclic and cyclic
amines, such as those illustrated in entries 1 and 2, were generally poor catalysts in terms
of efficiency.  In contrast, acyclic amines containing a proximal electron withdrawing
group, like an a-carbonyl moiety, provided moderate levels of reactivity (entries 3, 6 22-
42% conv.).  The most reactive catalysts, however, were cyclic amines proximal to an
electron withdrawing group (entries 4, 5 70-75% conv.).  The success of these catalysts
can presumably be attributed to their ability to balance the nucleophilicity of the amine
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with the reactivity of the iminium ion. The increased nucleophilicity of the cyclic amines
compared to their acyclic counterparts facilitates the formation of the reactive iminium
intermediate 38 (Figure 5), while the proximal electron withdrawing group assists in
further lowering the LUMO of 38, making this intermediate more reactive.  The
combination of these effects leads to highly reactive amine catalysts.
This survey also identified three catalysts that showed promising
enantioselectivities with reasonable reactivity (entries 4, 5, 6).  Most interestingly, N-
methyl tryptophan methyl ester • HCl (Entry 6, 42) salt was able to catalyze the desired
reaction in 75% ee (endo).  However, efforts to improve these enantioselectivities
through the derivatization of these catalysts were met with very little success.
In an effort to understand the origins of the observed enantioselectivities,
computational models of the iminium ion structures were examined (Figure 6).
Condensation of crotonaldehyde with N-methyl tryptophan methyl ester 42 results in the
formation of two different iminium ion isomers: one where the olefin is oriented cis to
the catalyst (43) and one where the alkene is oriented trans to the chiral center  (44).  As
MM3-43 and MM3-4422 illustrate, the indole ring of the catalyst effectively shields one
p-face of the olefin in both cases.  However, these models suggest that the asymmetric
environment associated with each iminium isomer will induce the opposite sense of
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enantioselectivity during the course of the cycloaddition reaction.  Whereas in MM3-43
it is the si-face that is left open to attack by the nitrone, leading to formation of the
cycloadduct (+)-endo-36, it is the re-face that is left open in the case of MM3-44 which
ultimately leads to the formation of the (–)-endo-36 adduct (the enantiomer of adduct
formed via MM3-43).  There is an energetic difference of only about 3 kJ/mol-1 between
the cis MM3-43  and trans MM3-44 iminium ion geometries, suggesting that both
iminium ion geometries are operational (Figure 6).  Catalysts that achieve poor levels of
iminium geometry control exhibit diminished enantiocontrol.  In order to improve the
selectivity of the reaction, iminium ion geometry has to be controlled.
One method for controlling iminium geometry is through C2-symmetry.
Condensation of an enal with a C2 symmetric catalyst, such as 45, results in an iminium
ion with only one possible geometry 46, since the two iminium isomers are degenerate.
Thus a C2 symmetric (2S,5S)-proline bismethyl ester 45 catalyst was synthesized23 and
found to catalyze the [3+2] nitrone cycloaddition (eq. 11) in 78% ee, and marked
improvement from the analogous C1 symmetric proline catalyst 33 (42% ee).  Although
subsequent efforts to increase selectivities though derivatization of the ester moiety
proved unsuccessful, these experimental results corroborate the theoretical importance of
iminium geometry control.
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Ultimately, it was determined that catalysts that utilize steric elements to control
iminium geometry are most effective.  The benzyldimethyl imidazolidinone (47)
architecture, which was first developed by Seebach and coworkers24-27 for use in chirality
transfer reactions, was found to be an extremely effective organic catalyst.  Initial results
in the Diels-Alder reaction28 found that catalyst 47 was capable of catalyzing the reaction
of cinnamaldehyde and cyclopentadiene (eq. 9) to generate the bicyclic product in
excellent yields and enantioselectivities (93% ee (endo), 1.3:1 exo:endo, 99% yield). The
success of catalyst 47 is due to several factors.  In terms of catalyst architecture, the
imidazolidinone system contains both characteristics that were found earlier to be
important to catalyst reactivity: (1) the amino functionality is proximal to an electron
withdrawing carbonyl group, and (2) the amine is integrated into a five-membered ring
infrastructure. The observed levels of enantiocontrol originate from the selective
formation of the (E)-iminium isomer cis-48 to avoid non-bonding steric interactions
between the substrate olefin and the geminal methyl substituents (Figure 7).  These steric
clashes are nontrivial.  MM3 calculations place cis-48 almost 10 kJ/mol-1 lower in energy
than trans-48, a significantly larger cis/trans energy difference than in the case of
tryptophan 42.  The use of these steric control elements to manipulate iminium ion
geometry ultimately translates into excellent levels of enantioselectivity.  Finally this
catalyst architecture benefits from the practical convenience of being readily accessed in
large quantities as a bench stable solid from an a-amino ester, acetone, and methyl
amine.
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The potential of the imidazolidinone catalyst framework in the [3+2] nitrone
cycloaddition was evaluated using a series of chiral imidazolidinone • HCl salts. As
revealed in Table 5, this reaction was successfully catalyzed by a number of
imidazolidinones containing a variety of chiral substituents (entries 1–7, yield >80%, 45-
91% ee) in CH3NO2–H2O at +4 °C.  A survey of catalyst architecture reveals that
incorporation of benzylic substituents at the 3 position on the imidazolidinone framework
provides the highest levels of diastereo– and enantiofacial discrimination (47 , R =
CH2Ph, 94% ee; 51, R = CH2-2-naphthyl, 86% ee; 53, R = CH2-4-MeOPh, 89% ee),
while the 3-phenyl and 3-ethylphenyl substituted catalysts (entries 2 and 3) were
substantially less stereoselective.  These effects can be rationalized by examining the
model of the benzyl catalyst complexed with crotonaldehyde, MM3-4829.  One methylene
unit situates the aryl ring at an appropriate distance away from the five membered ring so
that aryl moiety can effectively shield one p-face of the olefin.   Furthermore, the
superior performance of the aryl groups can potentially be attributed to p-stacking
interactions that help orient the aryl ring in a parallel geometry relative to the olefin,
therefore effectively shielding that p-face of the alkene.   Ultimately, in accord with the
Diels–Alder studies, the phenylalanine derived catalyst 47 was found to be most general
with respect to reaction substrates (vide infra).
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Surprisingly, during the course of reaction optimization using catalyst 47, it was
discovered that a small, but significant amount of a side product was being formed in the
[3+2] cycloaddition reaction.  This product was isolated and identified to be 54, the result
of a Henry reaction (eq. 12).30  This 1,4-addition product presumably arises from the
mechanism detailed in Scheme 1.  The discovery of this alternate reaction pathway was
particularly notable, since this represented a new reaction manifold that was susceptible
to organocatalysis, thus reasserting our belief that this methodology could be extended to
a broad range of chemical transformations.
C. Substrate Scope
Since these reaction conditions generated the desired crotonaldehyde-derived
cycloadduct 36 with good selectivities, other a,b-unsaturated aldehydes were examined
in an effort to expand the aldehyde substrate scope of the reaction.  John Wiener, who
subsequently joined the project, continued to investigate the potential of crotonaldehyde
to reaction with other N-benzyl C-aryl nitrones.
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A variety of a,b-unsaturated aldehydes were examined, and one enal that was
found to generate cycloadducts with good selectivities was acrolein (eq 13).
Unfortunately optimization of reaction conditions around the HCl salt 47 consistently
produced cycloadducts with good selectivities (91% ee (endo), 4:1 endo/exo) but poor
yields (36% yield).  In an effort to increase the reaction efficiency, the Brønsted acid
component of the benzyl imidazolidinone catalyst was examined (Table 6).  A number of
imidazolidinone acid salts were found to catalyze the formation of isoxazolidine (4S)-56
in good yield and in greater than 87% ee (entries 1-6).  Most notably, the choice in
cocatalyst appeared to have a dramatic effect on reaction efficiency.  Aside from the HCl
derived catalyst 47, imidazolidinone salts derived from more acidic co-catalysts, such as
59 and 60, produced higher isolable yields than their less acidic counterparts.
Mechanistic studies suggest that catalyst salts derived from acidic co-catalysts
engender higher equilibrium concentrations of the active iminium species (48).
Presumably, higher concentrations of the reactive iminium ion 48 allows the desired
[3+2] cycloaddition to out-compete the undesired nitrone decomposition pathway (Figure
5), while generally increasing reaction rates.  Preliminary investigations also suggest that
the observed variation in enantioselectivity as a function of co-catalyst can be attributed
to the extent of iminium activation in preference to achiral Brønsted acid promotion.  As
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such, it is important to note that the TFA-, HClO4-, and TfOH-derived catalysts
successfully partition the [3+2] cycloaddition toward the iminium pathway with ≥90%
selectivity (giving ≥90% ee).  The superior levels of asymmetric induction and
diastereocontrol exhibited by the TfOH salt 60 to afford isoxazolidine (4S)-56 in 92%ee,
86:14 dr, and 82% yield (20 mol% catalyst, –18 °C) prompted us to select this catalyst
for further exploration with acrolein.  A similar study conducted with crotonaldehyde in
lieu of acrolein revealed that the HClO4 salt 59 was most appropriate for reactions with
run with that enal substrate (94% ee, 94:6 dr, 98% yield with 20 mol% catalyst, –20 °C).
The scope of the organocatalytic 1,3-dipolar cycloaddition between a ,b-
unsaturated aldehydes and various nitrones has been investigated (Table 7). The reaction
appears quite general with respect to the nitrone structure (entries 1–8, 66–98% yield,
92:8 to 98:2 endo:exo, 91–99% ee).  Variation in the N-alkyl group (R1 = Me, Bn, allyl,
entries 1–3) is possible without loss in enantioselectivity (endo 94–99% ee).  As revealed
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with 4-chlorophenyl- and 4-methoxyphenyl-substituted nitrones (entries 4–6), the
reaction is tolerant to a range of aromatic substituents on the dipole (76–93% yield, 92:8
to 98:2 endo:exo, 91–95% ee).  Moreover, excellent levels of diastereo- and
enantioselectivity can be achieved with alkyl-substituted nitrones (entry 9, 96:4 endo:exo,
99% ee).
To demonstrate the preparative utility, the addition of nitrone 3 to crotonaldehyde
was performed on a 25 mmol scale with catalyst 8 to provide (R)-4 (94% ee, 94% yield).
Per the previous discussion, structural variation in the dipolarophile can also be
accommodated, as acrolein has been shown to react with a range of nitrones to generate
the isoxazolidine products in good yields and selectivities (entries 10-15, 90-92% ee,
80% yield).
Although this methodology was found to be compatible with a variety of nitrone
and a , b-unsaturated aldehyde substrates, there were a few limitations to this
methodology.  Attempts to react N-benzyl-C-phenyl nitrone 34 with cinnamaldehyde
(61), and a few b-alkyl substituted enals (62, 63) were largely unsuccessful due to the
sluggish nature of these reactions.  Presumably, the lack of reactivity observed with
cinnamaldehyde can be attributed to the highly stabilized nature of the resultant iminium
ion, thus making it reluctant to undergo the desired cycloaddition.
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In an attempt to probe the limitations of the reaction with respect to the nitrone
component, a few nitrones (e.g., 64, 65, 68) with different structural motifs were also
examined, although with limited success.  Cyclic nitrones such as 64 generally produced
unidentifiable complex mixtures of products.  Since a C-alkyl nitrone had been met with
a high level of success (Table 7, entry 9, 99:1 endo:exo, 99% ee), several other nitrones
of this type were also tested.  However, less hindered nitrone substrates, such as 68,
would decompose via the aforementioned (Figure 5) disproportionation pathway to
generate the more stable, conjugated nitrone 40 before they would react with the enal.
These conjugated nitrones were generally unreactive under these reaction conditions, but
attempts were made to the optimize conditions around the cinnamyl derived nitrone 67.
As expected, these substrates were not susceptible to the disproportionation
decomposition pathway, and thus afforded the desired functionalizable isoxzolidine 68
with moderate levels of selectivity and consistently low yields under partially optimized
reaction conditions.   It is notable, however, that although these substrates were greeted
with limited amounts of success using these 2-dimethyl-4-benzylimidazolidinone
catalysts, a more reactive and more selective second generation catalyst has been
developed (see next chapter); it is potentially within the capacity of this new catalyst to
promote the desired cycloaddition with these substrates.
Finally, one of the benefits of this organocatalytic methodology is that it is easily
modeled using currently available calculation methods, and thus can be used to
accurately predict selectivities in these amine catalyzed reactions.  The sense of
asymmetric induction and diastereoselectivity observed in all cases involving catalysts 59
and 60 are consistent with the calculated iminium model MM3-48 (see experimental
information for stereochemical proofs).  By inspection, it is evident that enforced
formation of the (E)-iminium isomer and the position of the benzyl group on the catalyst
framework effectively promote cycloaddition from the si-face of the dipolarophile.
Furthermore, cycloaddition through an endo-topography effectively alleviates
nonbonding interactions between the nitrone phenyl group and the neopentyl methyl
substituent on the catalyst framework.
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III. Conclusion
The first asymmetric, catalytic 1,3-dipolar cycloaddition between nitrones and
a,b-unsaturated aldehydes has been described.  Using a chiral imidazolidinone salt, we
can access aldehyde-functionalized isoxazolidine cycloadducts in good yields and with
excellent selectivities.  This methodology not only demonstrates the ability of this new
organocatalytic strategy to be extended to chemical processes other than the Diels-Alder
reaction, but also highlights its ability for accessing chemical transformations not
attainable though traditional Lewis acid catalysis.
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Experimental
General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1  Organic solutions were concentrated under
reduced pressure on a Buchi rotary evaporator.  Chromatographic purification of products
was accomplished using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63
according to the method described by Still.2  Thin-layer chromatography (TLC) was
performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of the
developed chromatogram was performed by florescence quenching or KMnO4 stain.
1H NMR and 13C NMR spectra were recorded on Bruker AM-400 (400 MHz and
100 MHz, respectively), Bruker DRX-500 (500 MHz and 125 MHz, respectively), Varian
Mercury-300 (300 MHz and 75 MHz, respectively), or Varian I-500 (500 MHz and 125
MHz, respectively) instruments, as noted, and are internally referenced to residual protio
solvent signals.  Data for 1H NMR are reported with chemical shift (d ppm), multiplicity
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling
constant (Hz), and assignment.  Data for 13C NMR are reported with chemical shift.  IR
spectra were recorded on an ASI React-IR 1000 spectrometer and are reported in terms of
frequency of absorption (cm-1).  Optical Rotations were recorded on a Jasco P-1010
polarimeter (WI lamp, 589 nm, 25 °C).  Mass spectra were obtained from the UC Irvine
Mass Spectral Facility.  Gas Chromatography was performed on Hewlett-Packard 5890A
and 6890 Series gas chromatographs equipped with a split-mode capillary injection
system and flame ionization detectors using a Bodman Chiraldex G-TA (30 m x 0.25
mm) column.  HPLC analysis was performed on a Hewlett-Packard 1100 Series HPLC at
254nm using the following Chiralcel columns: OD-H (25 cm) and OD guard (5 cm), AD
(25 cm) and AD guard (5 cm).
(5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one trifluoromethanesulfonic
acid salt (60).  Prepared from the hydrochloride salt 1a3 by treatment with saturated aq.
                                                 
1 Perrin, D. D.; Armarego, W.L.F. Purification of Laboratory Chemicals; 3rd ed., Pregamon Press, Oxford,
1988.
2 Still, W.C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
3 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243.
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NaHCO3 (100 mL) and extraction of the free amine with CHCl3 (3 x 100 mL).  The
solution was dried over Na2SO4, filtered, and concentrated.  The residue was taken up in
Et2O and trifluoromethanesulfonic acid was added to precipitate 5.  The precipitate was
recrystallized from 2-propanol to provide the title compound as colorless crystals.  IR
(CH2Cl2) 2363, 1730, 1290, 1182 cm-1; 1H NMR (300 MHz, d6-DMSO) d 10.35 (br s, 1H,
+NH2), 9.27 (br s, 1H, +NH2), 7.19–7.38 (m, 5H, C6H5), 4.67 (br d, J = 8.6 Hz, 1H,
COCH), 3.30 (dd, J = 3.3, 15.4 Hz, 1H, CH2C6H5), 2.93 (dd, J = 11.0, 15.4 Hz, 1H,
CH2C6H5), 2.79 (s, 3H, CH3NCO), 1.62 (s, 3H, CH3), 1.48 (s, 3H, CH3); 13C NMR (75
MHz, CDCl3) d  166.8, 136.6, 129.7, 129.3, 127.8, 77.5, 57.9, 34.4, 25.7, 24.6, 22.5;
LRMS (CI) m/z 219 (MH)+; HRMS (CI) exact mass calcd for (C17H19N2O)+ requires m/z
219.1497, found m/z 219.1497;  [a]D = –58.8 (c = 1.0, CH3OH).
(5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one trifluoroacetic acid salt (57).
Prepared from the hydrochloride salt 1a by treatment with saturated aq. NaHCO3 (100
mL) and extraction of the free amine with CHCl3 (3 x 100 mL).  The solution was dried
over Na2SO4, filtered, and concentrated.  The residue was taken up in Et2O and
trifluoroacetic acid was added to precipitate the title compound as white crystals.  IR
(film) 3437, 2920, 2742, 2518, 2418, 1722, 1653, 1491, 1429, 1398, 1274, 1182, 1074,
834, 695 cm-1; 1H NMR (300 MHz, d6-DMSO) d 9.97 (br s, 1H, +NH2), 7.22–7.37 (m,
5H, C6H5), 4.53 (br d, J = 7.1 Hz, 1H, COCH), 3.27 (dd, J = 3.3, 14.8 Hz, 1H, CH2C6H5),
3.00 (dd, J = 10.2, 14.8 Hz, 1H, CH2C6H5), 2.76 (s, 3H, CH3NCO), 1.59 (s, 3H, CH3),
1.46 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 167.6, 136.9, 129.8, 129.1, 127.5, 77.2,
58.0, 34.7, 25.6, 24.7, 22.8; LRMS (EI) m/z 218 (M)+; HRMS (EI) exact mass calcd for
(C17H18N2O)+ requires m/z 218.1419, found m/z 218.1424;  [a]D = –63.2 (c = 1.0, CHCl3).
(5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrobromide (58).
Prepared from the hydrochloride salt 1a by treatment with saturated aq. NaHCO3 (100
mL) and extraction of the free amine with CHCl3 (3 x 100 mL).  The solution was dried
over Na2SO4, filtered, and concentrated.  The residue was taken up in Et2O and
hydrobromic acid was added to precipitate the title compound as white crystals.  IR (film)
3414, 2912, 2711, 2557, 1707, 1607, 1390, 1274, 1197, 1159, 1058, 989, 703 cm-1; 1H
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NMR (300 MHz, d6-DMSO) d 10.41 (brs, 1H, +NH2), 9.69 (br s, 1H, +NH2), 7.24–7.43
(m, 5H, C6H5), 4.69 (br d, J = 7.1 Hz, 1H, COCH), 3.28 (dd, J = 3.0, 15.1 Hz, 1H,
CH2C6H5), 3.15 (dd, J = 10.4, 14.8 Hz, 1H, CH2C6H5), 2.77 (s, 3H, CH3NCO), 1.67 (s,
3H, CH3), 1.49 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 166.8, 136.7, 129.9, 129.2,
127.7, 77.6, 58.1, 33.9, 25.8, 24.5, 22.6; LRMS (EI) m/z 218 (M)+; HRMS (EI) exact
mass calcd for (C17H18N2O)+ requires m/z 218.1419, found m/z 218.1420;  [a]D = –21.3 (c
= 1.0, CHCl3).
(5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one perchloric acid salt (59).
Prepared from the hydrochloride salt 1a by treatment with saturated aq. NaHCO3 (100
mL) and extraction of the free amine with CHCl3 (3 x 100 mL).  The solution was dried
over Na2SO4, filtered, and concentrated.  The residue was taken up in Et2O and perchloric
acid was added to precipitate the title compound as white crystals.  IR (film) 3514, 3059,
2927, 2850, 1707, 1607, 1398, 1267, 1097, 927. 703 cm-1; 1H NMR (300 MHz, d6-
DMSO) d 10.37 (br s, 1H, +NH2), 9.25 (br s, 1H, +NH2), 7.26–7.43 (m, 5H, C6H5), 4.66
(br d, J = 8.8 Hz, 1H, COCH), 3.33 (dd, J = 3.3, 15.1 Hz, 1H, CH2C6H5), 2.94 (dd, J =
10.7, 15.1 Hz, 1H, CH2C6H5), 2.78 (s, 3H, CH3NCO), 1.62 (s, 3H, CH3), 1.48 (s, 3H,
CH3); 13C NMR (75 MHz, CDCl3) d 166.8, 136.5, 129.7, 129.3, 127.8, 77.6, 58.0, 34.4,
25.7, 24.6, 22.5; LRMS (EI) m/z  218 (M)+; HRMS (CI) exact mass calcd for
(C17H18NO2)+ requires m/z 218.1419, found m/z 218.1428;  [a ]D = –61.1 (c = 1.0,
CH3NO2).
General Procedure A.  A flask containing nitrone and imidizolidinone catalyst
was charged with CH3NO2, then treated with the appropriate amount of H2O.  After
cooling the solution to the desired temperature, a,b unsaturated aldehyde was added drop
wise to the flask.   After the appropriate reaction time, the resulting solution was passed
through a silica gel column with ethyl acetate.  Removal of volatiles resulted in an oily
residue, which was purified by silica gel chromatography to afford the title compounds.
General Procedure B.  A flask containing nitrone and imidizolidinone catalyst
was charged with CH3NO2, then treated with the appropriate amount of H2O.  After
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cooling the solution to the desired temperature, a,b unsaturated aldehyde was added drop
wise to the flask.  Additional aldehyde was added to the reaction mixture at 24 h intervals
until the specified reaction time was reached.  The resulting solution was passed through
a silica gel column with ethyl acetate.  Removal of volatiles resulted in an oily residue,
which was purified by silica gel chromatography to afford the title compounds.
General Procedure C: The Reduction of Isoxazolidine Products.  To a
solution of the isoxazolidine aldehyde in absolute ethanol (1ml) were added 3 equivalents
of NaBH4.  After 0.5 hours, the reaction mixture was quenched with H2O, and extracted
with 2 x 10mL of CH2Cl2.  The organic layer was dried over Na2SO4, filtered, and
concentrated.  Purification of the resultant residue by silica gel chromatography provided
the corresponding primary alcohol.
(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-phenylisoxazolidine (Table 7, entry
1).4  Prepared according to general procedure B from ( Z)-N-benzylidenebenzylamine N-
oxide (63 mg, 0.30 mmol), (5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one perchloric
acid salt (8) (19 mg, 0.06 mmol), crotonaldehyde (100 mL, 1.2 mmol followed by 5 x 75
mL, 0.90 mmol over 24 h intervals ) and H2O (16 mL, 0.90 mmol) in CH3NO2 (3.0 ml) at
–20 ˚C over the course of 144 h.  The resulting solution was passed through a silica gel
column with CH2Cl2 to provide the title compound as an oil in 94% yield (79 mg); 96:4
endo:exo.  Endo isomer: IR (CH2Cl2) 2853, 1722, 1494, 1455, 1374 cm-1; 1H NMR (400
MHz, CDCl3) d 9.81 (d, J = 2.4 Hz, 1H, CHO), 7.24–7.58 (m, 10H, C6H5 and CH2C6H5),
4.57 (dq, J = 6.1, 12.2 Hz, 1H, CHCH3), 4.21 (d, J = 7.8 Hz, 1H, CHC6H5), 4.02 (d, J =
14.4 Hz, 1H, CH2C6H5), 3.84 (d, J = 14.3 Hz, 1H, CH2C6H5), 3.15 (m, 1H, CHCHO),
1.52 (d, J = 6.2 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) d 198.5, 138.4, 137.3, 129.0,
128.6, 128.3, 128.2, 127.5, 127.1, 73.4, 71.5, 71.1, 59.5, 21.2; LRMS (CI) m/z 281 (M)+;
HRMS (CI) exact mass calcd for (C18H19NO2) requires m/z 281.1418, found m/z 281.1413
(M)+; [a]D = +82.5 ° (c = 1.0, CHCl3).  Diastereomeric ratios were determined by 1H
NMR analysis.  A portion of the title compound was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (30%
                                                 
4 Run by J. J. M. Wiener.
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EtOAc/hex) for the determination of enantiomeric purity; endo 94% ee. 1H NMR (500
MHz, CDCl3) d 7.22–7.47 (m, 10H, ArH), 4.22-4.24 (m, 1H, CHON), 4.00 (d, J = 14.6
Hz, 1H, CH2C6H5), 3.81 (d, J = 14.6 Hz, 1H, CH2C6H5), 3.74-3.75 (m, 2H, CH2OH), 3.65
(d, J = 8.3 Hz, 1H, CHC6H5), 2.36-2.42 (m, 1H, CHCH2OH), 1.46 (d, J = 6.4 Hz, 3H,
CH3).  Enantiomeric ratios were determined by HPLC with a Chiralcel OD-H column
and OD guard column (2.5% iPrOH/hex, 1 mL/min flow rate); endo isomers tr = 59.3 min
and 76.3 min.
(3R,4S,5R)-2-Allyl-4-formyl-5-methyl-3-phenylisoxazolidine (Table 7, entry
2).  Prepared according to general procedure B from (Z)-N-benzylideneallylamine N-
oxide (63 mg, 0.30 mmol), (5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one perchloric
acid salt (8) (19 mg, 0.08 mmol), crotonaldehyde (133 mL, 1.6 mmol followed by 5 x 75
mL, 1.2 mmol over 24 h intervals) and H2O (22 mL, 1.2 mmol) in CH3NO2 (4.0 ml) at –20
˚C over the course of 132 h to provide the title compound as a colorless oil in 73% yield
(68 mg); 93:7 endo:exo.  Endo isomer: IR (CH2Cl2) 2981, 2842, 1722, 1645, 1498, 1376
cm-1; 1H NMR (300 MHz, CDCl3) d 9.77 (d, J = 2.2 Hz, 1H, CHO), 7.14–7.24 (m, 5H,
C6H5), 5.84–5.98 (m, 1H, CH2=CHCH2), 5.06–5.28 (m, 2H, CH2=CH), 4.51 (dq, J = 6.0,
6.0 Hz, 1H, CHCH3), 4.10 (d, J = 7.7 Hz, 1H, CHC6H5), 3.46 (dd, J = 5.5, 14.3 Hz, 1H,
CH2=CHCH2N), 3.31 (dd, J = 6.6, 14.3 Hz, 1H, CH2=CHCH2N), 3.09 (ddd, J = 2.5, 5.8,
8.0 Hz, 1H, CHCHO), 1.50 (d, J = 6.0 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) d
198.7, 138.6, 133.9, 129.1, 128.4, 127.8, 118.1, 73.7, 71.9, 71.3, 59.1, 21.3; LRMS (CI)
m/z 231 (M)+; HRMS (CI) exact mass calcd for (C14H17NO2) requires m/z 231.1259,
found m/z 231.1256 (M)+; [a]D = +63.8 ° (c = 1.0, CHCl3).  Diastereomeric ratios were
determined by  1H NMR analysis.  A portion of the title compound was reduced to the
corresponding primary alcohol (general procedure C) and purified by silica gel
chromatography (30% EtOAc/hex) for the determination of enantiomeric purity; endo
98% ee.  1H NMR (300 MHz, CDCl3) d 7.13–7.41 (m, 5H, C6H5), 5.83–5.97 (m, 1H,
CH2=CHCH2), 5.08–5.22 (m, 2H, CH2=CH), 4.21 (dq, J = 6.4, 6.4 Hz, 1H, CHCH3),
3.64–3.83 (br s, 2H, CH2OH), 3.57 (d, J = 8.0 Hz, 1H, CHC6H5), 3.44 (dd, J = 5.2, 14.3
Hz, 1H, CH2=CHCH2N), 3.28 (dd, J = 6.6, 14.3 Hz, 1H, CH2=CHCH2N), 2.34 (m, 1H,
CHCH2OH), 1.44 (d, J = 6.1 Hz, 3H, CH3).  Enantiomeric ratios were determined by
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HPLC with a Chiralcel AD column and AD guard column (3% EtOH/hex, 1 mL/min
flow rate); endo isomers tr = 18.2 min and 24.2 min.
(3R,4S,5R)-2,5-Dimethyl-4-formyl-3-phenylisoxazolidine (Table 7, entry 3).
Prepared according to general procedure B from (Z)-N-benzylidenemethylamine N-oxide
(54.1 mg, 0.40 mmol), (5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one perchloric acid
salt (8) (26 mg, 0.08 mmol), crotonaldehyde (133 mL, 1.6 mmol followed by 5 x 100 mL,
1.2 mmol, over 24 h intervals) and H2O (22 mL, 1.2 mmol) in CH3NO2 (4.0 ml) at  –20 ˚C
over the course of 132 h to provide the title compound as a colorless oil in 66% yield (54
mg); 95:5 endo:exo. Endo  >99% ee Endo isomer: IR (CH2Cl2) 2974, 2873, 1722, 1552
cm-1; 1H NMR (300 MHz, CDCl3) d 9.74 (d, J = 2.5 Hz, 1H, CHO), 7.26–7.39 (m, 5H,
C6H5), 4.54 (dq, J = 6.0, 12.3 Hz, 1H, CHCH3), 3.83 (br s, 1H, CHC6H5), 3.09 (m, 1H,
CHCHO), 2.60 (s, 3H, NCH3), 1.50 (d, J = 6.3 Hz, 3H, CHCH3); 13C NMR (75 MHz,
CDCl3) d 198.6, 137.8, 129.1, 128.5, 127.8, 73.5, 72.2, 66.3, 43.6, 21.9; LRMS (CI) m/z
205 (M)+; HRMS (CI) exact mass calcd for (C12H15NO2) requires m/z 205.1103, found
m/z 205.1100 (M)+; [a ]D = +77.2 ° (c = 1.0, CHCl3).  Diastereomeric ratios were
determined by  1H NMR analysis.  Enantiomeric ratios were determined by GLC with a
Bodman b-PH column (100 °C, 23 psi); endo isomers tr = 38.0 min and 39.8 min.
(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-(4-chlorophenyl) isoxazolidine
(Table 7, entry 4).5  Prepared according to general procedure B from ( Z)-N-para-
chlorobenzylidenebenzylamine N-oxide (74 mg, 0.30 mmol), (5S)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (19 mg, 0.06 mmol), crotonaldehyde
(100 mL, 1.2 mmol followed by 7 x 75 mL, 0.90 mmol, over 24 h intervals) and H2O (16
mL, 0.90 mmol) in CH3NO2 (3.0 ml) at  –20 ˚C over the course of 160 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 78% yield (74 mg); 92:8 endo:exo.  Endo isomer: IR (film) 3429,
3066, 2981, 2873, 2835, 2726, 1722, 1599, 1491, 1452, 1375, 1089, 1020, 819, 734, 703
cm-1; 1H NMR (300 MHz, CDCl3) d 9.79 (d, J = 2.2 Hz, 1H, CHO), 7.24–7.38 (m, 9H,
C6H4Cl and CH2C6H5), 4.55 (m, 1H, CHCH3), 4.16 (d, J = 7.7 Hz, 1H, CHC6H4Cl), 3.97
                                                 
5 Run by J. J. M. Wiener.
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(d, J = 14.0 Hz, 1H, CH2C6H5), 3.84 (d, J = 14.3 Hz, 1H, CH2C6H5), 3.06 (ddd, J = 7.4,
5.5, 2.2 Hz, 1H, CHCHO), 1.50 (d, J = 6.0 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3) d
198.6, 137.5, 137.2, 134.1, 129.8, 129.6, 129.4, 129.1, 128.8, 128.6, 127.6, 21.3; LRMS
(CI) m/z 315 (M)+; HRMS (CI) exact mass calcd for (C18H18NClO2) requires m/z
315.1026, found m/z 315.1023 (M)+; [a]D = +69.8 (c = 1.0, CHCl3).  Diastereomeric
ratios were determined by 1H NMR analysis.  A portion of the title compound was
reduced to the corresponding primary alcohol (general procedure C) and purified by silica
gel chromatography (30% EtOAc/hex) for the determination of enantiomeric purity; endo
95% ee. 1H NMR (500 MHz, CDCl3) d 7.24–7.39 (m, 9H, ArH), 4.23 (m, 1H, CHON),
3.97 (d, J = 14.2 Hz, 1H, CH2C6H5), 3.84 (d, J = 14.2 Hz, 1H, CH2C6H5), 3.73-3.81 (m,
2H, CH2OH), 3.67 (d, J = 7.8 Hz, 1H, CHC6H4Cl), 2.31-2.33 (m, 1H, CHCH2OH), 1.44
(d, J = 6.4 Hz, 3H, CH3).    Enantiomeric ratios were determined by HPLC with a
Chiralcel AD column and AD guard column (2.4% EtOH/hex, 1 mL/min flow rate); endo
isomers tr = 47.7 min and 83.6 min.
(3R,4S,5R)-2,5-Dimethyl-4-formyl-3-(4-chlorophenyl) isoxazolidine (Table 3,
entry 5).6  Prepared according to general procedure B from ( Z)-N-para-
chlorobenzylidenemethylamine N -oxide (68 mg, 0.40 mmol), (5S)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (26 mg, 0.08 mmol), crotonaldehyde
(133 mL, 1.6 mmol followed by 8 x 100 mL, 1.20 mmol, over 24 h intervals) and H2O (22
mL, 1.20 mmol) in CH3NO2 (4.0 ml) at  –20 ˚C over the course of 160 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 76% yield (73 mg); 93:7 endo:exo.  Endo isomer: IR (film) 3429,
2974, 2927, 2850, 2781, 2734, 1908, 1722, 1599, 1490, 1460, 1375, 1344, 1298, 1205,
1089, 1020, 911.4, 818.7, 679.7 cm-1; 1H NMR (400 MHz, CDCl3) d 9.74 (d, J = 2.3 Hz,
1H, CHO), 7.25-7.33 (m, 4H, ArH), 4.51 (dq, Jd = 5.9, Jq = 6.1 Hz, 1H, CHCH3),  3.82-
4.01 (m, 1H, CHC6H4Cl), 3.02 (ddd, J = 8.0, 5.5, 2.3 Hz, 1H, CHCHO), 2.59 (s, 3H,
NCH3), 1.55 (d, J = 6.2 Hz, 3H, CHCH3); 13C NMR (125 MHz, CDCl3) d 198.3, 136.7,
134.3, 129.6, 129.5, 129.3, 129.1, 73.5, 73.1, 72.2; LRMS (FAB) m/z 239 (M)+; HRMS
(FAB) exact mass calcd for (C12H14ClNO2) requires m/z 239.0713, found m/z 239.0707
                                                 
6 Run by J. J. M. Wiener.
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(M)+; [a]D = +64.1 ° (c = 1.0, CHCl3).  Diastereomeric ratios were determined by 1H
NMR analysis.  A portion of the title compound was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (40%
EtOAc/hex) for the determination of enantiomeric purity; endo 94% ee.  1H NMR (300
MHz, CDCl3) d 7.24-7.38 (m, 4H, ArH), 4.20 (dq, Jd = 6.2, Jq = 6.0, 1H, CHON), 3.66-
3.75 (m, 2H, CH2OH), 3.35 (d, J = 8.52 Hz, 1H, CHC 6H4Cl), 2.28-2.34 (m, 1H,
CHCH2OH), 1.43 (d, J = 6.3 Hz, 3H, CH3).  Enantiomeric ratios were determined by
HPLC with a Chiralcel OD-H column and OD guard column (3.0% iPrOH/hex, 1
mL/min flow rate); endo isomers tr = 29.0 min and 45.3 min.
(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-(4-methoxyphenyl) isoxazolidine
(Table 7, entry 6).6  Prepared according to general procedure B (Z)-N -para-
methoxybenzylidenebenzylamine N-oxide (72 mg, 0.30 mmol), (5S)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (19 mg, 0.06 mmol), crotonaldehyde
(100 mL, 1.2 mmol followed by 5 x 75 mL, 0.90 mmol, over 24 h intervals) and H2O (16
mL, 0.90 mmol) in CH3NO2 (3.0 ml) at  –20 ˚C over the course of 136 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 93% yield (86 mg); 98:2 endo:exo.  Endo isomer: IR (film) 3429,
3035, 2974, 2935, 2835, 2726, 1722, 1614, 1514, 1452, 1375, 1298, 1251, 1174, 1035,
826, 734, 703 cm-1; 1H NMR (300 MHz, CDCl3) d 9.76 (d, J = 2.5 Hz, 1H, CHO),
7.23–7.38 (m, 7H, ArH), 6.87-6.91 (m, 2H, ArH), 4.52 (m, 1H, CHCH3), 4.06 (d, J = 8.2
Hz, 1H, CHC6H4OCH3), 3.99 (d, J = 14.3 Hz, 1H, CH2C6H5), 3.80 (s, 3H, OCH3), 3.76
(d, J = 14.6 Hz, 1H, CH2C6H5), 3.08 (ddd, J = 8.0, 5.5, 2.5 Hz, 1H, CHCHO), 1.50 (d, J =
6.3 Hz, 3H, CHCH3); 13C NMR (125 MHz, CDCl3) d 199.1, 159.8, 137.7, 130.1, 129.1,
128.7, 128.5, 137.4, 114.6, 73.6, 71.8, 71.2, 59.5, 55.6, 21.5; LRMS (CI) m/z 311 (M)+;
HRMS (CI) exact mass calcd for (C19H21NO3) requires m/z 311.1521, found m/z 311.1514
(M)+; [a]D = +71.8 ° (c = 1.0, CHCl3).  Diastereomeric ratios were determined by 1H
NMR analysis.  A portion of the title compound was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (30%
EtOAc/hex) for the determination of enantiomeric purity; endo 91% ee. 1H NMR (500
MHz, CDCl3) d 7.17–7.41 (m, 7H, ArH), 6.86-6.93 (m, 2H, ArH), 4.17 (dq, Jd = 5.9, Jq =
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6.0, 1H, CHON), 3.96 (d, J = 14.6 Hz, 1H, CH2C6H5), 3.80 (s, 3H, OCH3), 3.73 (d, J =
14.3 Hz, 1H, CH 2C6H5), 3.69-3.73 (m, 2H, CH 2OH), 3.56 (d, J  = 8.5 Hz, 1H,
CHC6H4OCH3), 2.29-2.38 (m, 1H, CHC H2OH), 1.43 (d, J  = 6.0 Hz, 3H, CH 3).
Enantiomeric ratios were determined by HPLC with a Chiralcel AD column and AD
guard column (3.0% EtOH/hex, 1 mL/min flow rate); endo isomers tr = 37.7 min and
69.5 min.
(3R,4S,5R)-2,5-Dimethyl-4-formyl-3-(4-tolyl) isoxazolidine (Table 7, entry 7).
Prepared according to general procedure B from (Z ) - N - p a r a-
methylbenzylidenemethylamine N-oxide (60 mg, 0.40 mmol), (5S)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (26 mg, 0.08 mmol), crotonaldehyde
(133 mL, 1.6 mmol followed by 7 x 100 mL, 1.20 mmol, over 24 h intervals) and H2O (22
mL, 1.20 mmol) in CH3NO2 (4.0 ml) at  –20 ˚C over the course of 160 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 82% yield (72 mg); 93:7 endo:exo.  Endo isomer: IR (film) 3429,
2974, 2927, 2873, 2726, 1722, 1514, 1452, 1375, 1344, 1112, 1066, 911, 811, 687 cm-1;
1H NMR (300 MHz, CDCl3) d 9.74 (d, J = 2.5 Hz, 1H, CHO), 7.12-7.26 (m, 4H, ArH),
4.53 (dq, Jd = 5.9, Jq = 6.3 Hz, 1H, CHCH3), 3.78 (bs, 1H, CHC6H4CH3), 3.09 (ddd, J =
8.4, 5.4, 2.5 Hz, 1H, CHCHO), 2.59 (s, 3H, NCH3), 2.34 (s, 3H, C6H4CH3), 1.51 (d, J =
6.3 Hz, 3H, CHCH3); 13C NMR (125 MHz, CDCl3) d 198.7, 138.3, 134.5, 130.0, 129.6,
128.0, 127.5, 73.6, 72.2, 43.7, 21.6; LRMS (CI) m/z 219 (M)+; HRMS (CI) exact mass
calcd for (C13H17NO2) requires m/z 219.1259, found m/z 219.1262 (M)+; [a]D = +67.9 ° (c
= 1.0, CHCl3).  Diastereomeric ratios were determined by 1H NMR analysis.  A portion
of the title compound was reduced to the corresponding primary alcohol (general
procedure C) and purified by silica gel chromatography (30% EtOAc/hex) for the
determination of enantiomeric purity; endo 97% ee. 1H NMR (300 MHz, CDCl3) d 7.13-
7.26 (m, 4H, ArH), 4.20 (dq, Jd = 6.2, Jq = 6.0 Hz, 1H, CHON), 3.63-3.71 (m, 2H,
CH2OH), 3.29 (d, J = 7.7 Hz, 1H, CHC6H4CH3), 2.55 (s, 3H, NCH 3), 2.33 (s, 3H,
C6H4CH3), 2.31-2.39 (m, 1H, CHC H2OH), 1.44 (d, J  = 6.0 Hz, 3H, CHCH 3).
Enantiomeric ratios were determined by HPLC with a Chiralcel AD column and AD
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guard column (3.0% iPrOH/hex, 1 mL/min flow rate); endo isomers tr = 40.2 min and
47.6 min.
(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-(2-napthyl) isoxazolidine (Table 7,
entry 8).7  Prepared according to general procedure B from ( Z)-N-2-
napthylidenebenzylamine N-oxide (78 mg, 0.30 mmol), (5S )-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (19 mg, 0.06 mmol), crotonaldehyde
(100 mL, 1.2 mmol followed by 5 x 75 mL, 0.90 mmol, over 24 h intervals) and H2O (16
mL, 0.90 mmol) in CH3NO2 (3.0 ml) at  –20 ˚C over the course of 138 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 98% yield (97 mg); 95:5 endo:exo.  Endo isomer: IR (film) 3429,
3059, 2981, 2927, 2866, 2726, 1954, 1722, 1607, 1498, 1452, 1375, 1313, 1120, 819,
742, 703 cm-1; 1H NMR (400 MHz, CDCl3) d 9.83 (d, J = 2.3 Hz, 1H, CHO), 7.84-7.89
(m, 5H, ArH), 7.61 (dd, J = 1.6 Hz, 1H, ArH), 7.49-7.52 (m, 2H, ArH), 7.24–7.38 (m,
2H, ArH), 4.61 (dq, Jd = 5.9, Jq = 6.1 Hz, 1H, CHC H3), 4.35 (d, J = 7.7 Hz, 1H,
CHNapth), 4.06 (d, J = 14.3 Hz, 1H, CH2C6H5), 3.89 (d, J = 14.3 Hz, 1H, CH2C6H5),
2.20 (ddd, J = 7.8, 5.5, 2.3 Hz, 1H, CHCHO), 1.55 (d, J = 6.2 Hz, 3H, CHCH3); 13C
NMR (125 MHz, CDCl3) d 198.8, 137.5, 136.0, 133.5, 133.4, 129.1, 128.7, 128.4, 128.1,
127.9, 137.4, 127.1, 126.6, 126.5, 125.1, 73.8, 71.6, 71.5, 59.8, 21.3; LRMS (CI) m/z 331
(M)+; HRMS (FAB) exact mass calcd for (C22H21NO2) requires m/z 331.1572, found m/z
331.1567 (M)+; [a]D = +53.1 ° (c = 1.0, CHCl3).  Diastereomeric ratios were determined
by 1H NMR analysis.  A portion of the title compound was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (30%
EtOAc/hex) for the determination of enantiomeric purity; endo 93% ee. 1H NMR (500
MHz, CDCl3) d 7.84–7.86 (m, 4H, ArH), 7.66-7.67 (m, 1H, ArH), 7.48-7.52 (m, 2H,
ArH), 7.20-7.40 (m, 5H, ArH), 4.28 (dq, Jd = 6.1, Jq = 5.9, 1H, CHON), 4.04 (d, J = 14.2
Hz, 1H, CH2C6H5), 3.75-3.87 (m, 4H, CH2C6H5, CH2OH, CHNapth), 2.46-2.51 (m, 1H,
CHCH2OH), 1.50 (d, J = 5.9 Hz, 3H, CH3).  Enantiomeric ratios were determined by
HPLC with a Chiralcel AD column and AD guard column (2.5% EtOH/hex, 1 mL/min
flow rate); endo isomers tr = 57.7 min and 107.6 min.
                                                 
7 Run by J. J. M. Wiener.
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(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-cyclohexyl isoxazolidine (Table 7,
entry 9).   Prepared according to general procedure B from (Z)-N-
cyclohexylmethylidenebenzylamine N-oxide (65 mg, 0.30 mmol), (5S)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one perchloric acid salt (8) (19 mg, 0.06 mmol), crotonaldehyde
(200 mL, 2.4 mmol followed by 2 x 75 mL, 0.90 mmol, over 24 h intervals) and H2O (16
mL, 0.90 mmol) in CH3NO2 (3.0 ml) at –20 ˚C over the course of 72 h.  The resulting
solution was passed through a silica gel column with CH2Cl2 to provide the title
compound as an oil in 63% yield (54 mg); 96:4 endo:exo.  Endo isomer: IR (film) 2927,
2858, 2719, 1722, 1498, 1452, 1383, 1328, 1074, 1027, 973, 703 cm-1; 1H NMR (300
MHz, CDCl3) d 9.80 (d, J = 3.0 Hz, 1H, CHO), 7.23-7.40 (m, 5H, ArH), 4.57-4.64 (dq, Jd
= 7.7, Jq = 6.1 Hz, 1H, CHON), 4.08 (d, J = 13.5 Hz, 1H, CH2C6H5), 3.82 (d, J = 13.2
Hz, 1H, CH2C6H5), 3.05 (dd, J = 7.7, 5.5 Hz, 1H, CH-chex), 2.86-2.91 (m, 1H, CHCHO),
1.35 (d, J = 6.1 Hz, 3H, CHCH3), 0.70-2.03 (m, 11H, chex-H); 13C NMR (75 MHz,
CDCl3) d 73.6, 72.8, 67.2, 62.0, 42.6, 30.9, 29.8, 26.7, 26.3, 26.2, 18.1; LRMS (EI) m/z
287 (M)+; HRMS (EI) exact mass calcd for (C18H25NO2) requires m/z 287.1885, found
m/z 287.1881 (M)+; [a ]D = +48.6 ° (c = 1.0, CHCl3) .   Diastereomeric ratios were
determined by 1H NMR analysis.  A portion of the title compound was reduced to the
corresponding primary alcohol (general procedure C) and purified by silica gel
chromatography (30% EtOAc/hex) for the determination of enantiomeric purity; endo
99% ee. 1H NMR (300 MHz, CDCl3) d 7.32-7.41 (m, 5H, ArH), 4.32-4.34 (m, 1H,
CHON), 4.14 (d, J = 12.7 Hz, 1H, CH2C6H5), 3.88 (d, J = 13.2 Hz, 1H, CH2C6H5), 3.73-
3.84 (m, 2H, CH2OH), 2.58 (dd, J = 6.1, 5.4 Hz, 1H, CH-chex), 2.14-2.18 (m, 1H,
CHCH2OH), 1.34 (d, J  = 6.4 Hz, 3H, CHCH3), 0.82-1.74 (m, 11H, chex-H).
Enantiomeric ratios were determined by HPLC with a Chiralcel OD-H column and OD
guard column (3.0% iPrOH/hex, 1 mL/min flow rate); endo isomers tr = 22.9 min and
26.7 min.
(3R,4S)-2-Benzyl-4-formyl-3-phenylisoxazolidine (Table 7, entry 11).
Prepared according to general procedure A from (Z)-N-benzylidenebenzylamine N-oxide
(63 mg, 0.30 mmol), (5S ) -5 -benzy l -2 ,2 ,3 - t r ime thy l imidazo l id in -4 -one
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trifluoromethanesulfonic acid salt (5) (22 mg, 0.06 mmol), acrolein (71 mL, 1.2 mmol)
and H2O (16 mL, 0.90 mmol) in CH3NO2 (3.0 ml) at –10 ˚C over the course of 35 h to
provide the title compound as a colorless oil in 80% yield (63 mg); 86:14 endo:exo.
Endo isomer:  IR (CH2Cl2) 2873, 1722, 1498, 1452, 1050 cm-1; 1H NMR (400 MHz,
CDCl3) d 9.80 (d, J = 2.1 Hz, 1H, CHO), 7.27–7.51 (m, 10H, C6H5 and CH2C6H5),
4.27–4.30 (m, 2H, CH2ON), 4.07 (d, J = 7.1 Hz, 1H, CHC6H5), 3.99 (d, J = 14.2 Hz, 1H,
CH2C6H5), 3.78 (d, J = 14.2 Hz, 1H, CH2C6H5), 3.44 (m, 1H, CHCHO); 13C NMR (100
MHz, CDCl3) d 198.4, 138.1, 137.1, 128.9, 128.6, 128.3, 128.2, 127.8, 127.3, 70.6, 65.8,
64.3, 59.6; LRMS (CI) m/z 267 (M)+; HRMS (CI) exact mass calcd for (C17H17NO2)
requires m/z 267.1259, found m/z  267.1268;  [a]D = +43.4 ° (c = 1.0, CHCl3).
Diastereomeric ratios were determined by 1H NMR analysis.  A portion of the title
compound was reduced to the corresponding primary alcohol (general procedure C) and
purified by silica gel chromatography (30% EtOAc/hex) for the determination of
enantiomeric purity; endo 90% ee. 1H NMR (300 MHz, CDCl3) d 7.19–7.51 (m, 10H,
C6H5 and CH2C6H5), 4.19 (dd, J = 8.2, 8.2 Hz, 1H, CH2ON), 3.94 (d, J = 14.3 Hz, 1H,
CH2C6H5), 3.88–3.92 (dd, J = 4.4, 8.2 Hz, 1H, CH2ON), 3.65–3.83 (m, 2H, CH2OH),
3.70 (d, J = 14.0 Hz, 1H, CH2C6H5), 3.47 (d, J = 7.7 Hz, 1H, CHC6H5), 2.72–2.83 (m,
1H, CHCH2OH).  Enantiomeric ratios were determined by HPLC with a Chiralcel AD
column (4% EtOH/hex,  1 mL/min flow rate); endo isomers tr = 15.8 min and 20.4 min.
(3R,4S)-2-Benzyl-4-formyl-3-(4-methylphenyl)isoxazolidine (Table 7, entry
12).  Prepared according to general procedure B from (Z ) - N -para-
methylbenzylidenebenzylamine N-oxide (72 mg, 0.30 mmol), (5S)-5-benzyl-2,2,3-
trimethylimidazolidin-4-one trifluoromethanesulfonic acid salt (5) (22 mg, 0.06 mmol),
acrolein (71 mL, 1.2 mmol followed by 4 x 36 mL, 0.60 mmol, over 24 h intervals), H2O
(16 mL, 0.90 mmol), and in CH3NO2 (3.0 ml) at  –18 ˚C over the course of 112 h to
provide the title compound as a colorless oil in 80% yield (66 mg) after silica gel
chromatography (17% EtOAc/hex); 85:15 endo:exo.  Endo isomer: IR (CH2Cl2) 2873,
1722, 1514, 1050 cm-1; 1H NMR (300 MHz, CDCl3) d 9.77 (d, J = 2.2 Hz, 1H, CHO),
7.19–7.47 (m, 7H, C6H4CH3 and CH2C6H5), 4.24–4.28 (m, 2H, CH2ON), 3.97–4.02 (m,
2H, CHNO and CH2C6H5), 3.75 (d, J = 14.0 Hz, 1H, CH2C6H5), 3.38–3.46 (m, 1H,
47
CHCHO), 2.39 (s, 3H, C6H4CH3); 13C NMR (100 MHz, CDCl3) d 199.1, 138.4, 137.5,
135.0, 129.9, 128.9, 128.5, 128.0, 127.5, 70.9, 66.2, 64.6, 59.9, 21.6; LRMS (CI) m/z
281 (M)+; HRMS (CI) exact mass calcd for (C18H19NO2) requires m/z 281.1416, found
m/z 281.1415; [a]D = +39.8 ° (c = 1.0, CHCl3).  Diastereomeric ratio was determined by
1H NMR analysis.  A portion of the title compound was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (30%
EtOAc/hex) for the determination of enantiomeric purity; endo 90% ee.  1H NMR (300
MHz, CDCl3) d 7.16–7.37 (m, 9H, C6H4CH3 and CH2C6H5), 4.18 (dd, J = 8.2, 8.2 Hz,
1H, CH2ON), 3.94 (d, J = 14.8 Hz, 1H, CH2C6H5), 3.87-3.91 (dd, J = 4.3, 8.1 Hz, 1H,
CH2ON), 3.67–3.82 (m, 2H, CH2OH), 3.65 (d, J = 14.3 Hz, 1H, CH2C6H5), 3.44 (d, J =
7.7 Hz, 1H, CHC6H4CH3), 2.70–2.81 (m, 1H, CHCH2OH), 2.35 (s, 3H, C6H4CH3).
Enantiomeric ratios were determined by HPLC with  Chiralcel AD column and AD guard
column (10% EtOH/hex, 1 mL/min flow rate); endo isomers tr = 9.1 min and 10.0 min.
(3R,4S)-2-Benzyl-4-formyl-3-(4-chlorophenyl)isoxazolidine (Table 7, entry
1 3 ) .   Prepared according to general procedure B from (Z ) - N -para-
chlorobenzylidenebenzylamine N-oxide (74 mg, 0.30 mmol), (5S)-5-benzyl-2,2,3-
trimethylimidazolidin-4-one trifluoromethanesulfonic acid salt (5) (22 mg, 0.06 mmol),
acrolein (71 mL, 1.2 mmol followed by 3 x 36 mL, 0.60 mmol, over 24 h intervals) and
H2O (16 mL, 0.90 mmol) in CH3NO2 (3.0 ml) at –18 ˚C over the course of 96 h to provide
the title compound as a colorless oil in 80% yield (70 mg) after silica gel chromatography
(20% EtOAc/hex); 80:20 endo:exo.  Endo isomer: IR (CH2Cl2) 2881, 1722, 1599, 1491
cm-1; 1H NMR (400 MHz, CDCl3) d 9.78 (d, J = 2.0 Hz, 1H, CHO), 7.26–7.44 (m, 9H,
C6H4Cl and CH2C6H5), 4.27–4.29 (m, 2H, CH2ON), 4.08 (d, J = 7.0 Hz, 1H, CHC6H4Cl),
3.96 (d, J = 14.0 Hz, 1H, CH2C6H5), 3.80 (d, J = 14.2 Hz, 1H, CH2C6H5), 3.34–3.40 (m,
1H, CHCHO); 13C NMR (100 MHz, CDCl3) d 198.4, 136.8, 134.0, 136.7, 129.1, 128.7,
128.2, 127.4, 129.1, 69.6, 65.8, 64.3, 59.7; LRMS (CI) m/z  (M); HRMS (CI) exact mass
calcd for (C17H16ClNO2) requires m/z 301.0870 (M)+, found m/z 301.0862; [a]D = +45.8 °
(c = 1.0, CHCl3).  Diastereomeric ratios were determined by 1H NMR analysis.  A portion
of the title compound was reduced to the corresponding primary alcohol (general
procedure C) and purified by silica gel chromatography (40% EtOAc/hex) for the
48
determination of enantiomeric purity; endo 91% ee.  1H NMR (300 MHz, CDCl3) d
7.04–7.42 (m, 9H, C6H4Cl and CH2C6H5), 4.17 (dd, J = 8.2, 8.2 Hz, 1H, CH2ON), 3.91
(d, J = 14.0 Hz, 1H, CH2C6H5), 3.86–3.90 (dd, J = 4.7, 8.2 Hz, 1H, CH2ON), 3.72–3.78
(m, 2H, CH2OH), 3.72 (d, J = 14.0 Hz, 1H, CH 2C6H5), 3.49 (d, J  = 7.7 Hz, 1H,
CHC6H4Cl), 2.68–2.76 (m, 1H, CHCH2OH).  Enantiomeric ratios were determined by
HPLC with a Chiralcel AD column and AD guard column (5% iPrOH/hex, 1 mL/min
flow rate); endo isomers tr = 20.7 min and 23.5 min.
(3R,4S)-2-Benzyl-4-formyl-3-napthylisoxazolidine (Table 7, entry 14).
Prepared according to general procedure A from (Z)-N-2-napthylidenebenzylamine N-
oxide (78 mg, 0.30 mmol), (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one
trifluoromethanesulfonic acid salt (5) (22 mg, 0.06 mmol), acrolein (71 mL, 1.2 mmol),
H2O (16 mL, 0.90 mmol), and in CH3NO2 (3.0 ml) at –18 ˚C over the course of 112 h to
provide the title compound as a colorless oil in 80% yield (75 mg) after silica gel
chromatography (25% EtOAc/hex); 86:14 endo:exo.  Endo isomer: IR (CH2Cl2) 3059,
2835, 1722, 1498, 1607 cm-1; 1H NMR (400 MHz, CDCl3) d 9.83 (d, J = 2.0 Hz, 1H,
CHO), 7.27–7.95 (m, 12H, C10H7 and CH2C6H5), 4.32–4.36 (m, 2H, CH2ON),  4.28 (d, J
= 7.0 Hz, 1H, CHC10H7), 4.01 (d, J = 14.1 Hz, 1H, CH2C6H5), 3.85 (d, J = 14.2 Hz, 1H,
CH2C6H5), 3.53 (m, 1H, CHCHO); 13C NMR (100 MHz, CDCl3) d 198.7, 137.1, 135.4,
133.3, 133.2, 128.9, 128.7, 128.2, 127.9, 127.8, 127.7, 127.3, 127.2, 126.4, 126.3, 125.0,
110.4, 70.8, 65.9, 64.2, 59.7; LRMS (CI) m/z  317 (M)+; HRMS (CI) exact mass calcd for
(C21H19NO2) requires m/z 317.1416, found m/z 317.1416; [a]D = +20.3 ° (c = 1.0, CHCl3).
Diastereomeric ratio was determined by  1H NMR analysis. A portion of the title
compound was reduced to the corresponding primary alcohol (general procedure C) and
purified by silica gel chromatography (30% EtOAc/hex) for the determination of
enantiomeric purity; endo 89% ee. 1H NMR (300 MHz, CDCl3) d 7.21–7.89 (m, 12H,
C10H7 and CH2C6H5), 4.26 (dd, J = 8.2, 8.2 Hz, 1H, CH2ON), 3.98 (d, J = 14.0 Hz, 1H,
CH2C6H5), 3.93–3.98 (dd, J = 4.6, 8.2 Hz, 1H, CH2ON), 3.75 (d, J = 14.0, 1H, CH2C6H5),
3.72–3.83 (m, 2H, CH2OH), 3.67 (d, J = 7.7 Hz, 1H, CHC10H7), 2.82–2.93 (m, 1H,
CHCH2OH).  Enantiomeric ratios were determined by HPLC with  Chiralcel AD column
49
and AD guard column (10% EtOH/hex, 1 mL/min flow rate); endo isomers tr = 12.7 min
and 17.5 min.
(3R,4S)-2-Benzyl-4-formyl-3-(4-methoxyphenyl)isoxazolidine (Table 7,  entry 15).
Prepared according to general procedure B from (Z ) - N - p a r a-
methoxybenzylidenebenzylamine N-oxide (72 mg, 0.30 mmol), (5S)-5-benzyl-2,2,3-
trimethylimidazolidin-4-one trifluoromethanesulfonic acid salt (5) (22 mg, 0.06 mmol),
acrolein (71 mL, 1.2 mmol followed by 3 x 36 mL, 0.60 mmol, over 24 h intervals), H2O
(16 mL, 0.90 mmol), and in CH3NO2 (3.0 ml) at  –18 ˚C over the course of 87 h to
provide the title compound as a colorless oil in 83% yield (73 mg) after silica gel
chromatography (30% EtOAc/hex); 91:9 endo:exo.  Endo isomer: IR (CH2Cl2) 2935,
1722, 1614, 1514, 1460, 1251 cm-1; 1H NMR (400 MHz, CDCl3) d 9.77 (d, J = 2.1 Hz,
1H, CHO), 7.26–7.42 (m, 7H, C6H4OCH3 and CH2C6H5), 6.94 (d, J = 8.7 Hz, 2H, ortho
C6H4OCH3), 4.22–4.28 (m, 2H, CH2ON), 3.96–4.00 (m, 2H, CHNO and CH2C6H5), 3.82
(s, 3H, OCH3), 3.73 (d, J = 14.2 Hz, 1H, CH2C6H5), 3.40 (m, 1H, CHCHO); 13C NMR
(100 MHz, CDCl3) d 198.9, 159.6, 137.3, 129.6, 129.0, 128.6, 128.2, 127.2, 114.3, 70.3,
65.8, 64.1, 59.4, 55.2; LRMS (CI) m/z 297 (M)+; HRMS (CI) exact mass calcd for
(C18H19NO3) requires m/z 297.1365, found m/z 297.1361. [a]D = +31.9 ° (c = 1.0, CHCl3)
Diastereomeric ratio was determined by  1H NMR analysis. A portion of the title
compound was reduced to the corresponding primary alcohol (general procedure C) and
purified by silica gel chromatography (40% EtOAc/hex) for the determination of
enantiomeric purity; endo 90% ee.  1H NMR (300 MHz, CDCl3) d 7.19–7.40 (m, 7H,
C6H4OCH3 and CH2C6H5), 6.92 (d, J = 1.9 Hz, 2H, C6H4OCH3), 4.16 (dd, J = 8.2, 8.2 Hz,
1H, CH2ON), 3.90 (d, J = 14.3 Hz, 1H, CH 2C6H5), 3.87 (dd, J = 4.4, 8.2 Hz, 1H,
CH2ON), 3.81 (s, 3H, C6H4OCH3), 3.66–3.79 (m, 2H, CH2OH), 3.65 (d, J = 14.3 Hz, 1H,
CH2C6H5), 3.42 (d, J = 7.6 Hz, 1H, CHC6H5OCH3), 2.69–2.80 (m, 1H, CHCH2OH).
Enantiomeric ratios were determined by HPLC with Chiralcel AD column and AD guard
column (8% iPrOH/hex, 1 mL/min flow rate); endo isomers tr = 15.4 min and 17.0 min.
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Determination of Absolute and Relative Stereochemistry through Chemical Correlation
and X-Ray Crystal Structure
Me O
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+
-
+
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NO
Ph
HClO4
20 mol%, -20 °C,
CH3NO2–H2O
N O
Bn
MePh
CHO
Me O
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O
Bn
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+
-
+
HCl
20 mol%, 25 °C,
CH3NO2–H2O
N O
Bn
MePh
CHO
N
H
CO2Me
1. NaClO2, NaH2PO4, 
     2-methyl-2-butene,
      H2O, t-BuOH
2. DCC, DMAP, i-PrOH
      CH2Cl2
N O
Bn
MePh
CO2i-Pr
[a] (found) = -7.4 °
[a] (lit.4) = -28.1 °
N O
Bn
MePh
NaBH4
EtOH
HPLC: t1 = 59.3 (minor enantiomer)
       t2 = 76.3 (major enantiomer)
OH
41% ee
94% ee
Table 3, entry 1
N O
Bn
MePh
OH
HPLC: t1 = 59.3 (major enantiomer)
       t2 = 76.3 (minor enantiomer)
NaBH4
EtOH
Determination of the Absolute Configuration of (3R,4S,5R)-2-Benzyl-4-
formyl-5-methyl-3-phenylisoxazolidine (Table 7, entry 1) by Correlation with
(3R,4S,5R)-2-benzyl-5-methyl-3-phenylisoxazolidine-4-carboxylic acid isopropyl
ester.
 (3S,4R,5S)-2-Benzyl-4-formyl-5-methyl-3-phenylisoxazolidine was prepared
according to general procedure B from (Z)-N-benzylidenebenzylamine N-oxide (105.6
mg, 0.50 mmol), (2S)-proline methyl ester hydrochloric acid salt3 (20.3 mg, 0.10 mmol),
crotonaldehyde (0.13 mL, 1.50 mmol) and H2O (5.0 mL, 0.09 mmol) in CH3NO2 (5.0 mL)
over the course of 24 h.  The resulting solution was passed through a silica gel column
with CH2Cl2 to provide an oil.  A portion of the product was reduced to the corresponding
primary alcohol (general procedure C) and purified by silica gel chromatography (30%
EtOAc/hex) for the determination of enantiomeric purity; endo 41% ee. Enantiomeric
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ratios were determined by HPLC with a Chiralcel OD-H column and OD guard column
(2.5% iPrOH/hex, 1 mL/min flow rate); endo isomers tr = 59.3 min (minor enantiomer)
and 76.3 min (major enantiomer).  The remainder of the product (59.4 mg, 0.21 mmol)
was dissolved in tert-butanol (4.4 mL).  To this solution was added 2-methyl-2-butene (1
mL, 90 mmol) and, dropwise, a solution of NaClO2 (175 mg, 1.93 mmol) and NaH2PO4
(203 mg, 1.47 mmol) in H2O (1.8 mL).  The biphasic solution was stirred for 11h.  The
reaction was concentrated, diluted with H2O, and washed with hexanes.  The aqueous
layer was acidified with 1N HCl to pH 2, and extracted twice with Et2O.  The combined
organic layers were washed with cold H2O, dried (Na2SO4), and concentrated.  To this oil
was added CH2Cl2 (0.75 mL), 4-dimethylamino-pyridine (1.0 mg, 0.008 mmol), and 2-
propanol (0.023 mL, 0.3 mmol).  This solution was added to dicyclohexylcarbodiimide
(19.3 mg, 0.09 mmol) and the reaction was stirred for 2h at which time it was filtered,
concentrated, dissolved in CH2Cl2, and filtered.  The filtrate was washed sequentially
with 0.5M HCl and sat. aq. NaHCO3, dried (Na2SO4), and concentrated.  The resulting oil
was purified by silica gel chromatography (10% EtOAc/hex) to afford an oil with spectral
data identical to those reported for (3S,4R,5S)-2-Benzyl-4-formyl-5-methyl-3-
phenylisoxazolidine isopropyl ester;8 [ a]D (literature) = -28.1 ° (c = 1.0, CHCl 3); [ a]D
(found) = -7.4 ° (c = 1.0, CHCl3).
Determination of the Absolute Configuration of (3R,4S,5R)-2-allyl-4-formyl-
5-methyl-3-phenylisoxazolidine (Table 7, entry 2) by Correlation with (2R)-[1-((R)-
allyl-benzyl-amino)-phenyl-methyl]-butane-1,(3R)-diol.
(2R)-[(R)-Benzylamino-phenyl-methyl]-butane-1,(3R)-diol, of known absolute
configuration (vida infra) (23.0 mg, 0.08 mmol), and K2CO3 (44.8 mg, 0.32 mmol) were
dissolved in 1 : 1 H2O : CH3CN (0.5 mL : 0.5 mL).  To the solution was added allyl
bromide (0.05 mL, 0.32 mmol) and the reaction was stirred for 63h.  The reaction was
extracted with Et2O.  The organic layer was dried (Na2SO4) and concentrated.  The
resulting oil was purified by silica gel chromatography (40% EtOAc/hex) to afford (2R)-
[1-((R)-allyl-benzyl-amino)-phenyl-methyl]-butane-1,(3R)-diol: 1H NMR (500 MHz,
CDCl3) d 7.45–7.21 (m, 10H, C6H5),  5.93–5.87 (m, 1H, CH2=CHCH2), 5.25–5.21 (m,
                                                 
4 Gothelf, K. V., Thomsen, I., Jørgensen, K. A., J. Am. Chem. Soc., 1996, 118, 59-64.
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2H, CH2=CH), 4.17-4.10 (m, 1H, CHCH3),  4.07 (d, J = 11.2 Hz, 1H, NCHC6H5), 4.02
(d, J = 13.7 Hz, 1H, CH2C6H5), 3.55-3.49 (m, 2H, CH2OH, CH2=CHCH2N), 3.31 (dd, J =
3.4, 11.3 Hz, 1H, CH2OH), 2.95 (d, J = 13.7 Hz, 1H, CH2C6H5), 2.55 (dd, J = 8.8, 13.2
Hz, 1H, CH2=CHCH2N), 2.26-2.22 (m, 1H, CHCH2OH), 1.33 (d, J = 6.3 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) d 138.5, 135.7, 133.9, 130.1, 129.4, 128.9, 128.5, 128.0,
127.6, 119.1, 70.2, 65.0, 61.8, 54.4, 53.1, 46.1, 21.2; [a]D = +74.3 ° (c = 1.0, CHCl3).
A solution of (3R,4S,5R)-2-allyl-4-formyl-5-methyl-3-phenylisoxazolidine (Table
3, entry 2), (51.0 mg, 0.22 mmol) was reduced to the corresponding primary alcohol
(general procedure C) and purified by silica gel chromatography (30% EtOAc/hex).  The
resulting oil (24.8 mg, 0.11 mmol) was dissolved in EtOH (3.5 mL) and heated to reflux.
Sodium metal (150 mg,  6.52 mmol) was added in 25 mg portions to the solution.  After 3
hours at reflux, when a white solid had formed, the reaction was cooled to room
temperature and quenched with water.  The mixture was diluted with EtOAc, washed
with NH4Cl, and extracted with EtOAc.  The organic extracts were combined, dried
(Na2SO4), and concentrated.  Purification of the resulting oil by silica gel chromatography
(4% Et3N/EtOAc) afforded a white solid.  The solid (5.4 mg, 0.023 mmol) was dissolved
in CH3CN (1.0 mL).  To the stirring solution was added benzyl bromide (3.0 mL, 0.025
mmol) and K2CO3 (5.7 mg, 0.041 mmol).  The reaction was heated to reflux for 12 hours.
The solution was filtered and concentrated.  The resulting oil was purified by silica gel
chromatography (50% EtOAc/hex) to afford a clear oil with 1H and 13C  NMR spectra
identical to those of (2R)-[1-((R)-allyl-benzyl-amino)-phenyl-methyl]-butane-1,(3R)-diol
above; [a]D = +72. 1 ° (c = 1.0, CHCl3).
Determination of the Absolute Configuration of (3R,4S,5R)-2,5-dimethyl-4-
formyl-3-phenylisoxazolidine (Table 7, entry 3) by Correlation with (2R)-[1-((R)-
benzyl-methyl-amino)-phenyl-methyl]-butane-1,(3R)-diol.
(2R)-[(R)-Benzylamino-phenyl-methyl]-butane-1,(3R)-diol, of known absolute
configuration (vide infra) (26.8 mg, 0.09 mmol), and K2CO3 (52.0 mg, 0.38 mmol) were
suspended in CH3CN (1.5 mL).  To the suspension was added iodomethane (5.8 mL, 0.09
mmol) and the reaction was stirred for 48h.  The reaction was diluted with H2O and
extracted with EtOAc.  The organic layer was dried (Na2SO4) and concentrated.  The
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resulting oil was purified by silica gel chromatography (50% EtOAc/hex) to afford (2R)-
[1-((R)-benzyl-methyl-amino)-phenyl-methyl]-butane-1,(3R)-diol: 1H NMR (500 MHz,
CDCl3) d 7.45–7.22 (m, 10H, C6H5), 4.24 (dq, J = 2.4, 6.4 Hz, 1H, CHCH3),  4.14 (d, J =
11.2 Hz, 1H, NCHC6H5), 3.61 (dd, J  = 2.4, 11.8 Hz, 1H, CH2OH), 3.48 (m, 2H,
NCH2C6H5), 3.37 (dd, J = 3.9, 11.7 Hz, 1H, CH2OH), 2.20-2.13 (m, 1H, CHCH2OH),
2.12 (s, 3H, NCH3), 1.38 (d, J = 6.4 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3) d 138.1,
133.5, 130.1, 129.3, 128.9, 128.5, 128.1, 127.7, 70.3, 69.9, 61.7, 60.0, 45.9, 37.0, 21.9;
[a]D = -10.3 ° (c = 1.0, CHCl3).
A solution of (3R,4S,5R)-2,5-dimethyl-4-formyl-3-phenylisoxazolidine (Table 3,
entry 3), (51.0 mg, 0.25 mmol) was reduced to the corresponding primary alcohol
(general procedure C) and purified by silica gel chromatography (30% EtOAc/hex).  The
resulting oil was dissolved in EtOH (5.0 mL) and heated to reflux.  Sodium metal (180
mg, 7.83 mmol) was added in 25 mg portions to the solution.  After 4 hours at reflux,
when a white solid had formed, the reaction was cooled to room temperature and
quenched with water.  The mixture was diluted with EtOAc, washed with NH4Cl, and
extracted with EtOAc.  The organic extracts were combined, dried (Na2SO4), and
concentrated.  Purification of the resulting oil by silica gel chromatography (10%
Et3N/EtOAc) afforded a white solid.  The solid (9.1 mg, 0.047 mmol) was dissolved in
CH3CN (1.0 mL).  To the stirring solution was added benzyl bromide (5.8 mL, 0.048
mmol) and K2CO3 (12.0 mg, 0.086 mmol).  The reaction was heated to reflux for 14h
hours .  The solution was filtered and concentrated.  The resulting oil was purified by
silica gel chromatography (65% EtOAc/hex) to afford a clear oil with 1H and 13C NMR
spectra identical to those of (2R)-[1-((R)-benzyl-methyl-amino)-phenyl-methyl]-butane-
1,(3R)-diol above; [a]D = -8.4 ° (c = 1.0, CHCl3).
Determination of the Absolute Configuration of (3R,4S,5R)-2-benzyl-4-
formyl-5-methyl-3-(4-chlorophenyl) isoxazolidine (Table 7, entry 4) by Correlation
with (2R)-[(R)-benzylamino-phenyl-methyl]-butane-1,(3R)-diol.9
(3R,4S,5R)-2-Benzyl-4-formyl-5-methyl-3-phenylisoxazolidine, of known
absolute configuration (Table 3, entry 1) (25.0 mg, 0.09 mmol), was reduced to the
                                                 
9 Experiment run by J. J. M. Wiener.
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corresponding primary alcohol (general procedure C) and purified by silica gel
chromatography (30% EtOAc/hex).  The resulting oil was dissolved in EtOH (1.2 mL)
and heated to reflux.  Sodium metal (180 mg, 7.83 mmol) was added in 25 mg portions to
the solution.  After 2.5 hours at reflux, when a white solid had formed, the reaction was
cooled to room temperature and quenched with water.  The mixture was diluted with
EtOAc, washed with NH4Cl, and extracted with EtOAc.  The organic extracts were
combined, dried (Na2SO4), and concentrated.  Purification of the resulting oil by silica gel
chromatography (2.5% Et3N/EtOAc) afforded (2R)-[(R)-benzylamino-phenyl-methyl]-
butane-1,(3R)-diol as a white solid: 1H NMR (300 MHz, CDCl3) d 7.42–7.20 (m, 10H,
C6H5),  4.07 (dq, J = 2.2, 6.0 Hz, 1H, CHCH3),  3.99 (d, J = 9.3 Hz, 1H, NCHC6H5), 3.60
(d, J = 12.6 Hz, 1H, CH2C6H5), 3.54 (d, J = 12.6 Hz, 1H, CH2C6H5), 3.52 (dd, J = 3.9,
11.3 Hz, 1H, CH2OH), 3.19 (dd, J = 3.3, 11.3 Hz, 1H, CH2OH), 1.74-1.66 (m, 1H,
CHCH2OH), 1.25 (d, J = 6.3 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) d 141.4, 139.0,
129.1, 128.8, 127.9, 127.6, 127.5, 69.6, 64.9, 61.6, 51.9, 51.7, 22.3; [a]D = +41.5 ° (c =
1.0, CHCl3).
A solution of (3R , 4S,5R)-2-benzyl-4-formyl-5-methyl-3-(4-chlorophenyl)
isoxazolidine, (25.0 mg, 0.08 mmol) was reduced to the corresponding primary alcohol
(general procedure C) and purified by silica gel chromatography (30% EtOAc/hex).  The
resulting oil was dissolved in EtOH (1.2 mL) and heated to reflux.  Sodium metal (180
mg, 7.82 mmol) was added in 25 mg portions to the solution.  After 2 hours at reflux,
when a white solid had formed, the reaction was cooled to room temperature and
quenched with water.  The mixture was diluted with EtOAc, washed with NH4Cl, and
extracted with EtOAc.  The organic extracts were combined, dried (Na2SO4), and
concentrated.  Purification of the resulting oil by silica gel chromatography (2.5%
Et3N/EtOAc) afforded a white solid oil with 1H and 13C NMR spectra identical to those of
(2R)-[(R)-benzylamino-phenyl-methyl]-butane-1,(3R)-diol above; [a]D = +35.5 ° (c =
1.0, CHCl3).
Determination of the Absolute Configuration of (3R,4S)-2-Benzyl-4-formyl-3-
phenylisoxazolidine (Table 7, entry 11) by Correlation with (S)-3-Benzylamino-3-
phenyl-propan-1-ol.  To Wilkinson's catalyst (72.2 mg, 0.078 mmol) was added a
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solution of (3R,4S)-2-Benzyl-4-formyl-3-phenylisoxazolidine (Table 3, entry 11) (20.4
mg, 0.078 mmol) in degassed benzene (3.5 mL).  The stirring solution was heated to
reflux under a nitrogen atmosphere.  After 20h, the reaction was cooled to room
temperature and H2O was added.  The mixture was extracted with Et2O, dried (Na2SO4),
and concentrated to give a red oil which was purified by silica gel chromatography (10%
EtOAc/hex).  The resulting oil was dissolved in EtOH (2 mL) and heated to reflux.
Sodium metal (120 mg, 5.22 mmol) was added in 25 mg portions to the solution.  After 4
hours at reflux, when a white solid had formed, the reaction was cooled to room
temperature and quenched with water.  The mixture was diluted with EtOAc, washed
with NH4Cl, and extracted with EtOAc.  The organic extracts were combined, dried
(Na2SO4), and concentrated.  Purification of the resulting oil by silica gel chromatography
(EtOAc) afforded an oil with  1H and 13C NMR spectra identical to those reported for (S)-
3-Benzylamino-3-phenyl-propan-1-ol;5  [a]D (literature) = -28.1 ° (c = 1.0, CHCl3); [a]D
(found) = +26.2 ° (c = 1.0, CHCl3).
Determination of the Relative Configuration of (3R,4S)-2-Benzyl-4-formyl-3-
phenylisoxazolidine (Table 7, entry 14) by X-ray Crystallography.  2-Benzyl-4-
formyl-3-phenylisoxazolidine (54 mg, 0.18 mmol) was dissolved in tert-butanol (3.9
mL).  To this solution was added 2-methyl-2-butene (1 mL, 90 mmol) and, dropwise, a
solution of NaClO2 (152 mg, 1.69 mmol) and NaH2PO4 (178 mg, 1.29 mmol) in H2O (1.7
mL).  The biphasic solution was stirred for 12h.  The reaction was then concentrated,
diluted with H2O and EtOAc and extracted twice with EtOAc.  The combined organic
layers were washed with cold H2O, dried (Na2SO4),  concentrated, and purified by silica
gel chromatography (40% EtOAc/Hex).  The resulting yellow oil was subsequently taken
up in methanol (0.5 mL) and cooled to 0 °C.  A solution of KOH (5 mg) in methanol (53
µL) was added to the reaction mixture.  After stirring for 3 hours, the solution was
concentrated and the resulting yellow solid was recrystallized from ethanol/THF to afford
racemic crystals suitable for single crystal X-ray diffraction.
                                                 
5 Shimizu, M.; Maruyama, S.; Suzuki, Y.; Fujisawa, T.  Heterocycles  1997, 45, 1883.
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Chapter 3
Enantioselective Organocatalytic
Intramolecular Diels-Alder Reactions
and Their Application toward the
Asymmetric Total Synthesis of (–)-Solanapyrone D
I. Introduction
Since its discovery over 70 years ago,1 the Diels-Alder reaction has become one
of the most widely used synthetic transformations in organic chemistry.  Its ability to
generate up to four stereocenters in a highly stereoselective and predictable fashion led to
its widespread application in solving difficult synthetic challenges.  The intramolecular
version of this process, in which the diene and dienophile are tethered by a connecting
chain, has similarly attracted a great deal of attention; numerous examples in the
literature attest to its utility in generating stereochemically complex polycyclic ring
systems from relatively simple starting materials.
In contrast to its bimolecular counterpart, of which there are a large number of
documented asymmetric catalytic variants,2 there are relatively few examples in the
literature of enantioselective catalytic intramolecular Diels-Alder (IMDA) reactions.
Therefore, we began a program to address the utility of asymmetric organocatalysis to the
intramolecular Diels-Alder cycloaddition, thus expanding the scope of this reaction. (eq.
1)  Furthermore, the successful application of this methodology to an enantioselective
synthesis of (–)-solanapyrone D is presented.
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A. Background
The IMDA reaction is one of the most efficient and elegant methods for
constructing polycyclic ring systems in the synthetic chemist’s toolbox of
transformations.  In a single step, functionalized bicyclic ring systems possessing up to
four contiguous stereocenters can be generated from relatively simple triene precursors.
Since the reaction proceeds though a highly ordered transition state, excellent levels of
regio- and diastereoselectivities are oftentimes observed.
The intramolecular Diels-Alder cycloaddition reaction can be broken down into
two major classes, identified based on the point of connection between the diene and the
dienophile (Figure 1).  Type I IMDA reactions involve trienes with the dienophile
tethered from the terminus of the diene, resulting in bicyclic products containing a fused
ring junction.  The stereo- and regioselectivities of these reactions are highly dependent
on the nature of the diene, dienophile, and tether.  Comprehensive reviews have been
published on this topic, and therefore it will not be discussed here.3-7   Type II IMDA
substrates, on the other hand, have the dienophile tethered from an internal position on
the diene, resulting in the formation of bridged bicycles containing highly strained
bridgehead double bonds (anti-Bredt olefin).  This reaction is notably powerful since
there are few methods for accessing these particularly complex frameworks, which are
prevalent in a number of natural products families.   Selectivity is also a potential concern
in these reactions; however, predicting  diastereoselectivity is somewhat simpler in these
cases as compared to the type I IMDA.   Substrates with bridging chains of three or four
atoms cyclize exclusively to give syn products because the transition state leading to the
anti diastereomer is prohibitively high in energy.8   Given the powerful nature of this
reaction, it is interesting to note that there is no asymmetric catalytic type II
intramolecular Diels-Alder variant reported in the literature to date.
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B. Diastereoselective Intramolecular Diels-Alder Reactions
There are many examples in the literature of diastereoselective IMDA reactions,
the most common type being where one or more stereocenters in the acyclic IMDA
precursor is used to relay stereochemistry to the newly formed chiral centers (eq. 2).9
These reactions are extremely useful, although somewhat limiting; since the
stereocontrol element is not easily removed in most cases, these reactions are only useful
when that chiral element is present in the target of interest.
A more general approach for accessing enantioenriched IMDA cycloadducts is
through the use of chiral auxiliaries, which can removed upon completion of the
cycloaddition reaction.  Mukaiyama was the first to publish on such a system in his
synthesis of sesquiterpene (+)-farnesiferol (eq. 3).10 Intramolecular cycloaddition of
furanyl diene 4 with the phenyl glycinol-derived unsaturated amide provided the desired
cycloadduct 6 in moderate yields and selectivities.   The authors speculated that the
reaction proceeded though the conformationally locked intermediate 5 which favored
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approach of the diene from the re-face of the dienophile; this therefore led to the
preferential formation of the desired diastereomer.  This example is a rare case of an
“internal” auxiliary (where the removable chiral element is embedded within the tether);
subsequent excision of the chiral auxiliary necessarily leads to the cleavage of the bicycle
formed in the IMDA reaction.
More commonly used are “external” chiral auxiliaries in which the auxiliary is
connected to the terminus of the dienophile.  In these cases, the polycyclic system formed
in the IMDA reaction can be left intact upon removal of the chiral controlling element.
To date, the two most successful chiral auxiliaries of this type are the acyl oxazolidinones
711-14 and acyl sultams 8.15
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Both auxiliaries have been shown to confer higher levels of reactivity and
selectivity on the IMDA reaction than any previously published auxiliaries (eq. 4, 5).
The imide and sultam cycloadditions are believed to proceed though similar transition
states.  Evans speculates that addition of a Lewis acid to 7 produces ion pair 9 in which
the si-face is left open to attack, leading to the observed product.  Likewise, chelated
intermediate 10 correctly predicts the stereochemistry of the sultam-mediated reaction.
The utility of these auxiliaries has been demonstrated by their use in the synthesis of
complex natural products. Evans and Black used a chiral imide-controlled IMDA reaction
to access a highly functionalized bicyclic intermediate on the way to (+)-lepicidin.16
Morimoto and coworkers have also disclosed their use of a chiral oxazolidinone auxiliary
to establish the key stereochemical relationships in the core of (–)-stenine.17
C. Enantioselective Intramolecular Diels-Alder Reactions
In contrast to the bimolecular Diels-Alder reaction, of which there are hundreds of
asymmetric catalytic variants, there are relatively few examples in the literature of
enantioselective catalytic IMDAs.  Furthermore, in a number of these examples, very few
substrates have been examined, since they are treated mainly as an extension of the
intermolecular Diels-Alder reaction, or substrate scope has been shown to be somewhat
limited.
Yamamoto and coworkers were one of the first groups to report the successful use
of a chiral Lewis acid to catalyze an asymmetric IMDA reaction.18  They found that
treatment of triene 12 with chiral acyloxyborane complex (CAB) 11 produced the desired
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[4.3.0] bicycle in good yields and with excellent diastereo- and enantiocontrol (eq. 6).
However, it was also found that this catalyst system was not generally applicable to the
IMDA reaction; cyclization of analogous trienal substrate 14 lacking a a-methyl group
proceeded in only 46% ee.
This shortcoming was later addressed by Yamamoto with the introduction of their
Brønsted acid-assisted chiral Lewis acid (BLA) 13.19,20 The reaction of a-unsubstituted
decatrienal 14 in the presence of 13 produced the desired [4.3.0] bicycle as a single
diastereomer in 95% yield and 80% ee (eq. 7).  Although a number of intermolecular
Diels-Alder substrates were studied, trienal 14 was the only IMDA substrate that was
examined in this study.
A more extensive study of asymmetric IMDA reactions was carried out by
Narasaka and coworkers, who found that Ti-TADDOL complex 15 was capable of
catalyzing the IMDA reaction of a number of trienimides.21 Although nonatrieneimides
reacted, decatrienimide reactions proceeded very slowly, or very poorly, and therefore
required high catalyst loadings and extended reaction times (3-10 days, eq. 8).  Reactivity
could be increased (reaction times of 3-4.5 days) by modifying the substrates to
incorporate a dithiane moiety on the tether, presumably due to Thorpe-Ingold
acceleration.22  Narasaka later demonstrated the potential utility of this methodology in
the elaboration of one of these IMDA cycloadducts into the hydronaphthalene core of the
mevinic acid family of natural products.
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 One of the more extensive studies on asymmetric catalytic IMDA reactions was
published recently by Evans and Johnson, who reported the successful application of
their cationic C2-symmetric Cu(II)-tert-butyl-bis(oxazoline) catalyst 16 to the IMDA
reaction (eq. 10).23  Unsubstituted and phenyl-substituted trienimides were found to
cyclize efficiently in the presence of 16 to afford [4.4.0] and [4.3.0] bicyclic ring products
in good yields and with good selectivities (Table 1, with the exception of 19).  The
synthetic utility of this process was demonstrated in the subsequent conversation of
IMDA cycloadduct 21b to the marine natural product (–)-isopulo’upone.
Although these studies have significantly advanced the field of asymmetric
catalytic intramolecular Diels-Alder reactions, there are still improvements that can be
made on the current technology.  None of these studies explore a particularly wide
substrate scope, and therefore it is difficult to draw conclusions as to the generality of
these catalyst systems toward the IMDA reaction.  Furthermore, the most useful systems
currently employ the use of an achiral oxazolidinone auxiliary, which must be removed
upon completion of the reaction.  Since our organocatalytic methodology allows for
direct access to aldehyde functionalities, we became interested in applying our
enantioselective organocatalytic technology to the IMDA reaction, in the hopes of
developing a broadly useful variant of the asymmetric, catalytic intramolecular Diels-
Alder reaction.
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II. Results and Discussion
A. Synthesis of Intramolecular Diels-Alder Reaction Substrates
The synthesis of tetraenal substrate 24 is outlined in Scheme 1.  Known aldehyde
2224 (prepared in one step from glutaric dialdehyde) was treated with a Wittig reagent
formed from n-BuLi deprotonation of (2E,4E)-2,4-hexadiene-1-triphenylphosphonium
bromide.  The resulting ester was then reduced to the primary alcohol with DIBAL-H to
give the tetraene as a 2:1 mixture of (2E, 7E, 9E, 11E)- to (2E, 7Z, 9E, 11E)- olefin
isomers.  Subjection of the alcohol to iodine olefin isomerization conditions produced 23
as a 6:1 mixture of olefin isomers, favoring the desired (2E, 7E , 9E, 11E)- isomer.
Subjection of the primary alcohol to oxidation conditions afforded the desired tetraenal
24.
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Synthesis of phenyl-substituted decatrienal 29 began with a one-pot DIBAL-H
reduction/Wittig olefination of commercially available e-caprolactone to produce diene
30 as a 1:1 mixture of olefin isomers.  Iodine mediated olefin isomerization equilibrated
the mixture to a 5:1 mixture favoring the desired (6E, 8E)-isomer.  Subsequent oxidation
of the alcohol to the aldehyde, followed by Wittig olefination with methyl
(triphenylphosphoranylidene)acetate furnished ester 27 in good yields.  DIBAL-H
reduction of the ester followed by TPAP oxidation afforded trienal 29.
Finally, it should be noted that this project was carried out in collaboration with
Rebecca Wilson, who originally began this work; one should refer to her thesis25 for the
synthetic details of any substrates in the subsequent discussion that are not covered in this
section.
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B. Organocatalytic Intramolecular Diels-Alder Reactions
Reaction Optimization.  Each of the IMDA substrates were individually studied
and optimized to maximize yield and selectivity.  There were four main side reactions
that had to be considered during optimization, since it was these alternate reaction
pathways that led to the degradation of product selectivity and yields.
First, polymerization of the starting materials under reaction conditions was
frequently a problem, which is not surprising given the notorious instability of trienals
and tetrenals.  Second, acid catalyzed racemic background reactions were frequently a
concern.  Since the two reacting partners in the IMDA reaction (the diene and dienophile)
are tethered to one another, simple dilution effects were generally ineffective at reducing
racemic background.  Because these background reactions proceed through an achiral
transition state, the resulting products are racemic; this therefore led to a degradation in
the optical purity (ee) of the bicyclic products.
Third, the products of the IMDA reaction were prone to epimerization at the
aldehydic stereocenter (eq. 12).  Given the somewhat acidic nature of the proton a to the
aldehyde, it was not surprising that that stereocenter was prone to epimerization in the
presence of bases, such as the amine catalyst and conjugate base of the cocatalyst.
Finally, it was found that under certain reaction conditions, a considerable amount
of aromatic side product 34  was formed.  This presumably occurs though the
dimerization mechanism outlined in Scheme 3.  Condensation of the chiral amine catalyst
with aldehyde 30 produces the iminium 31.   Since the dienophile is now activated, the
predicted course of action would be for the triene to cyclize to form the desired IMDA
cycloadduct.  However, the triene can also be g-deprotonated with the conjugate base of
the acid cocatalyst (X-), to form dienamine 32.  Subsequent intermolecular Diels-Alder
cyclization of the electron deficient olefin in 31 with the very electron rich diene 32
produces cyclohexene 33.  Hydrolysis of the iminium, followed by elimination and
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oxidation provides the observed fully aromatized side product 34 .  Since this
dimerization pathway lead to an undesired consumption of the IMDA substrate, this side
reaction would result in a decrease in the yield for the desired IMDA reaction.
Since the extent to which each of these side reactions factored into the IMDA
reaction was highly dependent on the inherent reactivity of the IMDA substrate being
studied, each substrate had to be optimized on an individual basis. Several reaction
variables were tuned to maximize yield and selectivity, and to minimize the
aforementioned undesired side reactions.
One variable that seemed to consistently have a large effect on the reaction was
the nature of the acid co-catalyst (Figure 3).  It was generally found that more acidic co-
catalysts (HClO4, HCl) were effective at decreasing product epimerization and starting
material dimerization.  This result is not surprising, since both of these side reactions are
base catalyzed pathways; decreasing the basicity of the co-catalyst’s conjugate base
should decrease the amount of epimerization and dimerization.
On the other hand, use of less acidic co-catalysts generally led to a decrease in the
acid promoted racemic background reaction and starting material polymerization
reaction. These trends ultimately lead to the general use of less acidic co-catalysts (TFA,
TCA) for more reactive substrates, while less reactive substrates generally required the
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use of more acidic co-catalysts (TfOH, HClO4).  Substrates that cyclized more readily,
such as nonatrienal 35, suffered mainly from an acid-catalyzed background reaction and
substrate polymerization; thus, less acidic co-catalysts such as TFA were generally most
appropriate.  In contrast, less reactive substrates, such as decatrienal 36, were affected
mainly by dimerization and epimerization side reactions, and hence co-catalysts such as
TfOH were often used in these IMDA reactions.  In general, less acidic co-catalysts
(TFA) are used for more reactive substrates and more acidic co-catalysts (such as HClO4)
are used for less reactive substrates.  The reactivity of most substrates lies somewhere
between the two extremes discussed above; thus, the optimal co-catalyst must be
independently determined for each substrate examined.
Temperature also seemed to have a large effect on the yields and selectivities of
the IMDA reactions (Figure 4).  Generally, lower reaction temperatures led to less
racemic background, epimerization, and dimerization, while often improving product
diastereo- and enantioselectivities.  However, higher reaction temperatures generally led
to increased reaction yields by reducing starting material polymerization, since this side
reaction occurs mainly when substrates do not undergo the desired IMDA cyclization.
Therefore, less reactive substrates are generally run at higher reaction temperatures since
they are unreactive at lower temperatures and simply polymerized.   However substrates
that are sufficiently reactive are generally run at lower temperatures, and thus benefited
from less background, dimerization, epimerization, and improved selectivities.
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Empirical results suggested that water and solvent play an important role in
mediating the amount of polymerization, epimerization, and background reaction in the
IMDA cyclization reactions.  Acetonitrile, chloroform, isopropanol, and butanol were
generally the best solvents.  In particular, CH3CN and CHCl3 are effective at reducing
substrate polymerization and increasing substrate and catalyst solubility.  On the other
hand, butanol and isopropanol appeared to be effective at minimizing the epimerization
side reaction.  In addition, a solvent:water ratio of about 98:2 was generally used to
maximize the rate of catalyst turnover.
Finally, one of the most important reaction variables was choice in amine catalyst.
In the time since the [3+2] cycloaddition project was completed, second generation
imidazolidinone catalyst 2 was developed by Christopher Borths and Joel Austin. Amine
2 has been found to be a more effective catalyst than 1 in some cases, producing IMDA
cycloadducts with better selectivities and yields and with reduced reaction times.    These
increases in reactivity and selectivity can be rationalized by examining the differences
between the two catalysts (Figure 5).  Whereas the amine lone pair is eclipsed by one of
the geminal dimethyl groups in 1, catalyst 2 does not contain the same eclipsing
interaction.  The lone pair in 2 is therefore more sterically accessible; this leads to greater
nucleophilicity and overall catalyst reactivity.    Moreover, compounds reacting with the
catalyst-1-derived iminium ion must encounter a retarding interaction with the illustrated
methyl substitutent, whereas the reactive enantioface of the catalyst-2-derived iminium
ion is free from obstruction; this leads to increased reactivity for 2.  Furthermore, the
methyl group syn to the benzyl functionality in 1 has been replaced by a tert-butyl group
in 2.  This allows catalyst 2 to control iminium ion geometry, just as catalyst 1 does, thus
allowing the benzyl group on the catalyst framework to effectively shield one p-face of
the olefin.    Due to its enhanced reactivity, catalyst 2 was particularly effective at
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promoting the cyclization of relatively unreactive IMDA substrates.  For many of the
substrates (although not all), catalyst 2 performed better than 1.
IMDA Reaction Scope. Using the aforementioned variables to tune the reaction
conditions, a variety of IMDA substrates were studied, the results of which are
summarized in Table 2.  The reaction appears to tolerate variation in the diene, tether, and
dienophile components of the IMDA substrates. Cycloadducts are generated in good
yields and selectivities from IMDA substrates containing aryl (37, 85% yield, 93% ee),
allyl (24, 75% yield, 93% ee), and substitution on the diene.  Furthermore, the less
reactive decatriene substrate 29, while unreactive with 1, reacts readily in the presence of
2 to afford the [4.4.0]-bicycle in excellent yield and selectivity (70% yield, 93% ee).
Furthermore, we were able to access a bicyclic system containing a quaternary carbon
stereocenter in excellent yield and enantioselectivity (cat. 1, 76% yield, 94% ee) from a
trisubstituted (Z)-dienophile.
There have been no reports to date of an asymmetric IMDA in which the substrate
contains a heteroatom in the tether, perhaps due to the incompatibility of some Lewis
acids with the heteroatom functionality. Because organocatalysis does not suffer from the
same functional group compatibility issues, we were able to generate ether cycladduct 44
in 84% yield and 93% ee.
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Tetraene 24 was one of the more reactive substrates examined in this study,
cyclizing in 12 hours with catalyst 2 at –20 °C to afford [4.3.0]-bicycle 39 in 94% ee
(endo).  This is not wholly unexpected, since the introduction of an electron releasing
group should increase the energy of the diene HOMO and reduce the activation energy,
thereby making the reaction more facile.  Since the reaction was so facile, background
reaction was somewhat of a problem.  Similar to nonatrienal 37, 24 cyclized in the
presence of catalyst 1 to produce cycloadducts with lower enantioselectivities. This is
presumably due to the fact that 24 (and 37) are so reactive that there is a reasonable
amount of background reaction taking place; the more reactive catalyst 2 is better able to
out-compete the racemic background to produce cycloadducts in higher ee’s.  Catalyst 2
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was also superior to 1 in minimizing product epimerization of cycloadduct 39; efforts to
improve product:epimer ratios beyond 2:1 using catalyst 1 were largely unsuccessful.
Yields were also generally low using catalyst 1, presumably due to the inability of the
catalyst to out-compete  the decomposition of the somewhat unstable tetraene moiety
(47% yield with catalyst 1).
The relative stereochemistry of bicycle 39 was determined though nOe analysis.
Confirmation that 39 was indeed the endo isomer was accomplished by the observation
of nOe enhancements between C-3 and C-4 methine protons, and the C-4 and C-6
protons (Figure 6).
Decatrienal 29 was examined to assess the ability of the organocatalytic IMDA
reaction to accommodate the formation of [4.4.0]-bicycles.  This substrate was noticeably
less reactive than most other substrates, and efforts to optimize the reaction using catalyst
1 were largely unsuccessful.  This was not unexpected given that IMDA cyclizations to
form [4.4.0] systems are well documented to be slower than triene cyclizations to form
[4.3.0] ring systems. Catalyst 2, however, was successful in increasing the rate of the
reaction to useful levels while producing cycloadduct 45 with good diastereo- and
enantioselectivities.  In contrast to nonatrienal substrates 37 and 24, endo vs. exo
selectivity was more of an issue in this reaction.  This is also surprising since the steric
requirements in the transition state leading to the formation of a decalin system are less
than that for a hydrindene system.7  Fortunately, reaction conditions could be carefully
optimized to maximize the diastereoselectivity of the reaction.
The absolute and relative stereochemistry of 40 was established by chemical
correlation to the known thioester 47 ([a]D = –437.3 (c 1, CHCl3)), whose absolute
configuration was previously established (Scheme 4).23
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The Type II IMDA is one of the most efficient and elegant routes to these
complex ring systems; thus it is notable that there have been no reported examples of an
asymmetric Type II IMDA to date. Due to the success of the imidizolidinone catalysts in
promoting a range of traditional Type I IMDA cyclizations, we sought to extend our
organocatalytic strategy to the Type II IMDA.  We were pleased to find that when triene
48 was treated with imidizolidinone catalyst 2 , it reacted to afford the Type II
cycloadduct 49  as a single isomer in good yields with excellent levels of
enantioselectivity (72% yield, 98% ee).25 To our knowledge, this is the first reported
example of an asymmetric, catalytic Type II intramolecular Diels-Alder reaction.
Again, one should refer to R.M. Wilson’s thesis for reaction details and analysis
of any substrates not discussed in this section.
C.  Asymmetric Total Synthesis of (–)-Solanapyrone D
Background.  The phytotoxic polyketide natural product solanapyrone D (3) was
isolated in 1989 by Oikawa and Ichihara26,27  from the fungus Altenaria solani as a side
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product in the biosynthesis of solanapyrone A.28  Its biological activity has yet to be fully
explored, although recent studies have shown that solanapyrone A is a selective inhibitor
of mammalian DNA polymerase b and g, suggesting that compounds of this type may
find utility in cancer chemotherapy.29  The relationship between solanapyrones A and D
suggested that the biosynthesis of these natural products could involve an enzyme
capable of catalyzing a [4+2] cycloaddition reaction.  Indeed, in 1998 Oikawa and
Ichihara reported the first direct experimental evidence for the existence of a Diels-
Alderase through their studies on the biosynthesis of solanapyrones A and D.28,30-33
Feeding experiments performed with labeled prosolanapyrone 50 allowed the authors to
unambiguously establish that the solanapyrone natural products were formed via an
enzymatically catalyzed exo-selective intramolecular Diels-Alder reaction.  Incubation of
the achiral triene 50 in the crude enzyme extract from A. solani provided solanapyrone A
in 53% yield and 98% ee.30
The first, and only, total synthesis of solanapyrone D to date was recently
accomplished by Hagiwara and coworkers in 19 steps via a diastereoselective domino
Michael reaction (Scheme 6).34   The key transformation in the synthesis involved a
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diastereoselective domino Michael reaction between enantiopure known trimethylsilyl
enol ether 51 and methyl crotonate, to produce the desired trans-fused bicycle 52
following base isomerization.  This core was then elaborated over 13 steps to afford
pyrone 53.  Given the nontrivial nature of installing the final C-14 formyl group, the
authors developed a new 4 step formylation protocol which ultimately allowed them to
access solanapyrone D (3).35,36
Given the Diels-Alderase studies and the presence of an appropriately substituted
trans-fused decalin system, we felt that solanapyrone D presented itself as an appropriate
platform for demonstrating the utility of our enantioselective organocatalytic IMDA
methodology.   This target molecule would also allow us to further probe the scope of
this IMDA reaction by testing the tolerance of catalyst 2 to alkyl substitution at the diene
terminus in the formation of [4.4.0] bicyclic ring systems.
Synthesis of (–)-Solanapyrone D.  The synthesis of cyclization precursor 57 was
initiated by Wittig olefination of known aldehyde 5530 (synthesized in 2 steps from
commercially available e-caprolactone) with methyl(triphenylphosphoranylidene) acetate
to provide triene 56.  Ester 56 was subjected to DIBAL-H reduction conditions and the
derived alcohol was treated with TPAP/NMO to afford the desired IMDA precursor 57.
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With the requisite trienal in hand, the key organocatalytic IMDA reaction was
attempted.  Extensive optimization of the previously discussed reaction variables
produced conditions that cyclized IMDA precursor 57 to [4.4.0] bicycle 58 as a single
detectable isomer in 81% yield (eq. 14).   The IMDA reaction proceeded with good
enantioselectivity (90% ee) to introduce the bicyclic solanapyrone D core containing all
four stereocenters in the required configuration.
The target 3 required that the aldehyde functionality of 58 be converted to a
pyrone moiety (Scheme 8).  This was achieved by using the precedented work in
Hagiwara’s synthesis as a guide.34 58  was reacted with methyl acetoacetate
bis(trimethylsilyl) enol ether in the presence of titanium tetrachloride to afford aldol
adduct 59 (1:1 mixture of alcohol isomers).  This hydroxyketoester was subjected to
Dess-Martin oxidation conditions, and subsequently cyclized with DBU at elevated
temperatures to furnish pyrone 60 in 87% yield.
Conversion of 60 to the natural product 3 proved to be nontrivial.  Although
pyrone 60 is only two functional group transformations away from the target product 3,
C-3 formylations of 4-hydroxypryones and 4-methoxypyrones (C-14 on 60) have been
documented to be difficult.  There are only a handful of methods for introducing this
functionality in the context of the pyrone system; all but one require lengthy multi-step
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sequences.37,38  The only one-step protocol requires harsh acidic conditions (TiCl4,
Cl2CHOMe), and was found to be unsuitable in the context of this synthesis; subjection
of 60 to these reaction conditions produced a complex mixture of products.  Hagiwara
developed a three-step sequence to address this shortcoming in his synthesis of
solanapyrone D (four steps including the methylation of C-15 hydroxyl, Scheme 6).35
Given the dearth of efficient methods for formylating 4-oxypyrones, we became
interested in developing an efficient protocol for effecting this transformation.
A variety of reaction conditions were examined in an effort to identify suitable
conditions for formylating 4-hydroxypyrones (e.g. 60) and 4-methoxypyrones (e.g. 61).
Extensive efforts were invested into finding Villsmeier-Haack or Fries-type
rearrangement conditions that could effect the desired transformation.  Unfortunately, the
former generally resulted in recovery of unreacted starting material, and the latter led to
the formation of dimerization products.  Attempts at directly condensing 60 and 4-
methoxypyrone 61 resulted only in the formation of dimeric products under a variety of
acidic and basic conditions.  Finally, attempts were made to iodinate at C-14 on 60 and
formylate with  Pd(0)/CO/Bu3SnH in a two step protocol.  This strategy was mildly
successful on the model system 4-methoxy-6-methyl-pyran-2-one (c.a. 15% yield in the
Pd(0) mediated coupling); however, iodination of 60 proved to be difficult because of the
alkene present in the decalin system.
Attempts to generate and trap the C-14 carbanion were, however, greeted with
success.   Methylation of 6o with methyl p-toluenesulfonate afforded 61 in 81% yield,
which was then subjected to n-BuLi to effect the ortho-lithiation of the pyrone moiety,
generating intermediate 62.  Subsequent addition of methyl formate then resulted in the
formation of 3 in c.a. 20% yield.  LDA was later identified to be a superior lithiation
reagent; it increased yields while decreasing decomposition of starting material.  Reaction
conditions were ultimately optimized to provide the desired product 3 in 57% yield (91%
yield based on recovered starting material).  The 1H NMR, 13C NMR, IR, and HRMS data
of the synthetic sample matched the literature data for 3.27  Furthermore, the optical
rotation, [a]D –227.8 (c 1, CHCl3), had the same sign as the natural product, lit. [a]D
–148.7 (c 1, CHCl3), there confirming the absolute and relative stereochemistry of the
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synthetic product 3.  Ultimately, the synthesis of (–)-solanapyrone D was achieved in 9
steps from known aldehyde 55, or 11 steps from commercially available e-caprolactone.
III. Conclusion
We have developed a new enantioselective organocatalytic intramolecular Diels-
Alder reaction capable of cyclizing a variety of trienals in good yields and with excellent
selectivities.  This reaction has been found to tolerate variation in the diene, tether, and
dienophile components of the IMDA substrate, thereby allowing access to range of
substituted [4.3.0] and [4.4.0] bicyclic ring systems.  This survey represents one of the
most comprehensive substrate studies reported to date on the asymmetric catalytic IMDA
reaction.   Furthermore, we have successfully developed the first asymmetric Type II
intermolecular Diels-Alder cyclization.  Finally, asymmetric organocatalytic IMDA
reaction comprised the pivotal bond construction in an efficient total synthesis of (–)-
solanapyrone D.  The desired decalin core containing all four contiguous stereocenters
was introduced in a single step.  In the course of this synthesis, an efficient new one-step
protocol was developed for the formylation of 4-methoxylpyrones.  This 9 step synthesis
of (–)-solanapyrone D (compared to the previously published synthesis of 19 steps)
effectively demonstrates the synthetic utility of this newly developed organocatalytic
IMDA methodology.
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Experimental
General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1  Organic solutions were concentrated under
reduced pressure on a Buchi rotary evaporator.  Chromatographic purification of products
was accomplished using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63
according to the method described by Still.2  Thin-layer chromatography (TLC) was
performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of the
developed chromatogram was performed by florescence quenching, anisaldehyde stain,
or potassium permanganate stain.
1H and 13C spectra were recorded on Bruker AM-400 (400 MHz and 100 MHz,
respectively), Bruker DRX-500 (500 MHz and 125 MHz, respectively), Varian Mercury-
300 (300 MHz and 75 MHz, respectively), or Varian I-500 (500 MHz and 125 MHz,
respectively) instruments, as noted, and are internally referenced to residual protio
solvent signals.  Data for 1H are reported with chemical shift (d ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz), and assignment.  Data for 13C are reported with chemical shift.  IR spectra were
recorded on an ASI React-IR 1000 spectrometer and are reported in terms of frequency of
absorption (cm-1).  Optical Rotations were recorded on a Jasco P-1010 polarimeter (WI
lamp, 589 nm, 25°C).  Mass spectra were obtained from the UC Irvine Mass Spectral
Facility.  Gas Chromatography was performed on Hewlett-Packard 5890A and 6890
Series gas chromatographs equipped with a split-mode capillary injection system and
flame ionization detectors using a Bodman Chiraldex G-TA (30 m x 0.25 mm) column,
Bodman Chiraldex b-DM (30 m x 0.25 mm) column or Bodman Chiraldex b-PH (30 m x
0.25 mm) column.  HPLC analysis was performed on a Hewlett-Packard 1100 Series
HPLC at 254nm using the following Chiralcel columns: OD-H (25 cm) and OD guard (5
cm), AD (25 cm) and AD guard (5 cm).
                                                 
1 Perrin, D. D.; Armarego, W.L.F. Purification of Laboratory Chemicals; 3rd ed., Pregamon Press, Oxford,
1988.
2 Still, W.C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
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Alcohol 23.  To a suspension of (2E, 4E)-hexadiene-1-triphenylphosphonium
bromide3,4 (1.9 g, 4.6 mmol) in 6.0 mL THF cooled to –30 °C was added 2.2 mL (4.6
mmol) nBuLi (2.13M in hexanes).  The dark red suspension was stirred at –30 °C for 1
hour, after which 7-oxo-hept-2-enoic acid methyl ester5 (0.65 g, 4.2 mmol) was added in
6.0 mL THF.  The solution was warmed to room temperature and stirred for an additional
1.5 hours.  The reaction was quenched with H2O, partitioned, and extracted with hexanes
(3 x 30 mL).  The organic extracts were combined and washed with brine, dried over
Na2SO4, filtered, and concentrated in vacuo. The crude ester 22a was taken immediately
onto the next step without further purification.
To a solution of crude ester 22a in 42 mL CH2Cl2 cooled to –78 °C was added 1.7
mL (12.6 mmol) of DIBAL-H.  The solution was allowed to stir for 15 minutes, after
which the reaction was quenched with methanol (5 mL).  Upon warming the reaction to
room temperature, a saturated solution of sodium potassium tartrate was added (50 mL)
and the mixture was stirred vigorously for 8 hours.  The mixture was extracted with
CH2Cl2 (3 x 40 mL), and the combined organic extracts were washed with brine, dried
over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude oil
was purified by silica gel chromatography (1:4 EtOAc/Hexanes) to afford the title
compound as a clear, colorless oil in 63% yield (0.51 g) as a 2.9:1 mixture of
(2E,7E,9E,11E)- and (2E,7Z,9E,11E)- olefin isomers. The mixture was redissolved in 10
mL of CH2Cl2 and 50 mg (0.2 mmol) of I2 was added.  After 30 minutes, 10 mL of
Na2S2O3 (saturated) were added and the layers were partitioned.  The aqueous layer was
extracted with CH2Cl2 (3 x 10 mL), and the combined organics were washed with brine,
dried over Na2SO4, filtered, and concentrated in vacuo to provide the title compound as a
                                                 
3 Synthesis 2000, 1, 113.
4 J. Am. Chem. Soc. 1993, 115, 7653.
5 House, H.O.; Cronin, T.H. J. Org. Chem. 1965, 30
87
5.5:1 (6E,8E):(6Z,8E) mixture of geometric isomers in 54% yield (2.1 g). Major isomer:
IR (film) 3391, 3012, 2927, 2858, 1668, 1444, 996 cm-1; 1H NMR (300 mHz, CDCl3) d
6.30-5.99 (m, 4H, CH=CH), 5.75-5.62 (m, 4H, CH=CH ), 4.08 (d, J=7.1 Hz, 2H,
CH2OH), 2.14-2.00 (m, 4H, CH2CH=CH, HC=HCCH2), 1.74 (d, J=6.6 Hz, 3H, CH3CH),
1.49-1.44 (tt, J=7.1, 7.1 Hz, 2H, CH2CH2CH2); 13C NMR (75 MHz, CDCl3) d 133.9,
133.03, 131.9, 131.1,130.6,129.4, 129.2, 125,9, 64.1, 32.6, 32.0, 29.0, 18.7; HRMS (EI)
exact mass calcd for (C13H20O) requires m/z 192.1514, found m/z 192.1507.
HO Me O
Me
Aldehyde 24.  To a solution of 60 mg (0.31 mmol) of alcohol 23 in 3 mL of
CH2Cl2 was added 140 mg (0.33 mmol) of Dess-Martin periodinane and 79 mg (0.90
mmol) of sodium bicarbonate.  The solution was stirred at room temperature for 20
minutes, after which 3 mL of 1:1 NaS2O3/NaHCO3 aq. solution was added. The aqueous
layer was extracted with CH2Cl2 (2 x 10 mL), and the combined extracts were washed
with brine.  The organic extracts were dried over Na2SO4, filtered, and concentrated in
vacuo. Flash chromatography on florisil (10% EtOAc/hexanes) in the absence of light
provided the title compound as a clear oil in 53% yield (32 mg).  Due to compound
instability, the aldehyde was used immediately without full characterization. 1H NMR
(300 mHz, CDCl3) d  9.50 (d, J=7.7 Hz, 1H, CHO), 6.84 (dt, J=7.1, 13.2 Hz, 1H,
CHCHCHO), 6.22-6.00 (m, 5H, CH=CH), 5.74-5.56 (m, 2H, CH=CH), 2.40-2.28 (m,
2H, CH2CH=CHCHO), 2.18-2.11 (m, 2H, CH2CH=CH),  1.76 (d, J=5.5 Hz, 3H,
CH3CH), 1.64 (tt, J=6.6, 6.6 Hz, 2H, CH2CH2CH2); 13C NMR (75 MHz, CDCl3) d 194.2,
158.7, 133.3, 132.7, 131.8, 130.6, 130.4, 130.3, 129.6, 32.5, 32.4, 27.8, 18.7.
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[4.3.0]-bicycle 39.  Using imidazolidinone catalyst 1. A flask containing tetraene
24 (20 mg, 0.22 mmol, 85% E,E-diene geometry) was charged with 0.40 mL of 2% v/v
H2O/CH3CN and then cooled to –20°C. (5S)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one
trifluoroacetic acid salt (6.5 mg, 0.02 mmol) was then added in one portion to the solution
and the reaction was shaken for 72 hours.  The mixture was then loaded onto a silica gel
column and eluted with CH2Cl2. Removal of volatiles resulted in a oily residue that was
purified by silica gel chromatography (5% EtOAc/hexanes) to afford the title compound
as a clear oil in 47% yield (7.8 mg); 1.7:1:0.25 endo:endo epimer:exo.   Endo isomer: IR
(film) 3020, 2950, 2873, 1707, 1452, 965 cm-1; 1H NMR (300 mHz, CDCl3) d 9.63 (d,
J=2.7 Hz, 1H, CHO), 5.88 (d, J=9.3, 1H, HC=CH), 5.56-5.29 (m, 3H, HC=CH), 3.36-
3.27 (m, 1H, HC=CHCHCH=CH), 2.52 (ddd, J=2.7, 6.0, 10.8 Hz, 1H, CHOCH), 2.05-
1.95 (m, 1H, CHCHCH2), 1.89-1.69 (m, 5H, CHCHCH2, CH2CH2CH2), 1.25-1.01 (m,
2H, CH2CH2CH2); 13C NMR (75 MHz, CDCl3) d 205.0, 130.1, 130.0, 129.4, 128.5, 56.5,
45.3, 41.6, 39.9, 28.8, 27.8, 22.8, 18.3; HRMS (EI) exact mass calcd for (C13H18O)
requires m/z  190.1358, found m/z  190.1356. [a]D = +196.2 (c =1.0, CHCl3).
Diastereomeric ratios were determined by 1H NMR analysis.  A portion of the title
compound was converted to the (2R, 4R)-pentane-2,4-diol acetal for the determination of
enantiomeric purity.  5.0 mg of the title compound was taken up in 1 mL of CH2Cl2. 4.0
mg of (2R, 4R)-pentane-2,4-diol and 0.5 mg of pTSA was added to the solution, and the
reaction was stirred for 0.5 hour.  NaHCO3 solution (saturated) was then added, and the
mixture was washed with EtOAc (2 x 5 mL).  The combined organic extracts were
washed with brine, dried over Na2SO4, and filtered.  The resultant filtrate was loaded onto
a short silica plug, eluted with EtOAc, and concentrated, to provide the acetal of the title
89
compound; (endo) 87% ee.  Enantiomeric excesses were determined by GC with a
Chiralex b-DM column (50 °C/10 min, 5 °C/min ramp, 200 °C /20 min); endo isomers
tr=41.9 min and 42.3 min.
[4.3.0]-bicycle 39.  Using imidazolidinone catalyst 2.  A flask containing tetraene
24 (42 mg, 0.22 mmol, 85% E,E-diene geometry) was charged with 1.5 mL of 2% v/v
H2O/CH3CN and then cooled to –20 °C. (2S , 5S)-5-Benzyl-2-tert-butyl-3-
methylimidazolidin-4-one trifluoroacetic acid salt (11.8 mg, 0.03 mmol) was then added
in one portion to the solution and the reaction was shaken for 12 hours.  The mixture was
then loaded onto a silica gel column and eluted with CH2Cl2. Removal of volatiles
resulted in a oily residue that was purified by silica gel chromatography (5%
EtOAc/hexanes) to afford a compound as a clear oil in 75% yield (26.7 mg) with spectral
data identical to those reported for # above; 6.4:1:<0.2 endo:endo epimer:exo. [a]D =
+212.3 (c=1.0, CHCl3).  Diastereomeric ratios were determined by 1H NMR analysis.  A
portion of the title compound was converted to the (2R, 4R)-pentane-2,4-diol acetal for
the determination of enantiomeric purity.  5.0 mg of the title compound was taken up in 1
mL of CH2Cl2. 4.0 mg of (2R, 4R)-pentane-2,4-diol and 0.5 mg of pTSA was added to the
solution, and the reaction was stirred for 1 hour.  NaHCO3 solution (saturated) was then
added, and the mixture was washed with EtOAc (2 x 5 mL).  The combined organic
extracts were washed with brine, dried over Na2SO4, and filtered.  The resultant filtrate
was loaded onto a short silica plug, eluted with EtOAc, and concentrated, to provide the
acetal of the title compound: 94% ee (endo).
O
O
Ph OH
Alcohol 26.  To a solution of e-caprolactone (2.0 ml, 18.0 mmol) in 30 mL of
THF cooled to –78 °C was added DIBAL-H (3.4 mL, 18.9 mmol) dropwise. The solution
was stirred at –78 °C for 1.5 hours.  In a separate flask, a suspension of cinnamyl
triphenylphosphonium chloride in 30 mL THF was cooled to 0 °C.  7.6 mL (18.0 mmol)
of nBuLi (2.35M in hexanes) was added to the Wittig reagent and the solution was stirred
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at that temperature for 1 hour.  The e-caprolactone/DIBALH solution was then
transferred via syringe into the flask containing the Wittig reagent, and the solution was
warmed to room temperature and stirred for an additional 2 hours.  The reaction was
quenched with saturated sodium potassium tartrate solution and stirred for 8 hours.  The
mixture was then partitioned and the aqueous layer was washed with EtOAc (3 x 30 mL)
The combined organic extracts were washed with brine, dried over Na2SO4, filtered, and
concentrated in vacuo.  The resulting oily residue was purified by column
chromatography (1:4 EtOAc/hexanes), providing the title compound as a 1:1 mixture of
geometric isomers.  The mixture was redissolved in 5 mL of CH2Cl2 and 50 mg (0.2
mmol) of I2 was added.  After 30 minutes, 5 mL of Na2S2O3 (saturated) were added and
the layers were partitioned.  The aqueous layer was extracted with CH2Cl2 (3 x 10 mL),
and the combined organics were washed with brine, dried over Na2SO4, filtered, and
concentrated in vacuo to provide the title compound as a 4.5:1 (6E,8E):(6Z,8E) mixture
of geometric isomers in 54% yield (2.1 g). Major isomer: IR (film) 3352, 3020, 2927,
2858, 1452,1058 cm-1; 1H NMR (300 mHz, CDCl3) d 7.31-7.07 (m, 5H, Ph-H), 6.67 (dd,
J=10.5, 15.4 Hz, 1H, C8H), 6.34 (d, J=15.4 Hz, 1H, C9H), 6.11 (dd, J=10.9, 14.6 Hz,
1H, C7H), 5.72 (dt, J=7.2, 14.5 Hz, 1H, C6H), 3.52 (t, J=6.0 Hz, 2H, HOC1H2), 2.10-
2.04 (m, 2H, C5H), 1.54-1.43 (m, 2H, CH2CH2), 1.42-1.26 (m, 4H, CH2CH2); 13C NMR
(75 MHz, CDCl3) d 137.7, 135.6, 130.8, 130.1, 129.5, 128.6, 128.6, 127.2, 126.2, 126.2,
62.7, 33.1, 32.9, 29.4, 25.7; HRMS (FAB) exact mass calcd for (C15H20O) requires m/z
216.1514, found m/z  216.1517.
Ph OH Ph O
Aldehyde 26a.  To a solution of 26 (2.0 g, 9.3 mmol) in CH2Cl2 (30 mL) was
added N-methyl morpholine ( 2.2 g, 18.5 mmol), followed by 250 mg of 4Å molecular
sieves.  After stirring for 20 minutes, tetrapropylammonium perruthenate (65 mg, 0.19
mmol) was added the mixture.  The reaction was worked up after an additional 30
minutes by loading the black colored mixture onto a silica column and eluting with
CH2Cl2.  Removal of volatiles provided a clear crude oily residue which was purified
though by silica gel chromatography (10% EtOAc/hexanes) to afford the title compound
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as a clear oil in 50% yield (1.0  g): IR (film) 3228, 2935, 2866, 2726, 1722, 1452, 1120,
988 cm-1; 1H NMR (300 mHz, CDCl3) d 9.73 (m, 1H, CHO), 7.45-7.18 (m, 5H, Ph-H),
6.76 (dd, J=10.5, 15.6 Hz, 1H, C8H), 6.46 (d, J=15.3 Hz, 1H, C9H), 6.21 (dd, J=10.5,
14.4 Hz, 1H, C7H), 5.79 (dt, J=6.6, 14.4 Hz, 1H, C6H), 2.42-2.37 (m, 2H, CH2CHO),
2.19-2.12 (m, 2H, C5H), 1.69-1.59 (m, 2H, CH2CH2), 1.49-1.42 (m, 2H, CH2CH2); 13C
NMR (75 MHz, CDCl3) d 202.5, 137.7, 135.1, 131.3, 130.5, 129.4, 128.8, 128.8, 127.4,
126.4, 126.4, 44.0, 32.9, 29.1, 22.0; HRMS (FAB) exact mass calcd for (C15H18O)
requires m/z 214.1358, found m/z 214.1353.
Ph O
OMe
Ph O
Ester 27.  The flask containing diene 26a (1.0 g, 4.7 mmol) was charged with 10
mL of THF, then treated with 1.8 g (5.2 mmol) of methyl
(triphenylphosphoranylidene)acetate.  The mixture was stirred for 12 hours, after which
volatiles were removed in vacuo.  The resulting solid was triturated with diethyl ether (3
x 30mL), filtered, and the filtrate concentrated.  The resulting crude yellow oily residue
was purified by silica gel chromatography (5% EtOAc/Hexanes) to afford the title
compound as an oil in 96% yield (1.1 g): IR (film) 3355, 2926, 2854, 1448, 987, 745, 691
cm-1; 1H NMR (300 mHz, CDCl3) d 7.43-7.17 (m, 5H, PhH), 6.75 (dd, J=10.4, 15.7 Hz,
1H, C10-H), 6.45 (d, J=15.7 Hz, 1H, C11-H), 6.20 (dd, J=10.2, 14.5 Hz, 1H, C9-H),
5.87-5.75 (m, 1H, C8-H), 5.70-5.64 (m, 2H, C2-H, C3-H), 4.09 (m, 2H, C1H2OH), 2.17-
2.12 (m, 2H, C7H2), 2.07 (m, 2H, C4H2), 1.45-1.42 (m, 4H, C5H2, C6H2); 13C NMR (75
MHz, CDCl3) d 137.7, 135.7, 133.3, 130.1,129.4, 128.7, 128.6, 127.2, 126.2, 124.4, 64.0
33.0, 32.3, 29.1, 28.9; HRMS (EI) exact mass calcd for (C17H22O) requires m/z 242.1671,
found m/z 242.1668.
Ph O
OMe
Ph OH
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Alcohol 28.  To a cooled solution (78 °C) of ester 27 (2.1 g, 7.8 mmol) in CH2Cl2
(77 mL) was added 3.0 mL (17.1 mmol) of DIBAL-H.  After 30 minutes, the reaction
was quenched with methanol and allowed to warm slowly to room temperature.  The
mixture was then treated with 50 mL of saturated sodium potassium tartrate solution.
After stirring 8 hours, the mixture was partitioned and the aqueous layer was extracted
with CH2Cl2 (3 x 20 mL).  The combined organic layers were washed with brine (1 x 40
mL), dried over Na2SO4, and concentrated in vacuo to afford 1.9 g (100%) of the title
compound as a yellow oil, which was carried onto the next step without further
purification. IR (film) 3355, 2926, 2854, 1148, 987, 745, 691 cm-1; 1H NMR (300 mHz,
CDCl3) d 7.43-7.17 (m, 5H, PhH), 6.75 (dd, J=10.4, 15.7 Hz, 1H, C3-H, C10-H), 6.45 (d,
J=15.7 Hz, 1H, C11-H), 6.20 (dd, J=15.9 Hz, 1H, C9-H), 5.87-5.75 (m, 1H, C8-H), 5.70-
5.64 (m, 2H, C2H, C3H), 4.09 (m, 2H, C1H2OH), 2.17-2.12 (m, 2H, C7H2), 2.07 (m, 2H,
C4-H2), 1.45-1.42 (m, 4H, C5H2, C6H2); 13C NMR (75 MHz, CDCl3) d 137.7, 135.7,
133.3, 1130.1, 129.4, 128.7, 128.6, 127.2, 126.2, 124.4, 64.0, 33.0, 32.3, 29.1, 28.9;
HRMS (EI) exact mass calcd for (C17H22O) requires m/z 242.1674, found m/z 242.1668.
Ph OPh OH
Aldehyde 29.  To a solution of 28 (100 mg, 0.55 mmol) in CH2Cl2 (1.9 mL) was
added N-methyl morpholine (128 mg, 1.1 mmol), followed by 25 mg of 4Å molecular
sieves.  After stirring for 20 minutes, tetrapropylammonium perruthenate (10 mg, 0.03
mmol) was added the mixture.  The reaction was worked up after an additional 30
minutes by loading the black colored mixture onto a silica column and eluting with
CH2Cl2.  Removal of volatiles provided a clear crude oily residue which was purified
though by silica gel chromatography (5% EtOAc/hexanes) to afford the title compound as
a clear oil in 62% yield (62 mg): IR (film) 3014, 2918, 2850, 1688, 1635, 989 cm-1; 1H
NMR (300 mHz, CDCl3) d 9.50 (dd, J=2.0, 8.1 Hz, 1H, CHO), 7.39-7.17 (m, 5H, PhH),
6.90-6.71 (m, 2H, C3-H, C10-H), 6.45 (d, J=15.9 Hz, 1H, C11-H), 6.26-6.08 (m, 2H,
C9-H, C2-H), 5.80 (dt, J=6.9, 15.3 Hz, 1H, C8-H), 2.39-2.32 (m, 2H, C4H2), 2.18 (dt,
J=6.9, 6.9 Hz, 2H, C7-H2), 1.58-1.44 (m, 4H, C5H2, C6H2); 13C NMR (75 MHz, CDCl3)
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d 194.2, 158.8, 137.7, 135.0, 133.3, 131.2, 130.6, 129.3, 128.8, 127.4, 126.3, 32.9, 32.8,
29.1, 27.7; HRMS (EI) exact mass calcd for (C17H20O) requires m/z 240.1514, found m/z
240.1510.
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(3R,4S,5R,6S)-Bicyclo[4.4.0]decene-3-phenyl-4-carbaldehyde 40. A flask
containing triene 29 (188.8 mg, 0.78 mmol, 80% E,E-diene geometry) was charged with
7.8 mL of 2% v/v H2O/CH3CN and then cooled to 4 °C. (2R,5R)-5-Benzyl-2-tert-butyl-3-
methylimidazolidin-4-one trifluoromethanesulfonic acid salt (38.5 mg, 0.15 mmol) was
then added in one portion to the solution and the reaction was shaken for 16 hours.  The
mixture was then loaded onto a silica gel column and slowly eluted with 5%
EtOAc/Hexanes.  Fractions containing product were combined and concentrated,
providing the title compound as a clear oil in 70% yield (106 mg); endo:exo:endo epimer
12:2:1.   Endo isomer: IR (film) 3028, 2927, 2858, 1715, 1452 cm-1; 1H NMR (300 mHz,
CDCl3) d 8.90 (d, J=5.5 Hz, 1H, CHO), 7.35-7.12 (m, 5H, PhH), 5.76 (d, J=9.6 Hz, 1H,
CH=CH), 5.61 (m, 1H, CH=CH), 3.83 (m, 1H, CHPh), 2.48 (m, 1H, CHCHO), 1.92-
0.92 (m, 10H, CH2CH2); 13C NMR (75 MHz, CDCl3) d 207.4, 138.9, 133.4, 130.1, 128.6,
127.3, 127.0, 56.2 43.6, 41.9, 35.2, 33.4, 30.6, 27.0, 26.7; HRMS (EI) exact mass calcd
for (C17H20O) requires m/z 240.1514, found m/z 240.1517; [a]D = +626.3 (c=1.0, CHCl3)..
Diastereomeric ratios were determined by 1H NMR analysis.  A portion of the title
compound was reduced to the corresponding primary alcohol for the determination of
enantiomeric purity.  To a solution of the title compound in absolute ethanol (1 mL) was
added 3 equivalents of NaBH4.  After 0.5 hours, the reaction mixture was quenched with
H2O and extracted with 2 x 10 mL CH2Cl2.  The organic layer was dried over Na2SO4,
filtered, and concentrated.  Purification of the resultant residue by silica gel
chromatography provided the corresponding primary alcohol: endo 92% ee. 1H NMR
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(300 mHz, CDCl3) d  7.35-7.19 (m, 5H, PhH), 5.68 (d, J=9.9 Hz, 1H, CH=CH), 5.61
(ddd, J=2.1, 3.9, 9.9 Hz, 1H, CH=CH), 3.75-3.64 (m, 2H, CH2OH), 3.34 (m, 1H, CHPh),
1.98-0.86 (m, 11H, CHCH2OH, CHCH2, CH2CH2); 13C NMR (75 MHz, CDCl3) d 141.5,
133.4, 130.3, 128.7, 128.6, 128.4, 128.3, 126.9, 62.6, 45.8, 44.63, 43.7, 37.0, 33.7, 29.6,
27.1, 27.0.  Enantiomeric ratios were determined by HPLC with a Chiralcel AD column
and AD guard column (5% EtOH/hex); endo isomers, tr = 11.1 min, 13.4 min.
H
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OHC H
H
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Proof of absolute stereochemistry of (3R,4S,5R,6S)-Bicyclo[4.4.0]decene-3-phenyl-4-
carbaldehyde.  S-Ethyl-(3R,4S,5R,6S)-Bicyclo[4.4.0]decene-3-phenyl-4-carbothioate
47.  32.1 mg (0.17 mmol) of 40 was dissolved in tert-butanol (2.9 mL).  To this solution
was added 2-methyl-2-butene (0.8 mL) and dropwise, a solution of NaClO2 (139 mg, 1.5
mmol) and NaH2PO4 (162 mg, 1.2 mmol) in H2O (1.6 mL).  The biphasic solution was
stirred for 12 hours.  The reaction was then concentrated, diluted with H2O, and washed
with hexanes.  The aqueous layer was acidified with 1N HCl to pH 2, and extracted with
Et2O.  The combined organic layers were washed with cold H2O, dried over Na2SO4,
filtered, and concentrated to provide the corresponding carboxylic acid 46: 1H NMR (300
MHz, CDCl3) d 7.44-7.12 (m, 5H, ArH), 5.71 (d, J=9.9 Hz, 1H, HC=CH), 5.60 (ddd
J=2.4, 3.9, 9.9 Hz, 1H HC=CH), 3.81-3.74 (m, 1H, CHPh), 2.78 (dd, J=6.6, 12.0 Hz, 1H,
CHCOOH), 2.20-1.15 (m, 10H, CH2CH2 and CHCH2); 13C NMR (125 MHz, CDCl3) d
178.8, 140.2, 133.1, 129.5, 128.1, 127.2, 126.7, 51.3, 44.4, 41.9, 36.0, 32.9, 30.4, 27.2,
26.7.
To acid 46 was added 1 mL CH2Cl2, 4-dimethylamino-pyridine (1.2 mg, 0.01
mmol), ethanethiol (9 mL, 0.12 mmol) and dicyclohexylcarbodiimide (24.8 mg, 0.12
mmol).  The reaction was stirred for 3 hours, after which time the mixture was filtered
and 1N HCl solution (1 mL) was added to resulting filtrate.  The layers were partitioned,
and the aqueous extracts were washed with  EtOAc (3 x 10 mL).  The combined organic
extracts were washed with brine, dried over Na2SO4, filtered, and concentrated.  The
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resulting oily residue was purified by silica gel flash chromatography (5%
EtOAc/hexanes) to afford compound in 71% yield (21 mg) with spectral data identical to
hose reported for S-Ethyl-(3R,4S,5R,6S)-Bicyclo[4.4.0]decene-3-phenyl-4-carbothioate:6
[a]D (literature) = –290 (c=0.7, CHCl3), [a]D = –437 (c=1, CHCl3).
Synthesis of Solanapyrone D
Me
HO
Me
O
Me
MeO
O
Ester 56.  To a solution of (6E,8E)-6,8-decadienol7 (1.7g, 11.0 mmol) in CH 2Cl2
(55mL) was added N-methyl morpholine (2.6 g, 22.0 mmol), followed by 300mg of 4Å
molecular sieves.  After stirring for 20 minutes, tetrapropylammonium perruthenate (77
mg, 0.22 mmol) was added the mixture.  The reaction was worked up after an additional
30 minutes by loading the black colored mixture onto a silica column and eluting with
CH2Cl2.  Most of the solvent was removed in vacuo over an ice bath; due to the volatility
of the aldehyde, the solution was not concentrated to dryness, and was immediately taken
on to the next step.
The flask containing (6E,8E)-decadienal was charged with 20mL of THF, then
treated with 3.8 g (10.6 mmol) of methyl (triphenylphosphoranylidene)acetate.  The
mixture was stirred for 12 hours, after which volatiles were removed in vacuo.  The
resulting solid was triturated with diethyl ether (3 x 100mL), filtered, and the filtrate
concentrated.  The resulting crude yellow oily residue was purified by silica gel
chromatography (5% EtOAc/Hexanes)to afford the title compound as an oil in 52% yield
over 2 steps (1.19 g): IR (film) 3020, 2935, 2858, 1722,1661, 1437, 1274, 1197; 1H NMR
(500 MHz, CDCl3) d  7.01-6.94 (m, 1H, CHCHCO2Me), 6.06-6.01 (m, 2H, CH=CH),
5.83 (d,  J= 9.3 Hz, 1H, CO2MeCH), 5.65-5.51 (m, 2H, CHCH2,CHCH3), 3.72 (s, 3H,
OCH3), 2.25-2.18 (m, 2H, MeO2CCHCH2), 2.12-2.07 (m, 2H, CHCH2), 1.73 (d, J=9.0
Hz, 3H, CHCH3), 1.52-1.40 (m, 4H, CH2CH2, CH2CH2); 13C NMR (125 MHz, CDCl3) d
                                                 
6 Evans, D.A.; Johnson, J.S.  J. Am. Chem. Soc. 1997, 62, 786.
7 Oikawa, H.; Kobayashi, T.; Katayama, K.; Suzuki, Y.; Ichihara, A. J. Org. Chem. 1998, 63, 8748.
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167.4, 149.8, 131.8, 130.9, 129.6, 129.1, 121.2, 51.6, 32.8, 32.5, 32.3, 29.1, 27.8;  HRMS
(FAB+) exact mass calculated for (C13H21O2) requires m/z 209.1542, found m/z 209.1541.
Me
O
OMe Me OH
Alcohol 56a.  To a solution of 56 (1.08 g, 5.2 mmol) in 50 mL CH2Cl2 cooled to
–78 °C was added 2.2 mL (12.6 mmol) of DIBAL-H.  The solution was allowed to stir
for 15 minutes, after which the reaction was quenched with methanol (5 mL).  Upon
warming the reaction to room temperature, a saturated solution of sodium potassium
tartrate was added (50 mL) and the mixture was stirred vigorously for 8 hours.  The
mixture was extracted with CH2Cl2 (3 x 40 mL), and the combined organic extracts were
washed with brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and
the resultant crude oil was purified by silica gel chromatography (1:5 EtOAc/Hexanes) to
afford the title compound as a clear, colorless oil in 91% yield (0.98 g): IR (film) 3344,
3020, 2927, 2858, 1444, 988 cm-1; 1H NMR (300 MHz, CDCl3) d 6.01-5.93 (m, 2H,
CH=CH), 5.70-5.63 (m, 2H, CH=CH), 5.62-5.48 (m, 2H, CH=CH), 4.06 (d, J=9.2 Hz,
2H, CH2OH), 2.11-2.00 (m, 4H, CHCH2, CHCH2), 1.72 (d, J=6.0 Hz, 3H, CH3CH),
1.46-1.33 (m, 4H, CH2CH2, CH2CH2); 13C NMR (75 MHz, CDCl3) d 133.4, 131.9, 131.8,
130.6, 129.1, 127.1, 64.1, 32.7, 32.4, 29.3, 29.0, 18.4;  HRMS (FAB+) exact mass calcd
for [(C12H19O)] requires m/z 179.1436, found m/z 179.1434.
Me OH Me O
Aldehyde 57.  To a solution of 56a (75 mg, 0.42 mmol) in CH2Cl2 (2 mL) was
added N-methyl morpholine (97 mg, 0.83 mmol), followed by 25 mg of 4Å molecular
sieves.  After stirring for 20 minutes, tetrapropylammonium perruthenate (3.0 mg, 0.0080
mmol) was added the mixture.  The reaction was worked up after an additional 30
minutes by loading the black colored mixture onto a silica column and eluting with
CH2Cl2.  Removal of volatiles provided a clear crude oily residue which was purified
though by silica gel chromatography to afford the title compound as a clear oil in 59%
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yield (44 mg): IR (film) 3020, 2927, 2858, 2734, 1692,1444, 1120, 980 cm-1; 1H NMR
(300 MHz, CDCl3) d  9.47 (d, J=8.2 Hz, 1H, CHO), 6.92 (dt, J=7.1, 15.4 Hz, 1H,
CHCHCHO), 6.07 (dd, J=7.8, 15.6 Hz, 1H, CHCHO), 6.00-5.90 (m, 2H, CH=CH,
CH=CH), 5.63-5.44 (m, 2H, CH2CH, CH3CH), 2.36-2.27 (m, 2H, CH2CHCHCHO),
2.17-2.01 (d, J=6.0 Hz, 3H, CH3CH), 1.70 (d, J=6.0 Hz, 3H, CH3CH), 1.54-1.37 (m, 4H,
CH2CH2, CH2CH2); 13C NMR (75 MHz, CDCl3) d 194.2, 158.9, 133.2, 131.6, 131.2,
131.0, 127.4, 32.9, 32.5, 29.2, 27.6, 18.4; HRMS (EI) exact mass calcd for (C12H18O)
requires m/z 178.1358, found m/z 178.1351.
OHC
Me H
H
OHC
Me H
H
OHC
Me H
H
Me
O
endo exo endo epimer
(3R,4S,5R,6S)-Bicyclo[4.4.0]decene-3-methyl-4-carbaldehyde 58. A flask
containing triene 57 (43.7 mg, 0.25 mmol, 84% E,E-diene geometry) was charged with
0.83 mL of 2% v/v H2O/CH3CN and then cooled to –5 °C. (2R,5R)-5-Benzyl-2-tert-
butyl-3-methylimidazolidin-4-one trifluoromethanesulfonic acid salt (19.4 mg, 0.050
mmol) was then added in one portion to the solution and the reaction was shaken for 48
hours.  The mixture was then loaded onto a silica gel column and slowly eluted with 5%
EtOAc/Hexanes.  Fractions containing product were combined and concentrated,
providing the title compound as a clear oil in 71% yield (26.1 mg); >20:1:1
endo:exo:endo epimer.   Endo isomer: IR (film) 2927, 1715, 1452, 1267 cm-1; 1H NMR
(300 MHz, CDCl3) d  9.73 (d, J=4.4 Hz, 1H, CHO), 5.53 (ddd, J=2.1, 4.5, 9.9 Hz, 1H,
CH=CHCH), 5.40 (d, 9.9 Hz, 1H, CH=CHCH), 2.61-2.55 (m, 1H, CHCH3), 2.37 (ddd,
J=4.5, 6.3, 11.1 Hz, 1H, CHCHO), 1.82-1.58 (m, 6H, CHCHCH2, CH2CH2), 1.42-1.20
(m, 4H, CH2CH2), 1.03 (d, J=7.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 207.1,
131.4, 131.1, 55.72, 42.4, 35.9, 33.3, 32.1, 30.5, 26.9, 26.8, 17.4; HRMS (CI) exact mass
calcd for (C12H18O) requires m/z 178.1358, found m/z 178.1351; [a]D = +168.0 (c=1.0,
CHCl3).. Diastereomeric ratios were determined by 1H NMR analysis.  A portion of the
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title compound was converted to the (2R , 4R )-pentane-2,4-diol acetal for the
determination of enantiomeric purity.  5.0 mg of the title compound was taken up in 1 mL
of CH2Cl2.  4.0 mg of (2R, 4R)-pentane-2,4-diol and 0.5 mg of pTSA was added to the
solution, and the reaction was stirred for 1 hour.  NaHCO3 solution (saturated) was then
added, and the mixture was washed with EtOAc (2 x 5 mL).  The combined organic
extracts were washed with brine, dried over Na2SO4, and filtered.  The resultant filtrate
was loaded onto a short silica plug, eluted with EtOAc, and concentrated, to provide the
acetal of the title compound: 90% ee (endo).  Enantiomeric ratios were determined by GC
with a Bodman b-DM column (23 psi, assay: hold 50 °C for 10 min, ramp 5 °C/min to
200 °C); endo isomers tr = 38.7 min and 39.0.
Me
H
H
OH O O
OMe
OHC
Me H
H
Methyl 5-hydroxy-5-[(1R,2R,4aR,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-2-
methylnaphthyl]-3-oxopentanoate 59. To a –78 °C solution of 143 mg (0.80 mmol) of
aldehyde 58 in 15 mL of CH2Cl2 under nitrogen atmosphere was added a solution of
methyl acetoacetate bis(trimethylsilyl)ether in 20 mL of CH2Cl2.  This solution was then
treated with 800 mL (0.80 mmol) of  TiCl4 (1M in CH2Cl2) from a newly opened bottle.
After stirring for 1 hour, the reaction was quenched with H2O and extracted with CH2Cl2
(2 x 30 mL).  The combined organic layers were washed with brine, dried over Na2SO4,
filtered, and concentrated. Purification of the resultant residue by silica gel
chromatography (20% EtOAc/hexanes) afforded 175 mg (75% yield) of the title
compound as a clear oil whose spectral characteristics matched those previously reported.
Me
H
H
OH O O
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H
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O
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M e t h y l  4 - [ ( 1 R , 2 R , 4 a R , 8 S ,8aR)-1,2,4a,5,6,7,8,8a,-octahydro-2-
methylnaphthyl]-3,5-dioxobutanoate 59a.  To a solution of 175 mg (0.60 mmol) of
alcohol 59  in 6.0 mL of CH2Cl2 was added 254 mg (0.60 mmol) of Dess-Martin
Periodinane.  The solution was stirred at room temperature for 2 hours, after which 10
mL of 1:1 NaS2O3/NaHCO3 aq. solution was added. The aqueous layer was extracted
with CH2Cl2 (2 x 10 mL), and the combined extracts were washed with brine.  The
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. Flash
chromatography on silica gel (10% EtOAc/hexanes) provided the title compound as a
yellow oil in 71% yield (124 mg) whose spectral characteristics matched those previously
reported.
Me
H
H
O O
OMe
Me
H
H
O
O
OH
O
4-Hydroxy-6-[(1R,2R,4aR,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-2-methylnap-
hthyl]-2H-pyran-2-one 60.   To a solution of the b,g-diketoester 59a (67 mg, 0.23
mmol) in 2.5 mL of benzene was added DBU (67 mL, 0.46 mmol), upon which the
solution immediately turned bright yellow in color.  The flask was sealed, and the
solution was stirred at 60 °C for 3 hours.  The reaction was then quenched with the
addition of 1N HCl (0.8 mL) and extracted with EtOAc (2 x 10 mL).  The combined
organic extracts where then washed with brine, dried over Na2SO4, filtered, and
concentrated in vacuo to afford the title compound as a bright yellow oil in 87% yield (58
mg) whose spectral characteristics matched those previously reported.   60 was taken on
immediately to the next step without further purification.
Me
H
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H
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O
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4-Methoxy-6-[(1R,2R,4aR,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-2-methylnap-
hthyl]-2H-pyran-2-one 61.   A suspension of 4-hydroxypyrone 60 (58 mg, 0.22 mmol),
methyl p-toluenesulfonate (1.0 mmol), and potassium carbonate (1.0 mmol) in DMF (3
mL) was stirred at room temperature for 5 hours.  The reaction was quenched with
saturated NH4Cl solution, and extracted with Et2O (3 x 10 mL).  The combined organic
extracts were washed with brine, dried over Na2SO4 and filtered.  Removal of volatiles
under reduced pressure provided a yellow oily residue which was purified by silica gel
flash chromatography (25% EtOAc/hexanes) to afford the title compound as a yellow oil
in 81% yield (49 mg): IR (film) 2927, 2858, 1722, 1645, 1568, 1452, 1413, 1251, 1159,
1159, 1035, 811; 1H NMR (300 MHz, CDCl3) d 5.77 (d, J=2.4 Hz, 1H, CH=COC=O),
5.55 (ddd, J=2.7, 4.4, 10.5 Hz, 1H, CH=CHCH), 5.45-5.39 (m, 2H, CH=CHCH,
O=CCHCOMe), 3.79 (s, 3H, OCH3), 2.62 (dd, J=6.0, 11.4 Hz, 1H, CHCOC=O), 2.44-
2.41 (m, 1H, CHC H3), 2.39-2.22 (m, 1H, CHCHC H2), 1.81-1.52 (m, 5H, CHC H2,
CH2CH2), 0.94 (d, J=6.9 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 167.2, 165.2,
131.6, 131.4, 130.0, 101.9, 87.7, 56.1, 49.2, 43.4, 36.7, 35.4, 33.4, 30.4, 26.9, 26.8, 18.1;
[a]D = –101.7 (c=1, CHCl3); HRMS (FAB+) exact mass calculated for [(C17H22O3)H]+
requires m/z 275.1647, found m/z 275.1640.
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(–) Solanapyrone D 3. To a –78 °C solution of diisopropyl amine (11.4 mL, 0.082
mmol) in 0.2 mL THF was added 28 mL (0.070 mmol) of nBuLi (2.5M in hexanes,
freshly titrated).  The solution was warmed to 0 °C and stirred for 20 minutes.  The
reaction was then cooled back to –78 °C, and 6.4 mg (0.023 mmol) of 4-methyoxypyrone
61 was added in THF (2 x 0.1 mL).  The solution was stirred for an additional 20
minutes, after which methyl formate (28 mL, 0.46 mmol, freshly distilled) was added.
After stirring for an additional 2.5 hours, the reaction was quenched with saturated NH4Cl
solution and extracted with EtOAc (3 x 10 mL).  The combined organic extracts were
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washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo.  The resultant
crude yellow oily residue was purified by silica gel chromatography to afford
Solanapyrone D as a yellow oil in 57% yield (3.9 mg, 91% yield based on recovered
starting material): [a]D = –201.1 (c=1, CHCl3), ): [a]D literature8 = –148.7 (c=1, CHCl 3);
IR (film) 2930, 2862, 1728, 1686, 1615, 1520, 1375, 1265 cm-1; 1H NMR (500 MHz,
CDCl3) d 10.16  (s, 1H, CHO), 6.12 (s, 1H, CHC(OMe)=C(CHO)), 5.57 (ddd, J=2.7, 4.2,
9.9 Hz, 1H, CH=CHC(Me)H), 5.45 (d, J=9.9 Hz, 1H, CH=CHCH), 4.07 (s, 3H, OCH3),
2.75 (dd, J=6.0,  11.0 Hz, 1H, CHC(Me)H), 2.50 (m, 1H, CHC(Me)H), 1.59-1.85 (m,
5H, CHCH2, CH2CH2), 1.40-1.25 (m, 2H, CH2CH2), 1.21-1.11 (m, 1H, CHCH2CH2),
0.99 (d, J=7.5, 3H, CHCH3), 0.96-0.88 (m, 1H, CHCH2CH2); 13C NMR (125 MHz,
CDCl3) d 186.8, 176.3, 173.8, 162.2,131.0, 130.7, 101.3, 96.0, 57.6, 50.8, 43.0, 36.5,
35.5, 30.2, 26.5, 26.3, 17.7; HRMS (FAB+) exact mass calcd for [(C18H22O4)H]+ requires
m/z 303.1596, found m/z 303.1585.
                                                 
8 Hagiwara, H.; Kobayashi, K.; Miya, S.; Hoshi, T.; Suzuko, T.; Ando, M.; Okamoto, T.; Kobayashi, M.;
Yamamoto, I.; Ohtsubo, S.; Kato, M.; Uda, H.  J. Org. Chem. 2002, 67, 5969.
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Chapter 4
Progress toward the
Total Synthesis of Guanacastepene A
I.  Introduction
The diterpene antibiotic guanacastepene A (1) was first isolated by Clardy and
coworkers in 2000 from an unclassified endophytic fungus CR115 in the Guanacaste
Conservation Area in Costa Rica.1  Interest in this natural product initially arose from its
promising biological activity; preliminary studies revealed that this compound exhibited
excellent antibiotic activity against drug-resistant strains of Staphylococcus aureus and
Enterococcus faecalis.  Methicillin-resistant S. aureus (MRSA) and vancomycin-resistant
E. faecalis (VREF) are two of the most problematic drug-resistant pathogens, since these
two antibiotics are often seen as the drug of last resort.2,3   Thus, its excellent activity
against MSRA and VREF made 1 a potentially powerful therapeutic drug.  However,
subsequent studies by Singh and coworkers determined that it possessed only moderate
activity against Gram-positive bacteria and poor activity against Gram-negative bateria.4
Furthermore, experiments revealed that 1 exhibits hemolytic activity against human
blood cells, thus suggesting nonspecific membrane lysis as its mode of action.   Despite
the discouraging implications of these results on its future as a therapeutic agent,
guanacastepene A has maintained the interest of the synthetic community, largely due to
its novel structure and the potential for studying the biological profile of related
compounds.
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The guanacastane skeleton, which had not been reported previous to Clardy’s
communication, is closely related to the marine-derived dolabellane family of natural
products.  The dolabellane ring system, which is characterized by an unusual trans-
bicyclo-[9.3.0] tetradecane nucleus, occupies a pivotal position in the biogenesis of
several novel diterpene skeletons, including the dolastanes and neodolabellanes (Figure
2).5  Although close to 150 dolabellanes have been reported, guanacastepene A is the first
in the guanacastane to be identified.
The structure of 1 was elucidated though single-crystal X-ray diffraction
techniques, and the resultant crystal structure (which defines only the relative
configuration of the natural product) reveals that guanacastepene A consists of a 5-7-6
tricyclic ring system with one highly oxidized edge and a hydrophobic opposite edge.
The natural product exists as two conformers in a dynamic equilibrium at room
temperature, thus making the 1H and 13C NMR spectra complex and difficult to interpret.
Clardy speculates that the observed NMR anomalies could result from flexibility in the
C9-C10 region of the central cycloheptane ring.  MM2 force field calculations identified
two gauche butane-like conformers around the C9-C10 bond that differ by 0.14 kcal/mol
and are separated by a 15 kcal/mol energy barrier.1  The slow interconversion of the two
conformers on the NMR time scale at room temperature would account for the observed
irregularity found in the NMR spectra of 1.
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More recently, the same research group reported their findings that the endophytic
fungus CR115 produces not only 1, but also a family of related, structurally diverse
metabolites.   Structural elucidation of guanacastepenes B-O (some of which are shown
in Figure 3) was also accomplished by X-ray crystallography, and the absolute
configuration of guanacastepenes E and L (as drawn) were determined by using
anomalous dispersion from the C-5 p-bromobenzoyl derivative of each natural product.6
Clardy and coworkers speculate that the chemical diversity of the guanacastepenes arises
from multiple biosynthetic pathways working in concert or as a single highly branched
biosynthetic grid, both of which are analogous to our methods for synthesizing libraries
of natural product-like compounds (e.g. parallel synthesis or split/pool synthesis).
Preliminary studies indicate that guanacastepene I is the only member of this newly
characterized family of natural products that exhibits pronounced antibacterial activity in
agar diffusion assays against S. aureus.  However, it is possible that others may be active
at higher concentrations or in other assays, since their studies were limited by the small
supplies of the natural products available for testing.
To date there has been only one reported total synthesis of (±) guanacastepene A,
which was published by Danishefsky and coworkers in late 2002.7-10 In addition, over 10
different groups4,11-25 have published on their synthetic strategies towards 1, testifying to
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the continuing interest that the synthetic community has in this family of natural
products.  Interestingly, the cultured fungus CR115 no longer produces guanacastepene
A,7 and therefore any further production of this natural product for biological studies
must be manufactured though synthetic means.
II.  Results and Discussion
A. General Synthetic Plan
Our initial interest in guanacastepene A derived from the challenge of devising a
novel, convergent route to its stereochemically dense 5-7-6 fused ring system.
Examination of its structure reveals several key synthetic challenges that should be
addressed during the course of a planned synthesis: (1) the western portion of the
molecule contains a fully functionalized cyclopentane ring with nontrivial stereochemical
relationships between its substituents, (2) the central cycloheptene ring includes two
quaternary carbon stereocenters, and (3) the six-membered ring contains an oxygenated
stereocenter remote to much of the other functionality in the molecule.
Our retrosynthetic analysis suggested that these issues could be addressed through
the plan detailed in Scheme 1.   We felt that guanacastepene A could be derived from
intermediate 2 through a selective hydrogenation and protecting group manipulations.  In
turn, tricycle 2 could be accessed though an intramolecular Diels-Alder (IMDA)
cyclization of cyclopentanone 3, thus establishing two stereocenters, one of which is
quaternary, and two of the three ring systems all in one step.   Although examples of
IMDA mediated formation of 7,6-fused ring systems are not common, there are several
notable examples.26  Thus, we felt that the favorable electronics and structural
preorganization in this IMDA substrate merited its exploration.  It also seemed that
IMDA precursor 3 could be efficiently accessed though a potential one-pot 3-component
coupling of cyclopentenone 4, diene 5, and commercially available aldehyde 6.  This
strategy would allow for extremely rapid access to the elaborated tricyclic core of
guanacastepene A in a highly convergent manner.
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B.  Synthesis of Cyclopenteone Fragment 4
Asymmetric Catalytic Approach.  Since our synthetic approach allowed for the
stereochemical information of the two stereocenters in fragment 4 to be relayed to
subsequently formed stereocenters in the molecule, our initial strategy involved the
asymmetric synthesis of cyclopentenone 4.  As Scheme 2 illustrates, we felt that 4 could
be derived from the acyclic enone 7 though an olefin metathesis reaction.  Although this
substrate was both sterically and electronically challenging, recent advances in metathesis
technology suggested that this enone could potentially cyclize under proper conditions.
In turn, we felt that the stereochemical relationship between the benzyloxy and isopropyl
substituents in enone 7 could be accessed via a Claisen rearrangement.  Recent work in
the Macmillan group by Tehshik Yoon revealed that magnesium complex 11 could be
used to promote the asymmetric acyl-Claisen rearrangement of a-oxygenated acid
chlorides and allylic morpholine amines to generate amide Claisen adducts in good yields
and with excellent enantioselectivities.  Therefore, we became interested in utilizing this
methodology to access the desired stereochemical array; this took us back to the allylic
amine 9 and commercially available acid chloride 10.
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The desired amine 9 was accessed in two steps from the known ester 12.  DIBAL-
H reduction of 12 provided the desired alcohol in 92% yield.  Subsequent in situ
conversion of the alcohol moiety to the bromide through treatment with NBS/PPh3
followed by displacement with morpholine afforded the necessary allylic amine 9 in 54%
yield.  Amine 9 was reacted with commercially available acid chloride 10 in the presence
of magnesium complex 11 under a variety of reaction conditions (varying temperature,
stoichiometries, concentrations); however, none of the desired rearrangement adduct 8
was ever observed.  Attempts to catalyze the reaction racemically with TiCl4 • 2THF
were also unsuccessful.  This result is not completely surprising; as transition state
structure 14 illustrates, the large isopropyl moiety occupies a pseudo-axial position in the
Claisen chair transition state, thus hindering the ability of this intermediate to undergo the
desired 3,3-sigmatropic rearrangement.
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Re-examination of the desired Claisen adduct 8 revealed that the acyl-Claisen
rearrangement substrate could be modified to decrease the steric bulk in the axial
positions of the Claisen transition state, potentially increasing the likelihood that the acyl-
ammonium intermediate would undergo the desired rearrangement.  As Scheme 4
illustrates, amide 8 can be derived from g,d-unsaturated amide 15 though a hydrogenation
and Wittig olefination.  Since there is a syn relationship between the benzyloxy and
ketone functionalities in 15, this g,d-unsaturated amide can be derived from an acyl-
Claisen rearrangement of acid chloride 10 and (E)-olefin 16.  In this case, the ketone
occupies a more favorable equatorial position in the Claisen chair-transition state (17),
thereby reducing the number of undesirable 1,3-diaxial interactions relative to the
unsuccessful intermediate 14.  Furthermore, Tehshik had found that electron deficient
allylic amines were excellent substrates for the asymmetric acyl-Claisen reaction,
whereas electron-rich or neutral olefins generally reacted poorly.  Thus the inclusion of
an electron-withdrawing ketone moiety in the amine substrate should favor the reaction
the desired rearrangement.
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Allyl amine 16 was synthesized (see experimental section) and subjected to a
variety of asymmetric (using complex 11) and racemic (TiCl4 • 2THF, MgBr2 • Et2O)
acyl-Claisen conditions, although none of them produced the desired rearrangement
product 15.  Instead, von Braun fragmentation product 16 was isolated as the major
product in these reactions.   This result was initially surprising, since Tehshik had found
that these types of von Braun fragmentation side products were only observed when
electron rich/neutral allyl amines were subjected to asymmetric acyl-Claisen conditions.27
However, subjection of the ketone substrate 16 to acyl-Claisen conditions probably
results in initial soft enolization of the ketone moiety, thus making the adjacent olefin
electron rich.  This then makes the acyl ammonium intermediate 19 prone to SN2-type
nucleophilic attack, therefore generating the observed morpholine amide 18.
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Racemic Approach.  Although the asymmetric acyl-Claisen approach could be
modified to circumvent the undesired von Braun fragmentation side reaction (e.g.
replacement of the ketone with an ester), we felt that the number of synthetic
manipulations in this route was becoming unnecessarily high.  Therefore we chose to
pursue a more efficient racemic route in the interest of producing the necessary material
to test the subsequent key steps.  As Scheme 6 illustrates, acid 20, which contains the
necessary stereochemical relationships to be elaborated into the desired 4 though olefin
methathesis of the corresponding enone, can be obtained from an Ireland-Claisen
rearrangement of the appropriately acetylated derivative of alcohol 13.  This modified
Ireland-Claisen route is not dependent on synthesizing large amounts of chiral
magnesium complex 11, and therefore would allow for more efficient access to greater
quantities of the desired cyclopentenone 4.
Although this modified strategy would produce racemic products, it is potentially
amenable to asymmetric synthesis in the future. An enantiomerically pure chiral
secondary alcohol, such as 21 (obtained though an asymmetric Noyori hydrogenation of
the corresponding methyl ketone), could be used to relay stereochemistry in the Claisen
rearrangement (via transition state 22) to the two newly formed stereocenters in 23.  The
extra methyl group (highlighted in blue) is excised in the course of the olefin metathesis
reaction of 24, thus providing cyclopentenone 4 in an enantioenriched form.
Using the racemic Ireland-Claisen route, the synthesis of cyclopentenone 4 began
with the acylation of alcohol 13  with a-benzyloxy acid chloride 10, providing
rearrangement precursor 25 in 85% yield. Gratifyingly, subjection of ester 25 to initial
Claisen-rearrangement conditions (LDA, TBSCl) afforded the desired adduct 26,
although in only 23% yield and with 4:1 anti:syn selectivity.  These conditions were
eventually optimized (through varying temperature, silylating agent, and additives) to
provide acid 26 in an acceptable 80% yield and 6:1 anti:syn selectivity.  Conversion of 26
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to the Weinreib amide 27 proceeded in 80% yield in the presence of MeHNOMe and
BOP.
Addition of vinyl grignard to 26 produced the desired enone 28, although in only
47% yield.  The major product formed was instead ketone 29, where the amine byproduct
NHMe(OMe) had added in a 1,4-fashion into the enone 28.  Experiments determined that
side product 29 was formed upon workup (with aqueous acid or on contact with the TLC
plate) therefore suggesting that the metal chelated intermediate 27 remained intact until
the reaction was quenched.  Therefore we speculated that yields of 28 could be increased
by revising the workup procedure to ensure that aqueous acid was always in excess;
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under these conditions any liberated HNMe(OMe) formed upon workup would be
immediately protonated and thus unable to add into 28.  Indeed, slowly adding the
reaction mixture to a saturated NH4Cl solution in the workup increased the isolated yields
of the desired enone dramatically; ultimately this procedure afforded the metathesis
precursor 28 in an acceptable 83% yield.
Olefin metathesis precursor 28 was subjected to ring-closing metathesis
conditions in hopes that 28 would cyclize to produce the desired cyclopentenone 4.  This
cyclization appeared to be nontrivial, since it involved the metathesis of two olefins of
low to moderate reactivity.  The terminally disubstituted olefin was adjacent to a
sterically demanding isopropyl group, thus making it potentially difficult to access.
Furthermore, olefins conjugated to ketones have been traditionally difficult to cyclize.
However with the recent development of more active metathesis catalysts (such the
second generation Grubbs ruthenium catalyst, 30) these substrates have been deemed
viable substrates for metathesis to varying extents.28  Gratifyingly, treatment of enone 28
with the Grubbs catalyst 30 produced the desired cyclopentenone 4 in good yields
(Scheme 9).  nOe analysis confirmed that the major diastereomer formed in the reaction
was indeed the syn-4 diastereomer.  Interestingly, the metathesis appeared to be
diastereoselective; cyclization of anti-28 proceeded faster than syn-28 under these
metathesis conditions, resulting in the formation of a product (4) with higher isomeric
ratios than the starting material (28).
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C.  Synthesis of Diene Fragment 5
Examining diene 5, we felt that the main challenge in synthesizing this fragment
would be in controlling the geometry around the tri-substituted olefin and enol ether.  In
considering the various approaches to the synthesis of this diene piece, we settled on a
strategy that would rely on using olefin isomerization chemistry developed by Shibasaki
to establish the desired olefin geometries.   In 1990, Shibasaki and coworkers reported the
development of a chromium(0) mediated diene isomerization reaction capable of
synthesizing silyl dienol ethers of the type 35 in a stereocontrolled manner from (1Z)-1-
[(silyloxy)methyl]butadiene derivatives such as 33.29  Coordination of the cisoid diene to
“Cr(CO)3” followed by hydrogen abstraction results in the U-shaped h5-intermediate 34,
which eventually leads the observed (1E, 3Z)-diene. The high stereoselectivity of this
process arises from the preferential formation of intermediate 34  because of the
unfavorable steric interactions in the other chromium-bound isomer 36.
Cuprate 5 could then be accessed from intermediate 31, which Shibasaki’s
methodology permits us to obtain from the terminal diene 32.  This molecule, in turn,
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could be made though a Pd(0) mediated coupling to two simpler olefinic compounds.  Of
the various options for synthesizing compound 32, a route involving a Sonogashira
coupling followed by syn-reduction was chosen over a Suzuki or Stille coupling, mainly
due to the ease with which intermediates in the former route could be handled.
The synthesis of fragment 5 began with the conversion of commercially available
3-butyn-1-ol to vinyl iodide 39 as a single regioisomer under in situ “HI” generated
conditions (Scheme 10).  Subjection of the resultant iodide to Sonagashira coupling
conditions with alkyne 40 afforded the desired enyne 41.  A variety of palladium sources,
amines and solvents were screened, and ultimately Cl2Pd(PPh3)2, NEt3, and THF were
found to be optimal, providing enyne 41 in 70% yield.   Initial attempts to reduce enyne
41 to Z-diene 32 with Lindlar’s catalyst were unsuccessful; instead these conditions
produced complex mixtures of olefin isomers and over-reduced products.  Catalyst
poisoning additives (quinoline, pyridine) were also applied in an effort to attenuate the
reactivity of the palladium catalyst, but these reactions also lead to the over-reduction of
the alkyne.30,31  Ultimately, we found that potassium-activated Reike Zinc/methanol/water
conditions were highly effective at providing the desired diene 32 cleanly and in good
yields without any sign of over-reduction or olefin isomerization.
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Isomerization of terminal diene 3 2  with catalytic amounts of
(naphthalene)Cr(CO)3 yielded silyoxy-diene 42 in excellent yields (92%) and as a single
isomer.  nOe analysis revealed that the geometric isomer formed was indeed the desired
(1E, 3E)-diene 42.  Alcohol 42 was converted to alkyl iodide 31 using standard
conditions, taking care to pre-form the active I-PPh3+ species prior to addition of the
alcohol 42 to prevent I2 mediated decomposition of the diene.  Not surprisingly, cuprate
precursor 31 was relatively unstable and was typically generated just prior to use in the
subsequent step.
D.  Synthesis of  the IMDA precursor via a conjugate addition/aldol reaction
Because of the scientific community’s interest in the prostaglandins during the
1970s and 1980s, a wealth of literature has been published on the synthesis of these
biologically relevant natural products.32  One of the most popular and efficient strategies
for accessing these molecules was a one-pot, 3-component coupling approach, which
generally involved the 1,4-conjugate addition of a cuprate species into a cyclopentenone
followed by trapping of the resultant enolate with an aldehyde or alkyl halide. We
initially looked to this body of literature in hopes of finding reaction conditions that
would produce the desired 3-component coupling.  Unfortunately, attempts at generating
the desired IMDA precursor 43 were unsuccessful using these (or variants of these)
protocols (eq. 1).33-37 This, however, was not surprising.  These reported procedures used
lower-order organocuprates or organozinc-cuprates to add conjugately into b-mono-
substituted enones; our system, however, involved the 1,4-addition of a nucleophile into a
di-substituted enone.  Copper mediated conjugate additions into these more sterically
demanding substrates are documented to be difficult, and lower-order organocuprates or
organozinc-cuprates are often not reactive enough to add to these substrates.  In fact, no
conjugate addition product was isolated in these attempted 3-component coupling
reactions, lending credence to the idea that a more appropriate copper nucleophile needed
to be found.
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We elected to redirect our focus towards first finding an organocopper species
that could effect the desired 1,4-conjugate addition.  We looked towards using more
reactive organocuprates such as the higher order cyanocuprate R2Cu(CN)Li2.  Lipshutz
and coworkers had success adding these cuprates into b,b-disubstituted enones,38-40 and
therefore we felt that this organocopper species might be more effective.   Indeed,
lithium-halogen exchange of iodide 31, followed by addition of CuCN resulted in the in
situ formation of the higher order cyanocuprate; this mixture was treated with
cyclopentenone 4 which, upon workup, provided the desired conjugate addition product
44 in 88% yield as a single diastereomer.  The excellent diastereoselectivity observed in
this reaction can be attributed to a large preference for the cuprate reagent to approach the
enone from the face opposite that with the benzyloxy functionality and sterically
demanding isopropyl group (Figure 5).  Treatment of cyclopentanone 44 with aldehyde 6
under optimized aldol conditions produced IMDA precursor 43 in 56% yield, again, as a
single isomer.
Nuclear Overhauser effect analysis confirmed the relative stereochemistry around
the cyclopentanone ring to be as drawn in Scheme 12 (see experimental details).  The
selectivity in this case can be rationalized by examining the transition state shown in
Figure 5.  The aldehyde favors approach from the face opposite the cyclopentanone ring
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and large isopropyl group in the 6-member chelated transition state, thus preferentially
forming diastereomer 43.
 A few attempts were made to use the higher order cyanocuperate in a 3-
component coupling reaction.  Unfortunately, the resultant cyanocopper enolate 45 is
much less nucleophilic than it’s lower order organocopper counterpart.  Efforts were
made to transmetallate enolate 45 to the more reactive zinc enolate with reagents such as
Me3ZnLi, but the desired 3-component coupling product 43 was never isolated (eq. 2).
E.  Attempted Intramolecular Diels-Alder Cyclizations
With the key intermediate in hand, attempts were made to cyclize the dienyne 43
into the desired tricyclic guanacastepene core 46  with a variety of thermal,
oxocarbenium- and iminium- accelerated intramolecular Diels-Alder conditions (Table
1).  Unfortunately none of these produced the desired cycloadduct 46; the diene moiety
was prone to decomposition under some of these conditions, and in all the other cases
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none of the desired product was observed.   Attempts were also made to deprotect the
acetal protecting group; not surprisingly, the diene moiety was incompatible since all
acidic deprotection conditions used to effect this transformation either caused
decomposition of the diene moiety, (initiated by cleavage of the silyl group) or failed to
deprotect the acetal.
Since formation of the electron-withdrawing group in situ was unsuccessful (in
the form of an iminium or oxocarbenium group), derivatives of 43 where the electron
withdrawing group was in place (48 and 49) were synthesized via the same aldol route.
Subjection of these compounds to a variety of thermal and Lewis acid conditions also did
not produce any of the desired adduct 46a.  Attempts were also made to bring in a
masked aldehyde in the form of a protected alcohol (50).  Unfortunately attempts to
oxidize the alcohol to the aldehyde were met with little success; most conditions caused
decomposition of the silyl-oxy diene moiety.
Given the lack of success at cyclizing these alkyne-containing substrates, models
of the IMDA precursors were examined in hopes of learning why they were reluctant to
undergo the desired cycloaddition reaction.  As the model in Figure 6 illustrates, the
orbital overlap between the diene and alkyne dienophile in the IMDA transition state of
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49 is non-ideal (51), thus making it difficult for this substrate to undergo the expected
cycloaddition.  We speculated that by converting the dienophile to an alkene, as in ester
52 the transition state of the IMDA cyclization (53) would look more product-like, thus
improving the p-orbital overlap between the diene and dienophile and hopefully making
the desired cycloaddition more facile.
 
Therefore alkene 52 was synthesized via an aldol reaction from cyclopentanone
44.  However, subjection of the IMDA substrate 52 to a variety of thermal and Lewis acid
conditions did not produce any of the desired cycloadduct 54 (eq. 5).
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In an effort to make the transition state of the IMDA reaction even more product-
like, substrate 56, which contains an olefin adjacent to the alkene dienophile, was
synthesized.  This cyclization precursor also possesses electronic properties favorable to
the IMDA; the dienophile is doubly activated and therefore more electron deficient than
it’s predecessors since it is conjugated to both the ester and the ketone.  Interestingly 56,
which was synthesized though an LDA mediated aldol condensation between
cyclopentanone 44 and aldehyde 55, was found to cyclize under mild conditions to
produce the tricycle 57.  This unusual product presumably arises from the reaction of the
enone olefin with the trisubstituted alkene of the diene, ostensibly though a stepwise
mechanism.  Attempts were made to utilize 57 in a productive fashion towards the
desired IMDA cycloadduct though a retro-[2+2]/[4+2] cyclization, but these efforts were
not greeted with any success.
Although tetraene 56 readily cyclized to tricycle 57, it did not eliminate the
possibility that 56 contained the structural elements (such as good p-orbital overlap)
necessary for the substrate to undergo the desired IMDA reaction.  It was speculated that
the nominal [2+2] reaction was out-competing the [4+2] cycloaddition because of the
highly electron-deficient nature of the reactive enone olefin.  Therefore we felt that the
formal [2+2] reaction could be prevented by adjusting the electronics of that alkene to be
less electron deficient.   Specifically, diketone 58 appeared to possess these desirable
traits.  Similar to 56, the dienophile olefin in 58 is conjugated to both the ester and a
ketone, thus electronically activating it towards the desired IMDA reaction.  Furthermore,
it is postulated that the diketone exists mainly in the enolic, fully conjugated form 58b.
In this case, the enol is not as electron deficient as the enone olefin in 56, and therefore
should be less likely to participate in an analogous [2+2] reaction.  In addition, similar to
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tetraene 56, 58b is able to provide access to the desired conformation that allows for
optimal p-overlap between the diene and dienophile.   And finally, in contrast to 56, 58b
should provide excellent control over the enolic olefin geometry, since 1,3-diketones are
well documented to exist in the geometry shown in 58b due to hydrogen bonding.  It is
for these reasons that we felt that diketone 58 contained electronic and structural features
that would allow it to undergo the desired [4+2] cycloaddition in lieu of the [2+2]
reaction.
LDA mediated acylation of ketone 44 with acid chloride 59 afforded the desired
diketone 58 as a single isomer; as expected, NMR chemical shifts suggested that the
compound existed predominantly in the enolic form 58b.  Exposure of 58 to a variety of
thermal and Lewis acid conditions, however, did not produce and of the desired
cycloadduct 60.  Interestingly, no [2+2] adduct was observed, suggesting that perhaps
electronics did play a large role in the formation of tricycle 57.
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F. Revised Route: Using an Intermolecular Diels-Alder Reaction
Since attempts to build the 5,7,6-tricycle core of guanacastepene though an IMDA
reaction were unsuccessful, we were interested in determining whether this phenomenon
was due to the unreactive nature of the silyoxy-diene moiety, or the inability of the
reaction to accommodate the formation of the seven-membered ring. In the interest of
seeing whether the silyoxy-diene moiety was reactive enough to undergo the Diels-Alder
reaction, the protected diene 61 was exposed to a highly reactive dienophile, maleic
anhydride (62) under thermal conditions.  Gratifyingly, this produced the desired
cycloadduct 63 as a single diastereomer whose relative stereochemistry was confirmed to
be as shown in eq. 6 by nOe analysis.  This suggested to us that it was the formation of
the seven-membered ring in the IMDA reaction that prevented the desired cyclization.  It
is of note that the Kwon group recently revealed that they pursued a similar synthetic
strategy to guanacastepene A involving an IMDA cyclization reaction.11  They too found
the heptacycle-forming IMDA reaction to be intractable.
However, this result was promising and was used to revise our synthetic plan
towards guanacastepene A.  Efforts have been directed towards converting 63 into iodide
65.  Conjugate addition of the corresponding cuprate into cyclopentenone 4 would
produce ester 66. Dieckmann condensations have been used extensively in the
preparation of seven membered carbocycles, and therefore treatment of 66 with base
should produce the core of guanacastepene A 67 in a relatively efficient manner.  In the
event that these efforts are successful, an asymmetric route to 65 would be devised, thus
leading to an efficient, asymmetric synthesis of guanacastepene A.
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III.  Conclusion
Progress has been made towards the total synthesis of guanacastepene A.
Significant efforts were directed towards pursuing a 3-component coupling/
intramolecular Diels-Alder approach towards the natural product.  IMDA precursors were
synthesized in an efficient and convergent manner.  It was found, however, that these
substrates were unable to undergo the desired cyclization.  By modifying our synthetic
approach towards guanacastepene A, we found that the stereochemically complex eastern
cyclohexene portion of the natural product could be synthesized via an intermolecular
Diels-Alder.  Therefore recent efforts have been directed towards pursuing a more
convergent intermolecular Diels-Alder/conjugate addition/Dieckmann condensation
strategy towards guanacastepene A.
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Experimental
General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1  Organic solutions were concentrated under
reduced pressure on a Buchi rotary evaporator.  Chromatographic purification of products
was accomplished using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63
according to the method described by Still.2  Thin-layer chromatography (TLC) was
performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of the
developed chromatogram was performed by florescence quenching or KMnO4 stain.
1H NMR and 13C NMR spectra were recorded on Varian Mercury-300 (300 MHz
and 75 MHz, respectively), or Varian I-500 (500 MHz and 125 MHz, respectively)
instruments, as noted, and are internally referenced to residual protio solvent signals.
Data for 1H NMR are reported with chemical shift (d ppm), multiplicity (s = singlet, d =
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz), and
assignment.  Data for 13C NMR are reported with chemical shift.  IR spectra were
recorded on an ASI React-IR 1000 spectrometer and are reported in terms of frequency of
absorption (cm-1). Mass spectra were obtained from the California Institute of
Technology Mass Spectral Facility.
Synthesis of Cyclopentenone 4.
HO
Me
MeO
Me
O
Alcohol 13.   To a solution of ester 123 (3.3g, 23.0 mmol) in 175 mL CH 2Cl2
cooled to –78 °C was added 9.0 mL (50.0 mmol) of DIBAL-H.  The solution was
allowed to stir for 15 minutes, after which the reaction was quenched with methanol (15
mL).  Upon warming the reaction to room temperature, a saturated solution of sodium
                                                 
1 Perrin, D. D.; Armarego, W.L.F. Purification of Laboratory Chemicals; 3rd ed., Pregamon Press, Oxford,
1988.
2 Still, W.C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
3 Varelis, P.; Johnson, B.L. J. Aust. Chem.  1997, 50, 43-52.
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potassium tartrate was added (200 mL) and the mixture was stirred vigorously for 8
hours.  The mixture was extracted with CH2Cl2 (3 x 100 mL), and the combined organic
extracts were washed with brine, dried over Na2SO4, and filtered. Volatiles were removed
in vacuo and the resultant crude oil was purified by silica gel chromatography (15%
EtOAc/Hexanes) to afford the title compound as a clear, colorless oil in 92% yield (2.4
g):  IR (film) 3406, 2958, 2873, 1460, 1383, 1267 cm-1; 1H NMR (300 MHz, CDCl3) d
5.12 (br d, J=9.6 Hz, 1H, CHCH=C(Me)CH2OH), 4.14 (s, 2H, CH2OH), 2.66-2.54 (m,
1H, CH(CH3)2), 1.77 (d, 3H, J=1.5 Hz, CH3CH=CH), 0.95 (d, J=6.6, 6H, CH(CH3)2); 13C
NMR (75 MHz, CDCl3) d 136.3, 131.9, 61.6, 26.8, 23.5, 21.1; HRMS (CI) exact mass
calculated for (C7H14O) requires m/z 114.1045, found m/z 114.1049.
HO
Me
O
H
N
N
MeO
Amine 9.  To a cooled (0°C) solution of alcohol 13 (300 mg, 2.65 mmol) and
triphenylphosphine (0.70 g, 2.65 mmol) in 2.5 mL THF was added N-bromosuccinimide
(NBS, 472 mgs, 2.65 mmol ) in portions.  Morpholine (0.56 mL, 6.36 mmol) was then
added by syringe to the yellow heterogeneous mixture.  The mixture was heated to reflux
for 5 hours, then filtered though celite.  The filtrate was acidified with 1N HCl, and then
washed with Et2O.  The aqueous extracts were then basified with 1N NaOH, and then
extracted with 2 x 30 mL Et2O. The combined organic extracts were washed with brine,
dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude
oil was purified by silica gel chromatography (20% Et2O/Pentane) to afford the title
compound as an oil in 54% yield (0.26 g): IR (film) 2958, 2866, 2811, 1452, 1367, 1298,
1120, 1004 cm-1; 1H NMR (300 MHz, CDCl3) d  5.09 (d, J =9.3 Hz, 1H,
CHCH=C(Me)CH2N), 3.64 (m, 4H, O(CH2)2(CH2)2N), 2.87 (s, 2H, (Me)CCH2N), 2.65-
2.50 (m, 1H, CH(CH3)2), 2.32 (m, 4H, O(CH2)2(CH2)2N), 1.66 (d, 3H, J=1.5 Hz,
CH3CH=CH), 0.87 (d, J=6.6, 6H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) d 137.6,
129.1, 67.3, 59.3, 53.7, 26.8, 23.5, 23.2; HRMS (CI) exact mass calculated for
(C11H21NO) requires m/z 183.1625, found m/z 183.1623.
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CO2Me CO2MeN
O
Amine 16.  To a solution of methyl 3,3-dimethyl acrylate (0.68 g, 6.0 mmol) in
CCl4 was added NBS (1.1 g, 6.0 mmol), followed by benzoyl chloride (8.7 mgs, 0.036
mmol).  The solution was heated to reflux for 1.5 hours, after which the mixture was
filtered.  The clear filtrate was added morpholine(0.51 mL, 6.0 mmol), and the mixture
was stirred for another 1.5 hours.  Volatiles were removed in vacuo, and 1N NaOH
solution was added.  The mixture was partitioned and the organic layer was acidified with
1N HCl and washed with water.  The aqueous layer was then basified with 1N NaOH,
and washed with diethyl ether. The combined organic extracts were washed with brine,
dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude
oil was purified by silica gel chromatography (20% EtOAc/hexanes) to separate the
isomers.  The desired trans isomer of the title compound was isolated as a red oil in 12%
yield (0.14 g):  IR (film) 2950, 2858, 2811, 1715, 1653, 1437, 1290, 1220, 1035 cm-1; 1H
NMR (300 MHz, CDCl3) d 5.80-5.79 (s, 1H, C=CHCO2Me), 3.581 (m, 7H, CO2Me and
O(CH2)2(CH2)2N), 2.84 (s, 2H, (Me)CCH2N), 2.30-2.27 (m, 4H, O(CH2)2(CH2)2N), 2.04
(s, 3H, CH3CH=CH); 13C NMR (75 MHz, CDCl3) d 166.9, 155.7, 116.8, 67.1, 53.9, 51.1,
17.6; HRMS (CI) exact mass calculated for (C11H22NO) requires m/z 184.1701, found m/z
184.0963.
HO
Me
O
O
BnO
Me
Cl
O
BnO
Ester 25.  To a solution of alcohol 13 (1.8 g, 16.1 mmol) in 32 mL of CH2Cl2 was
sequentially added pyridine (1.6 mL, 19.3 mmol), 4-dimethylaminopyridine (99 mg, 0.81
mmol), and (a-benzyloxy)-acetyl chloride (3.0 mL, 19.3 mmol).  After stirring 8 hours at
room temperature, the reaction was quenched by the addition of saturated NaHCO3
solution (30 mL) was added.  The mixture was partitioned and the aqueous layer was
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washed with 3 x 40 mL EtOAc.  The combined organic extracts were washed with brine,
dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude
oil was purified by silica gel chromatography (20% EtOAc/Hexanes) to afford the title
compound as a clear, colorless oil in 79% yield (3.3 g): IR (film) 2958, 2873, 1753, 1460,
1390, 1267 cm-1; 1H NMR (300 MHz, CDCl3) d  7.43-7.30 (m, 5H, ArH), 5.28 (dd,
J=0.60, 9.6 Hz, 1H, CHCH=C(Me)CH2OR), 4.73 (s, 2H, CH2OBn), 4.69 (s, 2H,
CHCH=C(Me)CH2O), 4.16 (s, 2H, O2CCH2OBn), 2.69-2.62 (m, 1H, CH(CH3)2), 1.76 (d,
J=2.5 Hz, 3H, CH3CH=CH), 0.99 (d, J=5.4 Hz, 6H, CH(CH3)2); 13C NMR (75 MHz,
CDCl3) d 170.5, 139.2, 137.2, 128.5, 128.1, 128.0, 126.9, 73.3, 67.2, 63.7, 27.2, 23.3,
21.4; HRMS (CI) exact mass calculated for (C16H23O3) requires m/z 263.1647, found m/z
263.1644.
O
O
BnO
Me
O
HO
MeOBn
Acid 20.  To a –78 °C solution of diisopropyl amine (6.4 mL, 45.8 mmol) in 150
mL THF was added 16.7 mL (42.0 mmol) of nBuLi (2.53M in hexanes, freshly titrated).
The solution was warmed to 0 °C and stirred for 20 minutes.  The reaction was then
cooled back to –100 °C, and 10.0 g (0.023 mmol) of ester 25 were added in 2 x 20 mL of
THF.  The reaction was stirred at that temperature for 1 hour, after which 6.3 mL (50.0
mmol) of freshly distilled trimethylsilylchloride was added dropwise.  After stirring for
an additional hour at –100 °C, the solution was slowly warmed to room temperature and
stirred for 12 hours.  The reaction was quenched with the addition of 1N NaOH (60 mL).
After stirring for 20 minutes to deprotect the trimethylsilyl ester, the volatiles were
removed in vacuo.  The resultant aqueous residue was washed with Et2O (1 x 100 mL),
then cooled to 0 °C and acidified to pH 1 with 1N HCl.  This aqueous solution was then
washed with 3 x 70 mL EtOAc. The combined organic extracts were washed with brine,
dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude
oil was purified by silica gel chromatography (10-20% EtOAc/Hexanes gradient) to
afford the title compound as a oil in 81% yield (8.1 g): 6:1 mixture of (desired) syn:anti
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diastereomers. IR (film) 3035, 2966, 2873, 1715, 1452, 1383 cm-1; 1H NMR (300 MHz,
CDCl3) d 7.41-7.30 (m, 5H, ArH ), 4.83 (m, 1H, H 2C=C), 4.78 (d, J=11.3 Hz, 1H
OCH2Ph), 4.75 (m, 1H, H2C=C), 4.36 (d, J=11.4 Hz,1H, OCH2Ph), 4.33 (d, J=3.6 Hz,
1H, HO2CHOBn), 2.15 (dd, J=3.5, 9.0 Hz, 1H, CHCH(CH3)2), 2.10-2.07 (m, 1H,
CHCH(CH3)2), 1.77 (s, 3H, CH3C=CHH), 0.88 (d, J=6.0 Hz, 3H, CH(CH3)2), 0.84 (d,
J=6.0 Hz, 3H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) d 178.1, 144.3, 137.6, 128.6,
128.1, 127.9, 115.4, 80.0, 73.5, 57.7, 26.5, 21.6, 21.3, 20.7; HRMS (CI) exact mass
calculated for (C16H23O3) requires m/z 263.1647, found m/z 263.1640.
O
HO
MeOBn
O
N
MeOBn
MeO
Me
Amide 26.  To a solution of acid 20 (2.82 g, 10.8 mmol) in 36 mL of CH2Cl2 was
added N,O-dimethylhydroxylamine hydrochloride (2.64 g, 27.0 mmol), followed by
diisopropylethylamine  (7.75 mL, 43.2 mmol) and Benzotriazol-yloxy-
tris(dimethylamino)phosphonium hexafluorophosphate (BOP reagent, 5.0 g, 11.3 mmol).
The mixture was stirred for 6 hours, after which volatiles were concentrated in vacuo.
The resultant reside was taken up in EtOAc (100 mL) and washed with 1M NaHSO4 (50
mL), brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the
resultant crude oil was purified by silica gel chromatography (10-20% EtOAc/Hexanes
gradient) to afford the title compound as a oil in 77% yield (2.52 g), which was taken
directly on to the next step without full characterization: IR (film) 2958, 1676, 1460,
1375 cm-1; 1H NMR (300 MHz, CDCl3) d 7.40-7.21 (m, 5H, ArH), 4.78-4.76 (br s, 1H,
H2C=C), 4.73 (d, J=11.4 Hz, 1H, OCH2Ph), 4.60-4.55 (br s, 1H, H2C=C), 4.48-4.45 (d,
J=5.3 Hz, 1H, O=CCHOBn), 4.25 (d, J=11.4 Hz, 1H, OCH2Ph), 3.63 (s, 3H, NO(CH3),
3.19 (s, 3H, N(CH3)), 2.22-2.28 (dd, J=5.0, 11.3 Hz, 1H, CHCH(CH3)2), 2.12-1.98 (m,
1H, CHCH(CH3)2), 1.79 (s, 3H, CH3C=CHH), 0.77 (d, J=7.5 Hz, 3H, CH(CH3)2), 0.71
(d, J=7.5 Hz, 3H, CH(CH3)2).
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Enone 28.  To a cooled (–78 °C) solution of amide 26 (0.84 g, 2.7 mmol) in 27
mL of THF was added vinyl grignard (1M in THF, 6.8 mL, 6.8 mmol) dropwise.  After
stirring 10 minutes at –78 °C, the cold bath was removed and the reaction was warmed to
room temperature.  After stirring an addition 2 hours, the reaction was quenched by
pouring the reaction mixture into 20 mL of 1M NaHSO4 solution.  The mixture was
washed with 3 x 20 mL EtOAc, and the combined organic extracts were washed with
brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant
crude oil was purified by silica gel chromatography (4% EtOAc/Hexanes) to afford the
title compound as a oil in 84% yield (0.62 g): IR (film) 2966, 1699, 1614, 1460 cm-1; 1H
NMR (300 MHz, CDCl3) d 7.42-7.29 (m, 5H, ArH), 6.76 (ddd, J=1.0, 10.5, 17.1 Hz, 1H,
HHC=CHC=O), 6.36 (ddd, J=1.2, 1.8, 17.1 Hz, HHC=CHC=O), 5.70 (ddd, J=1.2, 1.8,
10.5 Hz, 1H, HHC=CHC=O), 4.73 (m, 1H, H 2C=CMe), 4.68 (d, J=11.4 Hz, 1H,
OCH2Ph), 4.66 (m, 1H, H2C=CMe), 4.33 (d, J=11.4 Hz, 1H, OCH2Ph), 4.27 (d, J=3.9
Hz, 1H, O=CCHOBn), 2.21-2.05 (m, 2H, CHCH(CH3)2 and CHCH(CH3)2)), 1.80 (s, 3H,
CH3C=CHH), 0.94 (d, J=6.0 Hz, 3H, CH(CH3)2), 0.88 (d, J=6.0 Hz, 3H, CH(CH3)2); 13C
NMR (75 MHz, CDCl3) d 202.1, 143.8, 137.9, 132.1, 128.4, 128.0, 127.7, 127.6, 115.4,
85.4, 72.9, 57.5, 26.5, 26.5, 21.3, 20.9, 20.6.
O
BnO
Me
O
MeOBn
Ru
N N MesMes
PCy3 Ph
Cl
Cl
Cyclopentenone 4.  To a solution of enone 28 (15.4 mg, 0.054 mmol) in 5 mL of
toluene was added 2.3 mg (0.0027 mmol) of Grubbs second generation ruthenium
methathesis catalyst 30.4  The solution was refluxed for 36 hours, after which the reaction
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was cooled to room temperature and volatiles were removed in vacuo.  The resultant
brown solid was purified by silica gel chromatography (5-10-15% EtOAc/Hexanes
gradient) to afford the title compound as a mixture of separable isomers in 61% yield (8.5
mg, 91% yield based on recovered starting material): IR (film) 2966, 1715, 1614, 1460,
1383, 1174 cm-1; 1H NMR (300 MHz, CDCl3) d 7.40-7.25 (m, 5H, ArH), 6.00-5.99 (m,
1H, O=CCH=CMe), 4.99 (d, J=12.4 Hz, 1H, OCH2Ph), 4.77 (d, J=12.4 Hz, 1H,
OCH2Ph), 4.02 (d, J=6.3 Hz, 1H, O=CCHOBn), 2.88-2.85 (m, 1H, CHCH(CH3)2) 2.28-
2.20 (m, 1H, CHCH(CH3)2), 2.07 (s, 3H, CH 3C=CH), 1.03 (dd, J=1.1, 7.1 Hz, 3H,
CH(CH3)2), 0.83 (dd, J=1.1, 7.1 Hz, 3H, CH(C H3)2); 13C NMR (75 MHz, CDCl3)
d 207.3, 175.4, 138.3, 129.5, 128.5, 128.6, 129.8, 81.2, 73.3, 53.8, 28.1, 21.2, 20.6, 19.3;
HRMS (CI) exact mass calculated for (C16H21O2) requires m/z 245.1542, found m/z
245.1535.
nOe analysis to determine relative stereochemistry of the two isomers:
H
O
H
HH
O
O O
H3C
CH3
H3C
Me
H3C CH3
H
H
major isomer: syn minor isomer: anti
Synthesis of Alkyl Iodide 31.
HO HO I
Vinyl Iodide 39.  To a solution of NaI (79.2 g, 0.53 mole) in 500 mL was added
freshly distilled chlorotrimethylsilane (41 mL, 0.53 mole) followed by H2O (4.8 mL, 0.26
mole) upon which the solution turned yellow.  The mixture was stirred for 10 minutes to
allow for the in situ formation of HI, then 20 mL (0.26 mole) of 3-butynol was added.
The orange solution was stirred at room temperature in the dark for 5 hours.  Water was
then added (300 mL), and the mixture was washed with 3 x 300 mL Et2O.  The combined
134
organic extracts were washed with brine, dried over Na2SO4, and filtered. Volatiles were
removed in vacuo and the resultant crude oil was purified by silica gel chromatography
(30% EtOAc/Hexanes) to afford the title compound as a orange-red oil in 75% yield (39
grams): IR (film) 3321, 2881, 1413, 1197, 1128 cm-1; 1H NMR (300 MHz, CDCl3) d 6.18
(m, 1H, IC=CHH), 5.85 (m, 1H, IC=CHH), 3.76 (t, J=5.8 Hz, 2H, CH2OH), 2.62 (dt,
J=1.1, 5.8 Hz, 2H, HOCH2CH2CI); 13C NMR (75 MHz, CDCl3) d 128.1, 107.8, 60.8,
48.0; HRMS (CI) exact mass calculated for (C4H7OI) requires m/z 197.9542, found m/z
197.9544.
OTBDPSOH
Alkyne 40.  To a solution of propargyl alcohol (4.5 mL, 77.3 mmol) in 16 mL
DMF was added imidazole (6.7 g, 99.4 mmol), followed by tert-butyl- chloro-
diphenylsilane (15 mL, 57.3 mmol).  The solution was stirred for 3 hours, then quenched
with 1M NaHSO4 (70 mL).  The mixture was partitioned and the aqueous extracts were
washed with 3 x 50 mL EtOAc.  The combined organic extracts were washed with 2 x 30
mL 1M NaHSO4 , 2 x 40 mL H2O, brine, dried over Na2SO4, and filtered. Volatiles were
removed in vacuo and the resultant crude oil (16.2 g, 96% yield) was immediately carried
onto the next step without further purification.
HO I
OTBDPS
HO
OTBDPS
Enyne 41.  To a solution of vinyl iodide 39 (100 mg, 0.51 mmol) in 1 mL THF
was sequentially added alkyne 40 (193.3 mg, 0.66 mmol), triethylamine (0.21 mL, 1.5
mmol), Pd(PPh3)2Cl2 (17.7 mg, 0.025 mmol), and Copper(I) iodide (4.8 mg, 0.025
mmol).  The orange mixture was stirred at room temperature for 8 hours, then quenched
with saturated NH4Cl solution.  Volatiles were removed in vacuo and the resultant reside
was taken up in EtOAc (10 mL) and partitioned.  The aqueous phase was extracted with 2
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x 10 mL EtOAc, and the combined organic extracts were washed with brine, dried over
Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant crude oil was
purified by silica gel chromatography (10-25% EtOAc/Hexanes gradient) to afford the
title compound as an orange oil in 70% yield (131 mgs): IR (film) 3383, 2935, 2858,
1468, 1429, 1367, 1097 cm-1; 1H NMR (300 MHz, CDCl3) d 7.73-7.70 (m, 4H, ArH),
7.43-7.25 (m, 6H, ArH), 5.35 (s, 1H, C=CHH), 5.30 (m, 1H, C=CHH), 4.50 (s, 2H,
CH2OTBDPS), 3.76 (t, J =5.7 Hz, 2H, CH2OH), 2.39 (t, J =5.9 Hz, 2H,
HOCH2CH2C=CHH), 1.05 (s, 9H, OSiC(CH3)3Ph2); 13C NMR (75 MHz, CDCl3) d 135.1,
134.9, 132.6, 132.5, 129.2, 129.0, 127.1, 124.2, 63.3, 52.5, 39.7, 26.1, 18.8; HRMS
(FAB+) exact mass calculated for (C23H27O2Si) requires m/z 363.1780, found m/z
363.1768.
HO
OTBDPS
HO
OTBDPS
Diene 32.  317 mg (1.4 mmol) of anhydrous Zinc(II) Bromide was weighed out in
the glovebox, equipped with a stir bar, and transferred to an argon line.  The solid was
then by heated to liquidity under vacuum with a bunson burner.  Upon cooling to room
temperature, the flask was back-filled with argon, and charged with 1.5 mL THF.  107
mg (2.7 mmol) of potassium metal (washed with hexanes to remove the mineral oil) was
then added to the flask, and the mixture was heated to reflux for 3 hours, during which
the solution turned black.  Enyne 41 was then added in 1 mL of THF, 1.75 mL of
methanol, and 0.36 mL of H2O (slowly and very carefully).    The solution was refluxed
for 12 hours, during which time it turned grey, and then cooled back to room temperature.
30 mL of saturated NH4Cl solution was added, and the mixture was partitioned.  The
aqueous layer was washed with 2 x 15 mL Et2O, and the combined organic extracts were
washed with brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and
the resultant crude oil was purified by silica gel chromatography (25% EtOAc/Hexanes,
product cospots with enyne starting material) to afford the title compound as an orange
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oil in 72% yield (230 mgs): IR (film) 3833, 3704, 2935, 2858, 1622, 1468, 1429, 1112,
826 cm-1; 1H NMR (300 MHz, CDCl3) d  7.78-7.67 (m, 4H, ArH), 7.52-7.43 (m, 6H,
ArH), 5.92-5.80 (m, 2H, TBDPSOCH2CH=CHC and TBDPSOCH2CH=CHC), 5.04 (s,
1H, C=CHH), 4.74 (m, 1H, C=CHH), 4.45 (d, J=5.1 Hz, 2H, CH2OTBDPS), 3.65 (t,
J=6.3 Hz, 2H, CH2OH), 2.39 (t, J=6.3 Hz, 2H, HOCH2CH2C=CHH), 1.09 (s, 9H,
OSiC(CH3)3Ph2); 13C NMR (75 MHz, CDCl3) d 141.3, 135.6, 133.7, 132.8, 129.9, 129.7,
127.7, 126.8, 116.9, 61.1, 60.9, 40.1, 19.2 ; HRMS (FAB) exact mass calculated for
(C23H29O2Si) requires m/z 365.1937, found m/z 365.1937.
HO
Me
OTBDPS
HO
OTBDPS
Diene 42.  To a solution of diene 32 (5.0 g, 13.6 mmol) in 135 mL of acetone was
added 360 mg (1.3 mmol) of (naphthalene)Cr(CO)3.  The solution was deoxygenated
though 3 freeze-pump-thaw cycles, then stirred under argon for 8 hours.  The reaction
mixture was concentrated in vacuo then loaded onto a silica gel column and eluted with
2-4% EtOAc/hexanes to afford the title compound as a yellow oil in 92% yield (4.6 g):
IR (film) 3360, 2935, 2896, 1614, 1468, 1166, 1112, 1059, 702.9 cm-1; 1H NMR (300
MHz, CDCl3) d 7.68-7.66 (m, 4H, ArH), 7.44-7.25 (m, 6H, ArH), 6.51 (d, J=12.3 Hz,
1H, Ph2(CH3)3CSiOCH=CHHC=C(CH3)CH2),  6.01 (dd, J =12.3, 12.3 Hz, 1H,
R3SiOCH=CHHC=C(CH3)CH2), 5.68 (d, J=12.3 Hz, 1H, R3SiOCH=CHCH), 3.55 (t,
J=5.6 Hz, 2H, CH 2OH), 2.24 (t, J=5.6 Hz, 2H, HOCH2CH2C=C), 1.68 (s, 3H,
Ph2(CH3)3CSiOCH=CHHC=C(CH3)CH2), 1.08 (s, 9H, OSiC(CH3)3Ph2); 13C NMR (75
MHz, CDCl3) d 144.5, 135.7, 135.1, 132.7, 130.3, 128.1, 123.3, 110.3, 60.5, 43.0, 26.8,
19.5, 16.5; HRMS (FAB) exact mass calculated for (C23H29O2Si) requires m/z 365.1937,
found m/z 365.1928.
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nOe analysis used to confirm olefin geometry:
HO
Me
OTBDPS
Ha
Hb
Hc
Hd Hd
nOe analysis 
confirmed synthesis
of E,E diene
HO
Me
OTBDPS
I
Me
OTBDPS
Alkyl iodide 31.  To a cooled (0 °C) solution of triphenylphosphine (0.59 g, 2.25
mmol) and imidazole (153 mg, 2.25 mmol) in 10 mL of CH2Cl2 was added iodine (545
mg, 2.15 mmol).  The solution was stirred until the solid iodine disappeared.  Diene 42
(750 mg, 2.05 mmol) was then added in 4.0 mL of CH2Cl2 and stirred for 3 hours in the
dark at 4 °C.  The reaction was quenched with 10% NaS2O3, and then transferred to a
sepratory funnel.  The aqueous layer was washed with 3 x 15 mL Et2O, and then the
combined organic extracts were washed with 10% NaS2O3, brine, dried over Na2SO4, and
filtered. Volatiles were removed in vacuo and the resultant crude oil was quickly purified
by silica gel chromatography in the dark (1% EtOAc/Hexanes.  Note: product
decomposes on silica) to afford the title compound as clear, colorless oil in 69% yield
(703 mg).  Due to its instability, the compound was immediately carried onto the next
step without full characterization.  1H NMR (300 MHz, CDCl3) d  7.70-7.26 (m, 10H,
ArH ), 6.53 (d, J=11.5 Hz, 1H, Ph2(CH3)3CSiOCH=CHHC=C(CH3)CH2),  5.98 (dd,
J=11.5, 11.7 Hz, 1H, R3SiOCH=CHHC=C(CH3)CH2), 5.64 (d, J=11.7 Hz, 1H,
R3SiOCH=CHCH), 3.17 (t, J=7.8 Hz, 2H, CH2I), 2.53 (t, J=7.8 Hz, 2H, ICH2CH2C=C),
1.67 (s, 3H, Ph2(CH3)3CSiOCH=CHHC=C(CH3)CH2), 1.11 (s, 9H, OSiC(CH3)3Ph2); 13C
NMR (75 MHz, CDCl3) d 144.64, 135.6, 132.6, 131.7, 130.2, 128.0, 122.8, 110.3, 44.5,
26.9, 19.6, 16.2, 5.0.
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Synthesis of IMDA precursors.
I
Me
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Cyclopentanone 44.  Iodide 31 (224.4 mg, 0.47 mmol) was weighed into and
degassed under vacuum.  The vessel was charged with 2.0 mL of Et2O and cooled to
–78°C.  tert-Butyllithium (1.75M in pentane, 0.51 mL, 0.90 mmol) was added dropwise
to the flask , turning the solution bright yellow towards the end of the addition.  The
solution was stirred for 20 min at this temperature, then cannulated into a cooled (–78°C)
flask containing copper(I) cyanide (20.2 mg, 0.225 mmol), and washed with 1 mL Et2O.
The bright yellow mixture was slowly warmed to 0 °C, during with the yellow
heterogenous mixture gradually turned to a tan, clear, homogenous solution.  After 5
minutes, the solution was cooled back to –78 °C and cyclopentenone 4 (50 mg, 0.205
mmol) was added in 2 x 0.6 mL of Et2O; the solution immediately turned red once the
first drop of the cyclopentenone was added, and upon completion of the addition, the
solution was completely red-orange in color.  The solution was stirred at this temperature
for 10 minutes and then transferred to a –20 °C bath and stirred for another 8 hours.  The
reaction was quenched with the addition of saturated NH4Cl/10%NH4OH solution.  The
mixture was partitioned and the aqueous layer was washed with 3 x 20 mL EtOAc.  The
combined organic extracts were washed with brine, dried over Na2SO4, and filtered.
Volatiles were removed in vacuo and the resultant crude oil was purified by silica gel
chromatography (1-3% EtOAc/Hexanes) to afford the title compound as a clear colorless
oil in 88% yield (104.2 mg).  Note: product decomposes over prolonged exposure to
silica gel.  Chromatography should be done relatively rapidly. IR (film) 2935, 2866,
1738, 1460, 1383, 1267, 1112, 818 cm-1; 1H NMR (300 MHz, CDCl3) d 7.97-7.25 (m,
15H, (C6H5)2(CH3)3CSiO and (C6H5)CH2O), 6.49 (d, J =11.5 Hz, 1H,
SiOC14H=CHHC=C(CH3)CH2),  6.00 (dd, J=11.5, 11.5 Hz, 1H, SiOCH=C13HHC=C),
5.59 (d, J=11.5 Hz, 1H, SiOCH=CHC12H), 4.89 (d, J=11.4, 1H, PhC6H2), 4.42 (d,
J=11.4, 1H, PhC6H2), 3.61 (d, J=6.9 Hz, 1H, C2HOBn), 2.24 (d, J=6.9 Hz, 2H,
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O=CC5H2C), 2.21-2.13 (m, 1H, C7H(CH3)2), 2.05-1.87 (m, 2H, C10H2C(Me)=C), 1.77-
1.40 (m, 2H, C9H2CH2C(Me)=C), 1.66 (s, 3H, C=C(C15H3)CH2), 1.52-1.39 (m, 1H,
C3HCH(CH3)2), 1.19 (s, 3H, C16H3), 1.08 (s, 9H, OSiC(CH3)3Ph2), 1.04 (d, J=6.9 Hz,
3H, CH(C8H3)2), 0.92 (d, J=6.9 Hz, 3H, CH(C8H3)2); 13C NMR (75 MHz, CDCl3)
d 216.3, 143.6, 138.3, 135.6, 133.7, 132.8, 130.2, 128.4, 128.0, 127.7, 120.1, 110.6, 81.5,
72.5, 56.6, 51.9, 41.9, 41.7, 35.6, 26.9, 25.4, 23.4, 23.0, 19.6, 17.1; HRMS (FAB+) exact
mass calculated for (C39H50O3Si) requires m/z 594.3529, found m/z 594.3529.
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Acetal 43.  Cyclopentanone 44 was thoroughly dried prior to use (azeotroped
with benzene, and dried though a Na2SO4 plug).  To a –78 °C solution of diisopropyl
amine (24 mL, 0.17 mmol) in 0.2 mL THF was added 55 mL (0.13 mmol) of nBuLi
(2.42M in hexanes, freshly titrated).  The solution was warmed to 0 °C and stirred for 20
minutes.  The reaction was then cooled back to –78 °C, and 39.9 mg (0.067 mmol) of
cyclopentanone # was added in 0.2 mL THF + 0.1 mL THF (washing vessel).  The
solution was stirred at that temperature for 40 minutes, at which time 42 mg (0.27 mmol)
of 4,4-diethoxy-2-butyn-1-al was added in 0.1 mL THF.  After stirring for 20 minutes,
the reaction was quenched by pouring into a solution of cooled (0 °C) saturated NH4Cl
solution and stirring rapidly for 3 minutes.  The mixture was partitioned and the aqueous
layer was washed with 3 x 15 mL EtOAc. The combined organic extracts were washed
with brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the
resultant crude oil was purified by silica gel chromatography (1:5 EtOAc/Hexanes) to
afford the title compound as a clear colorless oil in 56% yield (28.2 mg).  Note: product
decomposes over prolonged exposure to silica gel.  Chromatography should be done
relatively rapidly. IR (film) 3468, 3422, 2966, 2896, 1730, 1614, 1460, 1112, 1020 cm-1;
1H NMR (300 MHz, CDCl3) d 7.97-7.25 (m, 15H, (C6H5)2(CH3)3CSiO and (C6H5)CH2O),
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6.49 (d, J=11.7 Hz, 1H, SiOC14H=CHHC=C(CH3)CH2),  6.00 (dd, J=11.7, 11.7 Hz, 1H,
SiOCH=C13HHC=C), 5.58 (d, J=11.7 Hz, 1H, SiOCH=CHC12H), 5.20 (s, 1H,
C20H(OEt)2), 4.97 (d, J=11.7, 1H, PhC6H2), 4.56-4.52 (m, 1H, (HO)C17H), 4.49 (d,
J=11.4 Hz, 1H, PhC6H 2), 3.81 (d, J=6.3 Hz, 1H, C2HOBn), 3.76-3.45 (m, 4H,
CH(OC21H2CH3)2), 3.36 (br d, J=10.5 Hz, 1H, HC17OH), 2.52 (d, J=4.2 Hz, 1H,
O=CC5H C), 2.17-1.68 (m, 6H, C9H 2CH2C(Me)=C and C10H 2C(Me)=C and
C7H(CH3)2) and C3HCH(CH3)2), 1.65 (s, 3H, C=C(C15H3)CH2), 1.56 (s, 3H, C16H3),
1.19 (m, 6H, C(OCH2C22H3)2), 1.08 (s, 9H, OSiC(CH3)3Ph2), 1.01 (d, J=6.0 Hz, 3H,
CH(C8H3)2), 0.92 (d, J=6.0 Hz, 3H, CH(C8H3)2); 13C NMR (125 MHz, CDCl3) d 218.3,
143.8, 138.0, 135.7, 135.0, 133.7, 132.9, 130.2, 129.9, 128.5, 128.0, 127.9, 127.9, 120.4,
110.7, 91.5, 84.3, 73.0, 64.1, 61.1, 60.6, 53.6, 45.0, 37.3, 35.3, 29.9, 25.6, 23.5, 23.2,
21.3, 19.5, 17.0, 15.3; HRMS (FAB+) exact mass calculated for (C47H62O6Si) requires
m/z 750.4316, found m/z 750.4315.
nOe analysis used to determine relative stereochemistry around the cyclopentanone ring:
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Benzoate ester 50.  Cyclopentanone 4 was thoroughly dried prior to use
(azeotroped with benzene, and dried though a Na2SO4 plug).  To a –78 °C solution of
141
diisopropyl amine (29 mL, 0.21 mmol) in 0.25 mL THF was added 70 mL (0.17 mmol) of
nBuLi (2.41M in hexanes, freshly titrated).  The solution was warmed to 0 °C and stirred
for 20 minutes.  The reaction was then cooled back to –78 °C, and 50.0 mg (0.084 mmol)
of cyclopentanone # was added in 0.15 mL THF + 0.1 mL THF (washing vessel).  The
solution was stirred at that temperature for 40 minutes, at which time 63 mg (0.34 mmol)
of benzoic acid 4-oxo-but-2-ynyl ester was added in 0.15 mL THF.  After stirring for 20
minutes, the reaction was quenched by pouring into a solution of cooled (0 °C) saturated
NH4Cl solution and stirring rapidly for 3 minutes.  The mixture was partitioned and the
aqueous layer was washed with 3 x 15 mL EtOAc. The combined organic extracts were
washed with brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and
the resultant crude oil was purified by silica gel chromatography (1:5 EtOAc/Hexanes) to
afford the title compound as a clear colorless oil in 50% yield (32.9 mg): 1H NMR (300
MHz, CDCl3) d  8.05-7.25 (m, 20H, (C6H5)2(CH3)3CSiO and (C6H5)CH2O and
O=C(C6H5)), 6.47 (d, J=11.4 Hz, 1H, SiOC14H=CHHC=C(CH3)CH2),  5.95 (dd, J=11.4,
11.4 Hz, 1H, SiOCH=C13HHC=C), 5.63 (d, J=11.4 Hz, 1H, SiOCH=CHC12H), 5.04 (d,
J=11.7 Hz, 1H, PhC6H2), 4.86 (s, 2H, C20H2), 4.67 (m, 1H, (HO)C17H), 4.46 (d, J=11.7
Hz, 1H, PhC6H2), 4.15 (d, J=3.9 Hz, 1H, C2HOBn), 3.69 (br d, J=6.9 Hz, 1H,
HC17OH), 2.57 (d, J=7.2 Hz, 1H, O=CC5HC), 2.23-1.70 (m, 6H, C9H2CH2C(Me)=C
and C10H 2C(Me)=C and C7H(CH3)2) and C3H C H ( C H3)2), 1.65 (s, 3H,
C=C(C15H3)CH2), 1.57 (s, 3H, C16H3), 1.06 (s, 9H, OSiC(CH3)3Ph2), 1.04 (d, J=6.3 Hz,
3H, CH(C8H3)2), 0.92 (d, J=6.3 Hz, 3H, CH(C8H3)2).
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Amide 48.  Cyclopentanone 4 and 4-oxo-but-2-ynoic acid dimethylamide were
thoroughly dried prior to use (azeotroped with benzene, and dried though a Na2SO4 plug).
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To a –78 °C solution of diisopropyl amine (17 mL, 0.12 mmol) in 0.2 mL THF was added
41 mL (0.098 mmol) of nBuLi (2.41M in hexanes, freshly titrated).  The solution was
warmed to 0 °C and stirred for 20 minutes.  The reaction was then cooled back to –78 °C,
and 29.4 mg (0.049 mmol) of cyclopentanone # was added in 0.1 mL THF + 0.1 mL THF
(washing vessel).  The solution was stirred at that temperature for 40 minutes, at which
time 25 mg (0.20 mmol) of 4-oxo-but-2-ynoic acid dimethylamide was added in 0.2 mL
THF.  After stirring for 20 minutes, the reaction was quenched by pouring into a solution
of cooled (0 °C) saturated NH4Cl solution and stirring rapidly for 3 minutes.  The mixture
was partitioned and the aqueous layer was washed with 3 x 15 mL EtOAc. The combined
organic extracts were washed with brine, dried over Na2SO4, and filtered. Volatiles were
removed in vacuo and the resultant crude oil was purified by silica gel chromatography
(10-40-50% EtOAc/Hexanes) to afford the title compound as a clear colorless oil in 32%
yield (11.0 mg): IR (film) 3414, 3360, 2935, 2866, 2248, 1746, 1622, 1460, 1398, 1174
cm-1; 1H NMR (500 MHz, CDCl3) d 7.70-7.28 (m, 15H, (C6H5)2(CH3)3CSiO and
(C6H5)CH2O), 6.52 (d, J=12.0 Hz, 1H, SiOC14H=CHHC=C(CH3)CH2),  6.01 (dd,
J=12.0, 12.0 Hz, 1H, SiOCH=C13HHC=C), 5.60 (d, J=12.0 Hz, 1H, SiOCH=CHC12H),
4.93 (d, J=11.5, 1H, PhC6H2), 4.67-4.65 (m, 1H, (HO)C17H), 4.52 (d, J=11.5 Hz, 1H,
PhC6H2), 3.89 (d, J=7.0 Hz, 1H, C2HOBn), 3.53 (br d, J=8.5 Hz, 1H, HC17OH), 3.11
(s, 3H, N(CH3)(CH3)), 2.94 (s, 3H, N(CH3)(CH3)), 2.62 (d, J=4.0 Hz, 1H, O=CC5HC),
2.19-2.09 (m, 6H, C9H 2CH2C(Me)=C and C10H2C(Me)=C and C7H(CH3)2) and
C3HCH(CH3)2), 1.66 (s, 3H, C=C(C15H3)CH2), 1.24 (s, 3H, C16H 3), 1.08 (s, 9H,
OSiC(CH3)3Ph2), 1.09 (d, J=6.0 Hz, 3H, CH(C8H3)2), 0.92 (d, J=6.0 Hz, 3H,
CH(C8H3)2); 13C NMR (125 MHz, CDCl3) d 219.1, 154.1, 153.6, 143.9, 138.0, 135.7,
134.4, 133.1, 132.9, 130.2, 128.6, 128.0, 127.9, 120.4, 119.3, 110.6, 90.1, 81.1, 73.1,
63.5, 61.1, 53.0, 43.3, 38.3, 35.6, 35.2, 34.2, 26.8, 25.8, 23.5, 22.5, 19.5, 16.8; HRMS
(FAB+) exact mass calculated for (C45H58NO5Si) requires m/z 720.4084, found m/z
720.4085.
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Ester 49.  Cyclopentanone 4 and 4-oxo-but-2-enoic acid methyl ester were
thoroughly dried prior to use (azeotroped with benzene, and dried though a Na2SO4 plug).
To a –78 °C solution of diisopropyl amine (20 mL, 0.14 mmol) in 0.2 mL THF was added
49 mL (0.11 mmol) of nBuLi (2.32M in hexanes, freshly titrated).  The solution was
warmed to 0 °C and stirred for 20 minutes.  The reaction was then cooled back to –78 °C,
and 33.8 mg (0.057 mmol) of cyclopentanone # was added in 0.1 mL THF + 0.1 mL THF
(washing vessel).  The solution was stirred at that temperature for 40 minutes, at which
time 50 mg (0.44 mmol) of 4-oxo-but-2-enoic acid methyl ester was added in 0.2 mL
THF.  After stirring for 20 minutes, the reaction was quenched by pouring into a solution
of cooled (0 °C) saturated NH4Cl solution and stirring rapidly for 3 minutes.  The mixture
was partitioned and the aqueous layer was washed with 3 x 15 mL EtOAc. The combined
organic extracts were washed with brine, dried over Na2SO4, and filtered. Volatiles were
removed in vacuo and the resultant crude oil was purified by silica gel chromatography
(5-10-20% EtOAc/Hexanes) to afford the title compound as a clear colorless oil in 53%
yield (21.3 mg): 1H NMR (500 MHz, CDCl3) d 7.74-7.25 (m, 15H, (C6H5)2(CH3)3CSiO
and (C6H5)CH2O), 7.01 (dd, J=6.3, 16.2, 1H, C18H ), 6.48 (d, J=11.4 Hz, 1H,
SiOC14H=CHHC=C(CH3)CH2),  6.10 (d, J=16.0, 1H, C19H), 5.98 (dd, J=11.4, 11.4 Hz,
1H, SiOCH=C13HHC=C), 5.60 (d, J=11.4 Hz, 1H, SiOCH=CHC12H), 5.03 (d, J=11.5,
1H, PhC6H2), 4.55-4.50 (m, 1H, (HO)C17H), 4.52 (d, J=11.5 Hz, 1H, PhC6H2), 3.83 (d,
J=7.8 Hz, 1H, C2HOBn), 3.81 (br d, J=7.0 Hz, 1H, HC17OH), 3.65 (s, 3H, CO2Me),
2.42 (d, J=4.0 Hz, 1H, O=CC5H C), 2.21-1.45 (m, 6H, C9H2CH2C(Me)=C and
C10H2C(Me)=C and C7H(CH3)2) and C3HCH(CH3)2), 1.64 (s, 3H, C=C(C15H3)CH2),
1.18 (s, 3H, C16H3), 1.08 (s, 9H, OSiC(CH3)3Ph2), 1.08 (m, 3H, CH(C8H3)2), 0.92 (d,
J=6.0 Hz, 3H, CH(C8H3)2); HRMS (FAB+) exact mass calculated for (C44H55O6Si)
requires m/z 707.3768, found m/z 707.3773.
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Tetraene 56.  Cyclopentanone 4 and 4-oxo-but-2-enoic acid methyl ester were
thoroughly dried prior to use (azeotroped with benzene, and dried though a Na2SO4 plug).
To a –78 °C solution of diisopropyl amine (25 mL, 0.16 mmol) in 0.2 mL THF was added
57 mL (0.13 mmol) of nBuLi (2.24M in hexanes, freshly titrated).  The solution was
warmed to 0 °C and stirred for 20 minutes.  The reaction was then cooled back to –78 °C,
and 38.0 mg (0.064 mmol) of cyclopentanone # was added in 0.1 mL THF + 0.1 mL THF
(washing vessel).  The solution was stirred at that temperature for 40 minutes, at which
time 51 mg (0.45 mmol) of 4-oxo-but-2-enoic acid methyl ester was added in 0.2 mL
THF.  After stirring for 2 hours, the reaction was quenched by pouring into a solution of
cooled (0 °C) saturated NH4Cl solution and stirring rapidly for 3 minutes.  The mixture
was partitioned and the aqueous layer was washed with 3 x 15 mL EtOAc. The combined
organic extracts were washed with brine, dried over Na2SO4, and filtered. Volatiles were
removed in vacuo and the resultant crude oil was purified by silica gel chromatography
(5-10-20% EtOAc/Hexanes) to afford the title compound as a bright yellow oil in 20%
yield (8.8 mg).  Owing to the somewhat unstable nature of the compound, it was
immediately taken onto the next step without full characterization: 1H NMR (300 MHz,
CDCl3) d 8.58 (d, J=13.0, 19.8 Hz, 1H, C18H), 7.72-7.20 (m, 15H, (C6H5)2(CH3)3CSiO
and (C6H5)CH2O), 6.54 (d, J=11.7 Hz, 1H, SiOC14H=CHHC=C(CH3)CH2), 6.18 (d,
J=13.0 Hz, 1H, C17H), 6.09 (d, 19.9 Hz, 1H, C19H), 6.00 (dd, J=11.7, 11.7 Hz, 1H,
SiOCH=C13HHC=C), 5.57 (d, J=11.7 Hz, 1H, SiOCH=CHC12H), 5.85 (s, 1H, C19H),
4.80 (d, J=11.5, 1H, PhC6H2), 4.46 (d, J=11.5 Hz, 1H, PhC6H2), 3.78 (s, 3H, CO2Me),
3.76 (m, 1H, C2HOBn), 2.06-1.52 (m, 6H, C9H2CH2C(Me)=C and C10H2C(Me)=C and
C7H(CH3)2) and C3HCH(CH3)2), 1.58 (s, 3H, C=C(C15H3)CH2), 1.23 (s, 3H, C16H3),
1.08 (s, 9H, OSiC(CH3)3Ph2), 0.98 (d, J=6.6 Hz, 3H, CH(C8H3)2), 0.89 (d, J=6.6 Hz, 3H,
CH(C8H3)2); HRMS (FAB+) exact mass calculated for (C44H54O5Si) requires m/z
690.3741, found m/z 690.3739.
145
O
BnO
Me
Me
OTBDPS
CO2Me
O
O
Me
Me
OTBDPS
CO2Me
Ph 1
2
3
5
6
7
8 9
18
16
15
14
13
12
10
8
19
17
Tricycle 57.  A solution of tetraene 56 (4.1 mg, 0.0059 mmol) in CDCl3 (0.5 mL)
was heated to 60 °C for 24 hours.  As the reaction progressed, the solution turned from its
initial almost fluorescent yellow color to a light, pale yellow color.  The reaction was
worked up by removing volatiles in vacuo.  Purification by silica gel chromatography
(5% EtOAc/Hexanes) afforded the title compound as a pale yellow oil in 51% yield (2.1
mg): IR (film) 2926, 2850, 2358, 1723, 1649, 1459, 1273, 1159, 1115 cm-1; 1H NMR
(500 MHz, CDCl3) d 7.73-7.11 (m, 15H, (C6H5)2(CH3)3CSiO and (C6H5)CH2O), 7.13 (dd,
J=7.0, 15.5 Hz, 1H, C18H), 6.27 (d, J=12.0 Hz, 1H, C14H), 5.66 (dd, J=1.0, 15.5 Hz,
1H, C19H), 4.96 (dd, J=9.5, 12.5 Hz, 1H, C13H), 4.85 (d, J=12.0 Hz, 1H, PhC6H2), 4.36
(d, J=12.0 Hz, 1H, PhC6H2), 3.68 (s, 3H, CO2(CH3)), 3.51 (d, J=5.5 Hz, 1H, C2HOBn),
2.60 (dt, J=1.5, 9.5 Hz, C17H), 2.51 (dd, J=9.0, 9.0, 1H, C12H), 2.15-2.13 (m, 1H,
C9H), 2.08-2.03 (m, 1H, C10H), 1.90-1.86 (m, 1H, C3H), 1.64 -1.52 (m, 2H, C9H,
C10H), 1.48-1.41 (m, 1H, C7H), 1.12 (s, 3H, C15H3), 1.08 (s, 9H, OSiC(CH3)3Ph2), 1.03
(d, J=7.0 Hz, 3H, CH(C8H3)2), 0.93 (s, 3H, C16H3), 0.89 (d, J=7.0 Hz, 3H, CH(C8H3)2);
connectivity of C19-C18-C17-C12-C13-C14 determined by 2D COSY analysis; 13C
NMR (125 MHz, CDCl3) d 215.2, 166.9, 148.3, 142.8, 135.7, 130.2, 128.4, 128.0, 127.9,
127.6, 120.9, 110.2, 81.9, 72.0, 55.4, 54.3, 54.2, 51.5, 44.1, 42.1, 41.1, 33.8, 29.9, 25.1,
24.8, 22.7, 22.4, 19.5, 18.1; LRMS (MALDI) exact mass calculated for (NaC44H54O5Si)
requires m/z 713.36, found m/z 713.64.
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Diketoester 58.  Cyclopentanone 4 was thoroughly dried prior to use (azeotroped
with benzene, and dried though a Na2SO4 plug).  To a –78 °C solution of diisopropyl
amine (20 mL, 0.14 mmol) in 0.2 mL THF was added 49 mL (0.11 mmol) of nBuLi
(2.27M in hexanes, freshly titrated).  The solution was warmed to 0 °C and stirred for 20
minutes.  The reaction was then cooled back to –78 °C, and 33.1 mg (0.055 mmol) of
cyclopentanone # was added in 0.1 mL THF + 0.1 mL THF (washing vessel).  The
solution was stirred at that temperature for 40 minutes, at which time 75 mL of 3-
chlorocarbonyl-acrylic acid methyl ester was added.  After stirring for 20 minutes, the
reaction was quenched by pouring into a solution of cooled (0 °C) saturated NH4Cl
solution and stirring rapidly for 3 minutes.  The mixture was partitioned and the aqueous
layer was washed with 3 x 15 mL Et2O. The combined organic extracts were washed with
brine, dried over Na2SO4, and filtered. Volatiles were removed in vacuo and the resultant
crude oil was purified by silica gel chromatography (5% EtOAc/Hexanes) to afford the
title compound as a clear colorless oil in 54% yield (20.0 mg): IR (film) 3460, 3074,
2958, 2866, 1730, 1468, 1429, 1259, 1112 cm-1; 1H NMR (500 MHz, CDCl3) d 7.78-7.09
(m, 15H, (C6H5)2(CH3)3CSiO and (C6H5)CH2O), 6.82 (s, 1H, C18H), 6.66 (d, J=11.7 Hz,
1H, SiOC14H=CHHC=C(CH3)CH2),  6.35 (dd, J =11.7, 11.7 Hz, 1H,
SiOCH=C13HHC=C), 5.60 (d, J=11.7 Hz, 1H, SiOCH=CHC12H), 5.85 (s, 1H, C19H),
4.65 (d, J=11.7, 1H, PhC6H2), 4.31 (d, J=11.7 Hz, 1H, PhC6H2), 4.17 (d, J=6.0 Hz, 1H,
C2HOBn), 3.53 (br d, J=8.5 Hz, 1H, HC17OH), 3.19 (s, 3H, CO2Me), 2.10-1.42 (m, 6H,
C9H2CH2C(Me)=C and C10H2C(Me)=C and C7H(CH3)2) and C3HCH(CH3)2), 1.55 (s,
3H, C=C(C15H3)CH2), 1.19 (s, 3H, C16H3), 1.07 (s, 9H, OSiC(CH3)3Ph2), 0.91 (d, J=6.6
Hz, 3H, CH(C8H3)2), 0.85 (d, J=6.6 Hz, 3H, CH(C8H3)2); 13C NMR (125 MHz, CDCl3)
d 198.6, 165.3, 162.5, 149.4, 143.3, 139.3, 135.6, 135.3, 134.9, 134.4, 133.2, 132.8,
129.8, 129.0, 128.4, 127.9, 127.1, 119.8, 110.7, 83.3, 73.1, 54.8, 52.8, 47.4, 39.3, 35.6,
30.1, 26.9, 25.5, 23.9, 22.6, 19.6, 17.0.
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Diene 61.  To a solution of diene 42 (317 mg, 0.87 mmol) in 3 mL of DMF was
added imidazole (147 mg, 2.1 mmol) followed by TBSCl (156 mg, 1.04 mmol).  The
solution was stirred for 3 hours at room temperature.  Saturated NH4Cl solution was
added to the reaction, and the mixture was then partitioned.  The organic extracts were
washed with 3 x 10 mL of Et2O, brine, dried over Na2SO4, filtered, then concentrated in
vacuo.  The resultant crude oil was purified by silica gel chromatography (10%
EtOAc/Hexanes) to afford the title compound as a clear colorless oil in 93% yield (380
mg): IR (film) 2935, 2858, 1614, 1468, 1429, 1251, 1104 cm-1; 1H NMR (300 MHz,
CDCl3) d  7.73-7.70 (m, 4H, ArH), 7.49-7.38 (m, 6H, ArH), 6.53 (d, J=11.4 Hz, 1H,
TBDPSOCH=CHHC=C(CH3)CH2),  6.05 (dd, J =11.4 ,  11 .4  Hz,  1H,
TBDPSOCH=CHHC=C(CH3)CH2), 5.64 (d, J=11.4 Hz, 1H, TBDPSOCH=CHCH), 3.67
(t, J=7.2 Hz, 2H, CH2OTBS), 2.22 (t, J=7.2 Hz, 2H, TBSOCH2CH2C=C), 1.70 (s, 3H,
Ph2(CH3)3CSiOCH=CHHC=C(CH3)CH2), 1.11 (s, 9H, OSiC(CH3)3Ph2), 0.89 (s, 9H,
OSiC(CH3)3Ph2), 0.05 (s, 6H, OSi[C(CH3)3](CH3)2); 13C NMR (75 MHz, CDCl3) d 143.5,
135.6, 132.8, 130.6, 130.2, 128.1, 122.3, 110.7, 62.5, 43.6, 26.8, 26.4, 19.5, 18.5, 17.3, -
4.8.
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Bicycle 63.  A solution of maleic anhydride (15 mg, 0.15 mmol) and diene 61 (25
mg, 0.52 mmol) in toluene (0.1 mL) was heated to 110 °C for 5 hours.  The reaction was
then concentrated in vacuo, and the resultant residue was purified by silica gel
chromatography to afford the title compound as an oil in 57% yield (49.4 mg): IR (film)
1789, 1720, 1600, 1425, 1360, 1120 cm-1; 1H NMR (500 MHz, CDCl3) d 7.78-7.09 (m,
10H, ArH), 5.69 (d, J=9.9 Hz, 1H, C4H), 5.38 (dd, J=4.8, 9.9 Hz, 1H, C3H), 4.55 (dd,
J=5.0, 5.9 Hz, 1H, C2H), 3.75 (t, J=6.6 Hz, 2H, C9H2), 3.32 (dd, J=6.0, 9.3 Hz, 1H,
C1H), 3.14 (d, J=9.3, 1H, C6H), 2.37 (ddd, J=6.9, 6.9, 13.5 Hz, 1H, C8H), 2.02 (ddd,
J=6.8, 7.8 Hz, 1H, C8H), 1.08 (s, 3H, C7H), 1.01 (s, 9H, OSi[C(CH3)3](CH3)2) 0.84 (s,
9H, OSiC(CH3)3Ph2), 0.04 (s, 6H, OSi[C(CH3)3](CH3)2); 13C NMR (125 MHz, CDCl3)
d 170.5, 169.8, 139.8, 136.5, 135.4, 130.3, 127.7, 125.9, 62.1, 60.0, 49.0, 46.9, 40.7, 31.8,
26.8, 26.2, 22.9, 19.2, 14.3, -5.2; HRMS (FAB+) exact mass calculated for (C33H46O5Si2)
requires m/z 579.2962, found m/z 579.2967.
nOe analysis used to determine relative stereochemistry:
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Diester 64.  To a solution of cyclohexadiene 63 (7.6 mg) in 0.5 mL of methanol
was added triethylamine (4 mL).  The solution was stirred for 3 hours, then quenched with
1M NaHSO4 solution (0.1 mL).  The mixture was partitioned and the aqueous extracts
were washed with EtOAc. The organic extracts were washed with 3 x 10 mL of EtOAc,
brine, dried over Na2SO4, filtered, then concentrated in vacuo.  The resultant crude oil
was purified by silica gel chromatography (10% EtOAc/Hexanes) to afford the title
compound as a clear colorless oil in 90% yield (7.3 mg): IR (film) 2950, 2858, 1746,
1429, 1197, 1104 cm-1; 1H NMR (500 MHz, CDCl3) d 7.76-7.36 (m, 10H, ArH), 5.62 (d,
J=10.5 Hz, 1H, C4H), 5.44 (dd, J=2.7, 10.3 Hz, 1H, C3H), 4.44 (m, 1H, C2H), 3.76 (m,
2H, C9H2), 3.69 (s, 3H, CO2CH3), 3.66 (s, 3H, CO2CH3), 3.07 (dd, J=4.2, 5.0 Hz, 1H,
C1H), 2.70 (d, J=4.2, 1H, C6H), 2.00-1.92 (m, 1H, C8H), 1.63-1.53 (m, 1H, C8H), 1.13
(s, 3H, C7H), 1.02 (s, 9H, OSi[C(CH3)3](CH3)2), 0.88 (s, 9H, OSiC(CH3)3Ph2), 0.05 (s,
6H, OSi[C(CH3)3](CH3)2); 13C NMR (125 MHz, CDCl3) d 172.5, 171.9, 136.4, 135.7,
134.1, 129.9, 127.8, 126.2, 67.0, 59.9, 51.8, 51.7, 46.1, 40.0, 36.3, 28.7, 27.1, 26.2, 19.4,
18.5, -5.1; HRMS (FAB+) exact mass calculated for (C35H51O6Si2) requires m/z 623.3224,
found m/z 623.3222.
